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ABSTRACT 
 
Background & Aims 
Endurance exercise can cause immunosuppression and increase the risk of upper 
respiratory illness (URIs). The exercise-induced stress response exhibits effects on 
circulating immune cell concentrations and their functional characteristics. The purpose of 
this thesis was to assess the effect of exercise-induced stress on the immune system. 
Specifically, cellular and cytokine components were of high importance. The form of 
exercise employed was prolonged, heavy-intensity cycling bouts, chosen to produce large 
changes in cellular redistribution (ingress and egress). The immediate, stress-induced 
changes, and the subsequent changes during the recovery period post-exercise were 
analysed, following single and repeated bouts of exercise.  
 
Methodology 
Three studies were designed to examine the effect of prolonged (1.5 – 2 h), heavy-intensity 
(above anaerobic threshold) exercise on the immune system. Ten subjects were recruited 
for Studies One (mean ± SEM: age 24.2 ± 1.7 yr; height 1.82 ± 0.02 m; body mass 73.8 ± 
2.0 kg; peak oxygen uptake 65.9 ± 2.3 ml.kg-1.min-1), Two (mean ± SD: age 24.0 ± 4.1 
years; height 1.81 ± 0.05 m; body mass 73.3 ± 5.8 kg; peak oxygen uptake 60.7 ± 4.6 
mL.kg-1.min-1), and Three (mean ± SD: age 23.2 ± 3.2 years; height 1.82 ± 0.06 m; body 
mass 74.8 ± 6.2 kg; peak oxygen uptake 59.0 ± 4.3 mL.kg-1.min-1). These three studies 
examined the effect of single and repeated bouts of prolonged, heavy-intensity cycling 
exercise on secretion of T helper cell-related cytokines following mitogen stimulation, and 
immune cell redistribution. Cytokines analysed were; IL-2, IL-4, IL-6, IL-10, TNF, IFN-γ, 
and IL17-A, and cells examined included; neutrophils, lymphocytes, monocytes, γδ T cells 
(and their subsets, memory phenotypes, and specific receptor expression), and dendritic 
cells (and their phenotypes). Focus was directed to both the initial, exercise-induced effect, 
as well as the subsequent recovery period post-exercise (>6 h post-exercise). Analysis was 
performed via flow cytometry. Analysis of cytokines was completed using a cytometric 
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bead array following mitogen stimulation with either phytohaemagglutinin (PHA) (Study I) 
or phorbol 12-myristate 13-acetate (PMA) and ionomycin (Study III). Cell populations 
were identified and quantified with the use of monoclonal antibodies bound to fluorescent 
dyes. Data were analysed using both traditional statistics and magnitude-based inferences.  
 
Results 
Qualitative analysis revealed post-exercise changes in concentrations of plasma cortisol, 
IL-2, TNF, IL-4, IL-6, IL-10, and IL-17A compared to pre-exercise values. A Th1/Th2 
shift was evident immediately post-exercise. Furthermore, for multiple cytokines 
including; IL-2 and TNF (Th1), IL-6 and IL-10 (Th2), and IL-17 (Th17) no meaningful 
(magnitude-based inference) change in concentration occurred until more than 4 hours 
post-exercise, highlighting the duration of exercise-induced changes in immune function. 
Study II demonstrated a significant decrease in the circulating concentration of γδ T cells 
and the δ2 subset up to 4 h post-exercise. Phenotypical differentiation revealed a 
significant decrease in circulating naïve and central memory δ2 cell concentrations. 
Additional analysis revealed preferential egress out of circulation of γδ T cells expressing 
CD11ahigh and CD62Lhigh. Finally, a significant decrease was evident in circulating total 
dendritic cell concentration at 1 h post-exercise, together with decreases in circulating 
myeloid dendritic cells and CD14-/lowCD16+ dendritic cells up to 2 h post-exercise. 
Additionally, Study IIIA showed significant increases in stimulated cytokine 
concentrations (compared to pre-exercise) of Th1 cytokine; IL-2, and Th2 cytokines; IL-4 
and IL-10. When adjusted for total leucocyte concentration at each time point, a significant 
increase from pre-exercise was observed in Th1 cytokines; IL-2, TNF, and IFN-, and Th2 
cytokines; IL-4 and IL-10. However, there were no significant differences between the 
single and repeat exercise bout trials at any time point. Finally, Study IIIB revealed a 
significant exercise-induced increase in circulating concentrations of total lymphocytes, 
neutrophils, total γδ T cells, δ1 and δ2 subsets, total dendritic cells, and the plasmacytoid 
dendritic cells. Furthermore, among the γδ T cells, those with high expression of CD11a 
and CD62L were preferentially mobilised. However, no significant differences were 
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observed between the single and repeated exercise trials for any variable, except total 
circulating lymphocyte and neutrophil concentrations.  
 
Conclusion 
The results of the present thesis were hoped to be two-fold; 1) expand the knowledge base 
for a number of novel immune markers previous unexamined under severe, prolonged 
stress stimuli, and 2) provide further evidence of how repeated immune stimulation may be 
detrimental to healthy immune function when recovery between sessions is not sufficient. 
The first aim provided fairly expected results;  T cells were highly responsive to 
exercise-induced stress, as were DCs. Furthermore, cytokine production via whole blood or 
PBMC stimulation appeared to be enhanced following exercise bouts. The second aim 
however, resulted in some unexpected effects. Primarily, that repeated exercise did not 
result in a “carry-on” effect from the first exercise bout to the second may suggest repeated 
exercise with minimal recovery may not be as detrimental to cellular components of 
immune function as previously thought, provided there is adequate energy intake between 
sessions. Together, these results highlight the multifactorial nature of both; the stress 
response, and the immune system with its complex interactions of proteins, cells and 
structures functioning together to defend the host against invading pathogenic agents. 
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1. INTRODUCTION 
 
Heavy-intensity prolonged aerobic exercise regularly completed by endurance athletes is 
associated with transient changes in immune function, circulating leucocyte concentrations, 
and an increased risk of symptoms associated with upper respiratory illnesses (URIs) [1-5]. 
While many uncertainties remain, a rapid growth in the peer-reviewed publications since 
the mid 1980’s has vastly increased the scope and understanding of the immune system’s 
response to exercise. Originally, many studies utilised epidemiological evidence to identify 
an association between exercise “dose” and an increased incidence of symptoms associated 
with URIs. Later research, often measuring the concentration of specific leucocyte subsets 
in the peripheral circulation, noted an exercise-induced leucocytosis, influenced by the 
intensity and duration of the exercise. Additionally, studies examining particular 
interventions to improve immune system health and recovery from exercise, and studies 
charting the immunological impact of exercise stress on a larger scale have been 
undertaken. A great deal of knowledge has been amassed in the last thirty years. However, 
with all areas of research, the more knowledge that is discovered, the more one realises the 
dearth of knowledge still to be uncovered.  
The immediate ingress of leucocytes in response to stress and/or exercise has been of great 
importance in exercise immunology research. However, less examination has surrounded 
the subsequent period following the cessation of the exercise-induced stress. This recovery 
period is important, as during this time changes in circulating stress hormone 
concentrations, leucocyte concentrations, and cellular function occur, each of these 
potentially causative agents in the exercise-induced increase in symptoms associated with 
URIs. Furthermore, the long-standing ‘open-window’ theoretical framework (discussed 
Chapter 1.3) suggests that it is during the period immediately following exercise that the 
immune system is most susceptible to invasion from infectious agents. Throughout this 
thesis, the immune system “recovery period” will be regarded as the time following the 
cessation of an acute stressor when cellular redistribution is occurring, until the point of 
where circulating cell concentration returns to resting levels. 
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The purpose of this research is to monitor immune system of highly trained cyclists in 
response to acute bouts of prolonged heavy-intensity exercise, and examine a number of 
important immune variables during the post-exercise recovery period. 
In Chapter One, the literature review will examine the neuroendocrine and immunological 
response to stress and exercise with a particular focus on prolonged heavy-intensity 
exercise. Prolonged-intensity heavy exercise will be defined as exercise lasting one and a 
half hours or greater at or above the heavy-intensity exercise domain (i.e., above the 
anaerobic threshold). A number of cell types will be reviewed including lymphocytes and 
their subsets (mediating both innate and adaptive immunity), dendritic cells (DC) (immune 
system regulation) and neutrophils (early-onset innate immunity). Regulation of the 
immune system by neuroendocrine and cytokine mediators will also be discussed. Finally, 
the influence of repeated exercise bouts on the immune system, during activation and the 
recovery period will be considered. All the above will be considered in the context of the 
increased rate of symptoms associated with URIs during periods of heavy training and 
competition. 
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1.1 Upper Respiratory Illnesses in Endurance Athletes 
Upper respiratory illnesses, often referred to as the common cold, are characterised by an 
inflammation of the upper respiratory tract. Symptoms presented including cough, sore 
throat, runny nose, head ache, nasal congestion, low grade fever, sinus pressure and 
sneezing. Illness generally lasts 7-10 days, with symptoms presenting 1-3 days after the 
exposure to the pathogen. It has been suggested that the pathogenic nature of URI is 
predominantly viral, with a small percentage of cases (~10%) caused by bacterial 
infections [6-8]. While athletes regularly present with upper respiratory symptoms (URS) 
[9, 10], debate still remains whether symptoms such as a ‘sore throat’ are always indicative 
of a URI, or rather airway inflammation without infection [11, 12]. This is due to the 
considerable cost and time required for identifying the underlying cause by a pathologist. 
Regardless of the underlying cause, any URS are likely to interrupt an athlete’s training 
schedule, impeding their ability to train and compete optimally. Previous research in 
overtraining has demonstrated URS are associated with significant persisting fatigue and 
poor performance [13-17]. 
Endurance athletes regularly undergo significant physiological stress caused by large 
training volumes and high training intensities. Training may occur multiple times per day, 
every day of the week, resulting in repetitive stress-induced activation of the immune 
system [18-20]. This is important, particularly in the context of ‘peaking’ for competition, 
as increased rates of symptoms associated with URIs have been reported during periods of 
heavy training and competition. While many anecdotal reports circulate, suggesting 
symptoms associated with URIs are more common in elite athletes, very little documented 
evidence exists. Comparison between elite and general populations have highlighted that 
elite athletes experience URI symptoms at a similar rate to the general population [21-23], 
however differences remain in their temporal occurrence. While the general population 
exhibits the normal seasonal pattern, elite athlete symptoms associated with URIs appear to 
be much more prevalent during or around competitions [8, 24-26]. More frequent 
exhibition of URS appear to occur during periods of heavy training, the taper period, and 
following competition [8, 13, 14, 26-28].  
A dose–response relationship has been observed between training volume and the 
incidence of symptoms associated with URI. For example, a year-long study of 530 
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runners found that those who trained less than 778 km per year had an average of 1.2 
episodes of URI per year compared with runners who trained 778–1384 km per year who 
experienced two episodes, and runners who trained >1384 km who had 3.5 episodes per 
year [29]. In support of these findings Nieman et al. (1990) found that runners who 
exercised >97 km per week were twice as likely to display symptoms of URI compared 
with those who trained <32 km per week in the two months before a marathon. A similar 
incidence of symptoms associated with URI was also found in three studies involving 
ultramarathon runners, where the incidence of symptoms associated with URI was 
significantly higher in athletes following an ultramarathon event than in sedentary 
individuals [8, 30, 31]. A higher rate of symptoms associated with URI was also found in 
elite swimmers during four weeks of intense training [32], in elite hockey players during an 
intense 10-day training camp [5], in elite squash players during a 10-week training block 
[5], and in elite swimmers following a 12-week training cycle [3]. In contrast, another 
study failed to identify any relationship between an increased risk of contracting a URI 
following a marathon in a cohort of almost 1700 runners. However, these researchers 
found that athletes who had displayed symptoms associated with URI in the three weeks 
preceding the marathon had twice the chance of experiencing a second URI episode after 
the race compared with those athletes who had not reported URI symptoms in the three 
weeks before the race [33].  
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1.2 Overreaching, Overtraining, and Underperformance 
Immune systems perturbations, risk of URI, and the effects of overtraining on performance 
are regularly discussed in tandem [13-17, 34-37]. The process of intensifying training is 
commonly used by athletes in an attempt to enhance performance. However the 
combination of excessive overload with inadequate recovery should be avoided. As a 
consequence, the athlete may experience acute feelings of fatigue and decreases in 
performance as a result of a single intense training session or an intense training period 
[38]. Under normal healthy training, the resultant acute fatigue after a training session can 
be alleviated by adequate rest period. This may be followed by a positive adaptation or 
improvement in performance; this is the basis of effective training programs. However, if 
the balance between appropriate training stress and adequate recovery is disrupted, an 
abnormal training response may occur and a state of overreaching (OR) may develop [39]. 
When athletes do not sufficiently respect the balance between training and recovery, non-
functional overreaching (NFOR) can occur. If not managed properly, more severe 
overtraining (OT) can develop. Both NFOR and OT includes maladaptations and 
diminished competitive performance [40]. As mentioned above, previous research has 
highlighted an increased presentation of symptoms associated with URI during periods of 
heavy training and competition [8, 13, 14, 26-28]. This is when NFOR or overtraining are 
likely to occur. One of the hallmarks of overreaching and overtraining is underperformance 
[38, 40, 41]. Of course, in professional athletes underperformance can be detrimental to 
one’s career, and can be compounded by bouts of URI. While, the increased presentation 
of symptoms associated with URI and NFOR/OT are not the same phenomenon, it is 
important to note the similar underlying causes. And while, NFOR/OT may not necessarily 
result in an increase in URI, and URI episodes are not always an indication of NFOR/OT, 
they both do occur during periods of heavy training, competition, and can result in 
underperformance. 
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1.3 The ‘J’ Curve & ‘Open Window’ Theories 
The high frequency of illness that some elite athletes experience may cause major 
interruptions in training continuity and performance ability during competition. The 
relationship between exercise and infection risk can be illustrated by the ‘J’ curve [42], 
suggesting that individuals engaging in moderate physical activity have a decreased chance 
of displaying symptoms associated with URI compared with sedentary individuals [25]. 
However, an excessive training workload (both training volume and intensity) may 
increase the risk of contracting a URI [3, 21, 29, 32]. More recently, the ‘J’ curve theory 
was altered to a proposed ‘S’ curve relationship between training load and risk of infection 
[43]. This proposed modification reflected the separation of ‘high’ and ‘elite’ exercise 
loads when examining sick days per year in research previously published, where a 
decrease in infection risk is observed in elite athletes compared to highly trained athletes. It 
was suggested that to compete at the elite level athletes require not only a state-of-the-art 
physique, but an immune system able to withstand infections even during sever 
physiological and psychological stress.  
 
 
 
 
 
 
 
 
 
Figure 1.1. Modified version of the ‘J’ curve and ‘S’ curve of infection risk vs. physical activity [42, 43] 
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this when planning increases in intensity and/or duration of training, as it is during these 
periods of increased total work when the athletes are most at risk [8, 24-26]. These 
occurrences of symptoms associated with URI are believed to be related to 
immunosuppression explained by the ‘open window’ theory as represented in Figure 1.2. 
 
Although potentially now an out-of-date concept due to advancements in exercise and 
stress immunology, the ‘open window’ theory suggests that, in the hours following 
strenuous endurance exercise, suppression of some immune variables may cause the host to 
be more susceptible to pathogens that have entered the body [44]. This was hypothesised 
due to changes identified in lymphocyte concentrations, natural killer (NK) cell function 
and NK cell concentration, and secretory immunoglobulin A (sIgA) levels in the hours 
following exercise, possibly causing an increased risk of contracting a URI. While the 
concept still remains in exercise immunology, placing the ‘blame’ on a functional decrease 
in a single immune variable appears narrow, considering the size and relationship among 
the immune system’s many variables. 
 
 
 
 
 
 
 
 
 
Figure 1.2. The ‘open window’ theory of immunosuppression [44] 
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The following sections contain a brief overview of the immune system, including changes 
in immune variables number and function, and regulation of these systems in response to 
acute bouts of endurance exercise. 
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1.4 The Immune System 
Our environment is heavily populated by both pathogenic and non-pathogenic microbes, 
containing a vast array of potentially toxic or allergenic substances that threaten normal 
homeostasis. A huge range of pathogenic microbes replicate and spread by a diverse 
collection of mechanisms, threatening normal host functions [45]. To combat this threat, 
the immune system uses a complex array of protective mechanisms to control and usually 
eliminate these organisms and toxins. These protective mechanisms rely on detecting 
structural features of the pathogen or toxin that mark it as distinct from the host cells. Such 
discrimination between structures is essential to permit the host to eliminate the threat 
without damaging its own tissues [46]. The immune system is composed of various tissues, 
cells, and molecules involved in the defence of the body against infectious agents [47]. 
This occurs by identifying pathogens and destroying such agents [48].  
 
1.4.1 Innate & Adaptive Immune Responses 
The immune system can be divided into two sub sections: the innate (non-specific) 
immune response and adaptive (specific) immune response. The innate immune response is 
regarded as the body’s “first line of defence” against pathogens and is immediately 
available to combat a wide range of micro-organisms, in addition to tissue damage, repair, 
and remodelling [45]. Because the recognition molecules used by the innate system are 
expressed broadly on a large number of cells, this system is able to act rapidly after an 
invading pathogen or toxin is encountered. Conversely, the adaptive immune system 
develops a specialised response to an identified pathogen, exhibiting exquisite specificity 
for epitopes (recognised part of antigen identified by antibodies, T cells and B cells) of 
individual pathogens [49]. 
The innate immune system is composed of physical barriers such as epithelial cell layers 
that express tight cell-cell contacts, the secreted mucus layer that overlays the epithelium in 
the respiratory, gastrointestinal and genitourinary tracts, and the epithelial cilia that sweep 
away this mucus layer [46]. The innate response also includes soluble proteins and 
bioactive small molecules such as the complement proteins, defensins, and ficolins, 
cytokines, chemokines, lipid mediators of inflammation, reactive free radical species, and 
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bioactive amines and enzymes [46]. Major cells of the innate immune system include 
neutrophils which are “first-line” defenders against bacterial infection, dendritic cells 
which serve to orchestrate immune responses, macrophages that perform important 
phagocytic, regulatory and antigen presentation functions, and NK cells which recognize 
altered host cells (e.g. virally infected or transformed) [50].  
In contrast to the innate immune system, the adaptive system is composed of small 
numbers of cells with specificity for any individual pathogen, toxin or allergen. Cells 
responding to a pathogen must proliferate to attain sufficient numbers to mount an 
effective response [47]. It is because of this mounted response that the adaptive immune 
system response generally expresses itself temporally after the innate response in host 
defence [45]. A key feature of the adaptive response is that it produces long-lived cells. 
These cells exist in an apparent dormant state, but can re-express effector functions rapidly 
after another encounter with their specific antigen [46]. Essentially, this means the adaptive 
response possesses the ability to manifest immunological “memory”. This immune 
memory allows a more effective host response against specific pathogens or toxins when 
they are encountered a second time [51]. It is a response that manifests exquisite specificity 
for its target antigens. Antigen-specific receptors of the adaptive response are encoded to 
allow the assembly of antigen receptors from a collection of a few hundred germ-line-
encoded gene elements [46]. This permits the formation of millions of different antigen 
receptors, each with potentially unique specificity for a different antigen. The adaptive 
immune system response is mediated primarily by T and B lymphocytes and soluble 
proteins called immunoglobulins [50].  
 
1.4.2 Primary & Secondary Lymphoid Tissues 
Leucocytes may be found in the body distributed as single cells in the tissues and 
circulation, as lymphoid accumulations (e.g., Peyer’s patches), or within lymphoid organs 
(e.g., thymus, spleen, lymph nodes). Organs of the immune system are classified as 
primary or secondary lymphoid organs. Primary lymphoid organs; the thymus and bone 
marrow, are the site for development of lymphocytes. The secondary lymphoid organs 
(e.g., spleen, lymph nodes, lymphoid accumulations) trap and concentrate immunogens in 
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addition to providing sites where large numbers of circulating immune cells can make 
contact with each other [52].  
The primary lymphoid organs, the thymus and bone marrow, serve as lymphocyte 
maturation centres. Although all lymphocytes originate within the bone marrow, those 
committed to the T-cell lineage migrate via the circulation to the thymic cortex. These 
cortical thymocytes acquire T-cell receptors (TCRs), and CD4 and CD8 surface molecules. 
Other lymphocytic lineage cells remain within the bone marrow, destined to become 
immunoglobulin-producing lymphocytes undergo their early stages of differentiation 
within the bone marrow to become B cells [47].  
Secondary lymphoid tissues function as filtration devices removing foreign matter, dead 
cells, and protein aggregates from the circulation. The major secondary lymphoid organs 
are the spleen and lymph nodes. The tonsils and Peyer’s patches also act as secondary 
lymphoid accumulations [47]. These organs are richly supplied with blood and lymphatic 
vessels facilitating movement of lymphocytes, monocytes, and dendritic cells into and out 
of the tissues. Specialized regions of the vasculature, called high endothelial venules 
(HEVs), allow movement of cells between the blood and these secondary lymphoid tissues 
[53, 54]. These secondary lymphoid tissues facilitate cellular interaction, providing 
leucocytes an environment in which they can exchange regulatory signals, undergo further 
development, and proliferate before re-entering the circulation [45].  
 
1.4.3 Lymph Nodes & Lymphocyte Trafficking 
The trafficking of immune cells in lymph nodes has a crucial role in immunity. Throughout 
the human body are hundreds of lymph nodes (~450), essential for the encounter of 
circulating naïve lymphocytes with antigens and antigen-presenting cells (APCs) [55]. 
These small round or oval-shaped secondary lymphoid organs are the site of leucocyte 
accumulations occurring periodically throughout the lymphatic circulatory system. They 
function as filters to purify lymph, the fluid and cellular content of the lymphatic 
circulatory system, and provide sites for mingling of lymphocytes, monocytes, and 
dendritic cells for initiation of immune responses [52]. Recirculation of lymphocytes 
through lymph nodes allows naïve lymphocytes specific for a given antigen to survey the 
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lymph throughout the body for the presence of their target antigen [46]. During 
homeostasis, lymphocytes continuously recirculate from the blood to lymphoid organs and 
back to the blood as often as once or twice per day [56]. This recirculation and migration 
(or ‘homing’) of lymphocytes between the blood and lymph nodes occurs via HEVs [53, 
54]. Essentially, the trafficking of lymphocytes is a three step process. Initially, naïve B 
and T cells are transported through HEVs or afferent lymphatics via an adhesion cascade 
[53, 54]. Secondly, specific intranodal migration and positioning where T cells migrate to 
the lymph node paracortex, whereas B cells enter the B cell follicles in the cortex. Finally, 
egress via efferent lymphatics. If ‘visiting’ lymphocytes do not recognize their specific 
antigen, they leave the lymph node through the efferent lymphatic vessel and return to the 
circulation through the thoracic duct [57, 58].  
 
1.4.4 Adhesion Molecules 
Adhesion molecules are essential in leucocyte redistibution to secondary lymphoid tissues 
and to peripheral tissue sites of microbial invasion [47]. To maintain adequate host 
defence, cellular adhesion molecules and chemotactic proteins both contribute importantly 
to this process [51]. Three main families of cell adhesion proteins exist: selectins, integrins, 
and Ig domain cell adhesion molecules [46]. While mediating cell recruitment to tissues as 
their primary function, these molecules contribute to cell-cell interactions between 
leucocyte subsets and can contribute to intercellular and intracellular signalling [45]. 
Selectins are expressed on the surfaces of all leucocytes and on endothelial cells [46]. In 
addition, ligands for selectins are also present on all leucocytes. Low affinity interactions 
between selectin ligands on leucocytes and selectins on vascular endothelium lead to 
rolling of cells along the vessel wall, allowing cells to ingress into circulation and be 
transported [47]. Furthermore, the combined effects of integrins and Ig domain cell 
adhesion molecules allow leucocytes to adhere firmly to the endothelium when required 
[47]. Together, adhesion molecules allow for precise control of leucocytes during cellular 
redistribution.  
 
 53 
1.4.5 Cluster of Differentiation 
An intact immune response includes contributions from many subsets of leucocytes. The 
different leucocyte subsets can be discriminated morphologically by analysis of the 
spectrum of glycoprotein differentiation antigens that are displayed on their cell 
membranes [46]. These differentiation antigens are detected by their binding of specific 
monoclonal antibodies [47]. These cell phenotype-determining antigens are assigned 
cluster of differentiation (CD) numbers. There are over 350 defined CD antigens [59].  
 
1.4.6 Major Histocompatibility Complex & Antigen Presentation 
As part of normal function, the immune system is required to identify host cells that have 
been infected by microbes. If left to their own devices, these microbes will use the cell to 
multiply within the host. These infected cells that serves as a “factory” for production of 
progeny microbes must be identified and destroyed. A major role of the adaptive immune 
system is to identify and destroy infected cells [47]. Along with identification of infected 
cells, T cells can recognize peptide fragments of antigens displayed by APCs [45]. In order 
for T cells to recognise infected host cells, the immune system must differentiate “self” 
from “non-self”. This is solved by the use of major histocompatibility complex (MHC) 
molecules. MHC molecules are cell surface glycoproteins that bind peptide fragments of 
proteins that either have been synthesized within the cell (class I MHC molecules) or that 
have been ingested by the cell and proteolytically processed (class II MHC molecules) 
[51]. MHC class I and class II molecules are similar in function: they present peptides at 
the cell surface to CD8+ and CD4+ T cells, respectively [60]. As such, these molecules are 
essential for specific host defence. 
 
1.4.7 Neutrophils 
Neutrophils are large granulocytes produced and matured in the bone marrow that form 
part of the innate immune system [47]. The process of eliminating an invading pathogen 
involves the phagocytosis (engulfing) of the micro-organism followed by the destruction 
by lysosomes and the respiratory burst, through the NADPH-oxidase system [49]. 
Neutrophils account for 60–70% of all circulating leucocytes [61]. Neutrophils are 
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recruited early to the site of infection functioning to stop an invading pathogen from 
replicating inside the host. This occurs via penetration of the vascular endothelium by the 
neutrophil, moving into the tissues at the site of infection [49]. The process of 
phagocytosis, by which neutrophils identify and destroy pathogens involves transduction of 
the neutrophil plasma membrane and cytosolic constituents, and activation of the NADPH-
oxidase complex to produce reactive oxygen species targeted at the now phagocytosed 
pathogen to destroy it.  
 
1.4.8 Dendritic Cells 
Dendritic cells function as “professional” APCs which play a critical role in the regulation 
of the adaptive immune response. These cells are referred to as “professional” APCs 
because their principal function is capturing antigens, processing, and presenting them, and 
because only DCs have the ability to induce a primary immune response in naïve T 
lymphocytes [62]. Additionally, DCs are critical in establishing immunological memory by 
the maintenance of B cell function and recall responses [62]. DCs are able to activate both 
CD4+ and CD8+ T cells via antigen presentation [47]. Immature DCs originate in the bone 
marrow and migrate throughout the body waiting to interact with invading pathogens. 
These cells undergo a maturation process once they exit the circulation, into the tissue [63]. 
Once captured, an antigen is processed by a number of potential pathways. For MHC class 
I presentation to stimulate CD8+ cytotoxic T cells, the antigen (or protein) is engulfed by 
phagocytosis or receptor mediated endocytosis into the cytosol of the DC. The antigens are 
further degraded in the cytosol via proteasomes and enter the endoplasmic reticulum where 
peptides bind to MHC class I molecules newly produced for presentation on the cell 
surface [52]. For MHC class II presentation to stimulate CD4+ T helper cells, rather than 
by phagocytosis or receptor-mediated endocytosis in to the cytosol, the antigen or protein 
is taken up to endosomes where proteolysis occurs. The peptides enter a vesicle containing 
MHC class II where they bind and are transported to the cell surface [64]. 
DCs are derived from hematopoietic stem cells; however, they can originate from both 
lymphoid and myeloid lineages. In humans, myeloid lineage DCs (HLA.DR+/lin-/CD11c+ - 
mDCs) are considered the “classical” DC. Myeloid DCs originate from myeloid committed 
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CD34+ progenitor cells and monocytes. These cells can be stimulated to convert to mDCs 
in the presence of cytokines; GM-CSF, TNF, and IL-4 [63, 65-70]. These mDCs are 
capable of activating naïve CD4 and CD8 T cells, and inducing differentiation of naïve B 
cells to antibody secreting plasma cells [71]. By contrast, plasmacytoid DCs 
(HLA.DR+/lin-/CD123+ - pDCs) originate from CD34+ cells committed to the lymphoid 
lineage [65, 66]. These pDCs are CD11c- and are stimulated to become pDCs by IL-3 [72]. 
These DCs have the capacity to produce IFN-α, are closely involved in regulatory T cell 
and cytotoxic T cell activation, and reside in the T cell compartment of lymphoid tissues 
[73]. Finally, CD16+ DCs (HLA.DR+/lin-/CD11c+/CD16+) are derived from monocytes, 
and activate T helper (Th) cells in an allogeneic fashion [65, 74]. Less is known about this 
miniscule population of mDC-related dendritic cells [71, 75]. Together, these cells play a 
crucial role in initiating and regulating both cellular and humoral immune responses. 
 
1.4.9 Lymphocytes 
 
T-cells and B-cells are lymphocytes involved in adaptive immunity, derived from the bone 
marrow lymphoid progenitor which bear variable cell-surface receptors used to identify 
and bind onto antigens (described below) [47]. T and B lymphocytes constitute 
approximately 20% of all circulating leucocytes and serve a wide variety of immune 
functions, including initiation of immune responses, production of cytokines and 
antibodies, cytotoxicity and memory of previous antigens [76]. 
 
Thymus-derived T cells account for approximately 70% of all lymphocytes (including NK 
cells) in the circulation. The major class of T cells is defined by its surface expression of 
the αβ TCR [47]. This receptor has evolved primarily to recognize peptide antigens 
presented in a complex with class I or class II MHC proteins [46]. αβ-T cells differentiate 
into several different subsets, CD4+ T cells (predominantly T helper cells) or CD8+ T cells 
(cytotoxic T cells) [47]. Cytotoxic T cells act primarily to kill cells infected with 
intracellular microbes, whereas Th cells act primarily to regulate the cellular and humoral 
immune responses. With only a few exceptions, the acquired immune response is initiated 
by APCs presenting an antigen to the Th cell within the peptide binding groove of MHC 
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class II molecules [45]. Primary functions of Th cells include forming a key part of the 
cell-mediated immune response, which involves cytokine secretions which activate further 
immune responses, and termination of infected cells by cytotoxic T-cells [49]. In addition 
to CD4 and CD8, T cells can be further defined according to the presence of CD45RA, 
CCR7, CD27, and CD28. As these cells mature, naïve T cells can differentiate into effector 
memory and central memory subsets. These subset changes reflect functional differences 
found under varying conditions. During active antigenic stimulation (e.g., during primary 
viral infection), effector memory phenotypes are able to eliminate viruses or tumours by 
different effector functions. In contrast, central memory T cells remain present in the 
absence of antigenic stimulation and have the capacity to expand rapidly upon secondary 
challenge [77]. 
Approximately 5–10% of T cells in the peripheral blood, lymph nodes, and spleen are 
CD4−CD8−. Some of these cells use αβ TCR and others use γδ TCR. γδ T cells have been 
labelled ‘the bridge between innate and adaptive immunity’, playing an important role in 
early immune responses to a variety of pathogens [78]. Displaying a wide array of 
functions including MHC-independent activation, T cell receptor-dependent recognition of 
antigens, and professional antigen presentation, while possessing protective memory and 
reactive memory capabilities [78, 79]. γδ T cells constitute only 1-5% of T lymphocytes in 
the blood stream in humans and mice [80]. These cells are, however, found in abundance in 
the epithelia of skin, genital, intestinal and respiratory tracts, highlighting their importance 
as an early responder to invasion [81-83]. Two major subsets (δ1 and δ2)—can be divided 
into four memory phenotypes (according to the presence of CD45RA and CD27)— known 
as naïve (CD45RA+/CD27+), central memory (CD45RA-/CD27+), effector memory 
(CD45RA-/CD27-) and terminally differentiated effector memory (CD45RA+/CD27-) 
phenotypes [84-87]. These memory phenotypes reflect functionally distinct populations 
based on cell maturity. Naïve cells have never encountered their cognate antigen and lack 
cytotoxic effector functions. Whereas, central memory, effector memory, and terminally 
differentiated effector memory cells are all antigen-experienced [85-88]. As these cells 
mature, characteristics present include greater cytotoxic capabilities and ability to migrate 
to sites of infection with a reduced lymph node migratory potential [85-91].  A number of 
cell surface receptors will be analysed on γδ T cells. These include CD11a, CD62L, and 
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CD94. The surface receptor CD11a is involved in cellular adhesion, and is typically up-
regulated on endothelial cells in the proximity of inflamed tissues [92]. CD62L (also 
known as L-selectin) is also a cell adhesion molecule found on lymphocytes. Specifically, 
it functions as a “homing receptor” for lymphocytes to enter secondary lymphoid tissues 
via HEVs [93]. Essentially, CD62L expression reflects lymph node-migratory potential 
[86]. Finally, the CD94 receptor which is expressed primarily on NK cells and CD8+ T 
cells (in addition to γδ T cells) is involved in innate recognition of aberrant MHC 
expression on infected and cancerous cells, used to stimulate or inhibit cytotoxic activity of 
these cell types[94, 95].  
Finally, B-cells identified by expression of CD19, are involved in the secretion of vast 
amounts of immunoglobulins specific to the antigen that has initiated an immune response. 
This is part of the memory component of adaptive immunity [47].  
 
1.4.10 Cytokines 
Cytokines are a category of low molecular weight proteins (~5-20 kDa) that are important 
in cell signalling [49]. Cytokines act on cells via specific transmembrane cell surface 
receptors, typically by autocrine or paracrine signalling. Binding of the cytokine to the 
receptor elicits its cellular response by activating an intracellular signal transduction 
pathway that ultimately leads to induction of new gene transcription and synthesis of new 
cellular proteins [46]. Cytokines are involved in an array of processes in the body. They 
allow communication between various cell types and tissues, and are involved in the 
inflammatory response during exercise, trauma and infection. This involves the regulation 
by both pro- and anti-inflammatory cytokines. These cytokines can change in response to 
various stimuli (including exercise, trauma, infection, stress) and can influence the activity 
and function of other immune cells and tissues [96-98]. 
The immune system is regulated in part by circulating cytokines that change in 
concentration following various stimuli by paracrine cell-to-cell communication. Pro-
inflammatory cytokines are up-regulated when stress occurs in the body, either during 
exercise, trauma or infection [96]. Major pro-inflammatory cytokines include interleukins 
(IL)-1, IL-6, tumour necrosis factor (TNF), and interferon-gamma (IFN-γ). The effect of 
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these pro-inflammatory cytokines on inflammation can be affected by anti-inflammatory 
cytokines including IL-1ra, IL-4, IL-6, IL-10, IL-11, and IL-13. They can attenuate 
inflammation by restricting pro-inflammatory cytokine production, up-regulating their 
soluble antagonist binding proteins, and suppressing inflammatory cell activity  [99]. 
Activation of different immune response pathways during infection can be explained by the 
Th1 (T-helper cell (CD4+) Type 1)/Th2 (T-helper cell (CD4+) Type 2) cytokine balance 
(Figure 1.3). These T-helper cells regulate different immunological pathways. Resting 
naïve Th cells release very low levels of cytokines. Soon after stimulation by an antigen 
and APC, the Th cells begin to produce IL-2 and are designated Th0. As the Th cells 
continue to respond to the activating signal, they progress towards polar extremes of 
differentiation designated Th1, Th2, and Th17 depending on the nature of the cytokines 
present at the site of activation. The Type 1 pathway of cellular immunity is recruited to 
fight viruses and other intracellular pathogens, whereas the Type 2 pathway up-regulates 
antibody production to fight extracellular organisms as part of a humoral immunity 
response [49]. The Type 1 response involves pro-inflammatory cytokines where an APC 
presenting an intracellular pathogen releases IL-12 which act on NK cells, causing a 
release of IFN-γ. Together, IL-12 and IFN-γ act on naïve T-cells (Th0) to become Th1 
cells. IFN-γ, IL-2, and lymphotoxin (previously known as TNF-β) are released from Th1 
cells to activate the cellular immune response. These cytokines also act as a negative 
feedback mechanism to down-regulate the Th2 response. Conversely, the Type 2 response 
involves anti-inflammatory cytokines, where an APC presenting an extracellular pathogen 
releases IL-6 and IL-10, along with IL-4. This cytokine release drives naïve T-cells to 
become Th2 cells. IL-4, IL-10, and IL-13 are released from Th2 cells to activate the 
humoral immune response. These cytokines also act as a negative feedback mechanism to 
down-regulate the Th1 response [100]. This “balance” between these divergent pathways is 
important for maintaining immune health. Th1 cells drive the type-1 pathway to fight 
viruses and other intracellular pathogens, eliminate cancerous cells, and stimulate delayed-
type hypersensitivity (DTH) skin reactions. Th2 cells drive the type-2 pathway and up-
regulate antibody production to fight extracellular organisms. Over-activation of either 
pattern can cause disease, and either pathway can down-regulate the other [101]. 
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Figure 1.3. Th1/Th2 response (adapted from [100]) 
 
Apart from the Th1/Th2 response, T-helper cells can be differentiated into other cell 
pathways including the Th17 response. The Th17 subset is the first CD4+ subset to be 
generated when mounting a response against infection. When APCs such as dendritic cells 
encounter a pathogen, a number of cytokines including IL-6, transforming growth factor 
(TGF)-β, and IL-23 are released, and act on naïve T-cells. The naïve T-cells then 
differentiate into Th17 cells, releasing IL-17A and IL-17E. These cytokines drive the 
release of chemokines; CXCL8, and CXCL2. This allows release of granulocyte colony-
stimulating factor and granulocyte-macrophage colony-stimulating factor from epithelial 
cells. These chemokines recruit neutrophils directly from the lumen, whereas the colony-
stimulating factors drive proliferation and differentiation of cells in the bone marrow, to 
produce a release of neutrophils and monocytes [49]. Together, these actions allow rapid 
response to early infection. 
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CD8+ T cells also can manifest type 1 and type 2 cytokine responses, in which case the 
cells are designated T cytotoxic cell type 1 (Tc1) and T cytotoxic cell type 2 (Tc2).  
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1.5 Stress, Exercise and Immune Function  
The stress-induced redistribution of leucocytes is a well-documented phenomenon [102]. A 
large portion of exercise immunology literature involves the characterization of changing 
cellular concentrations in the blood in response to various forms of exercise. For the 
purpose of consistency throughout this thesis, an increase in cell concentration of any 
leucocyte population in the blood following a stress response will be defined as cellular 
ingress into peripheral circulation. Furthermore, a decrease in cell concentration of any 
leucocyte population in the blood following a stress response will be defined as cellular 
egress out of peripheral circulation. These two phenomenon will collectively be described 
as cellular redistribution. An integrated definition of stress proposes that “stress is a 
constellation of events, consisting of a stimulus (stressor), that precipitates a reaction in 
the brain (stress perception), that activates physiological fight or flight systems in the body 
(stress response)” (reproduced with permission) [102, 103]. Previous research has 
highlighted a rapid ingress into peripheral circulation of neutrophils and lymphocytes in 
response to stressors such as psychological stress [104], exercise [1], and surgery [105]. 
This is regularly followed by a swift cellular egress [1, 106]. Specifically, ingress occurs 
by transportation of cells from areas of storage (i.e. spleen, lungs, marginated pool of 
respiratory tract, bone marrow, lymph nodes), into the circulation (i.e. blood vessels and 
lymphatics) and out to the tissues (i.e. skin, lung, gastro-intestinal and urinary-genital 
tracts, mucosal surfaces, and lymph nodes) [106, 107]. This stress response may 
(incidently) prepare immune cells to respond to infectious pathogens which may be 
imposed by the actions of the stressor [106, 108]. It has been suggested that the effect of 
stress on the immune system depends on the duration of the exposure to stress. Acute and 
intense stress may enhance immune function, and mild stress of moderate duration may 
promote immunosurveillance, while chronic stress may cause immune dysregulation [102, 
109]. 
 
1.5.1 Leucocyte Demargination 
There are a number of mechanism driving leucocyte redistribution during stress and 
exercise. While much of this thesis will discuss the role of neuroendocrine regulation of the 
immune system, it is important to mention the role of shear stress on changes in peripheral 
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blood leucocyte concentration. Leucocyte demargination is the process of cellular ingress 
into circulation as a result of increased blood flow (shear stress) [110]. In the early stages 
of acute exercise, leucocytes that were adhered to blood vessel walls, particularly those 
blood vessels in the lungs, spleen and the liver (marginated pool of leucocytes) become 
detached and enter the circulating pool. This is driven by both the shear stress of increased 
blood flow during exercise, and the actions of catecholamines (adrenaline and 
noradrenaline) [111]. The combined effects of shear stress and stress hormones drives a 
reduction in adhesion molecule expression on the cell surface of leucocytes and endothelial 
cells, making them ‘less sticky’, and increasing the concentration of leucocytes in 
circulation [112]. 
 
1.5.2 Neuroendocrine Regulation of Immune Function  
Stressors such as exercise are characteristically met by a series of coordinated hormonal 
responses controlled by the central nervous system [113]. As mentioned above, the “flight 
or fight” stress response causes a cellular redistribution. Critical for mediating the effects 
of stress, the physiological stress response results in the release of neurotransmitters, 
hormones, peptides and other factors into the circulation or locally within tissues. The 
major mediators of stress effects are norepinephrine and epinephrine that are released by 
the sympathetic nervous system, and corticotrophin-releasing hormone, 
adrenocorticotropin, and cortisol, that make up the hypothalamic–pituitary–adrenal (HPA) 
axis [114]. A number of exercise and hormone infusion studies have elucidated several 
mechanisms driving cellular redistribution. As such, it has been hypothesized that just as 
the stress response prepares the cardiovascular, musculoskeletal and neuroendocrine 
systems for “fight or flight”, under certain conditions, stress may also prepare the immune 
system for challenges (e.g. wounding or infection) that may be imposed by a stressor (e.g. 
predator or surgical procedure) [108]. This cellular redistribution is largely dependent on 
the concentration and duration of stress hormone release [115, 116]. These factors are 
dictated by the duration and intensity of the stress, the perception of the stimuli resulting in 
a stress response. Stress hormones release into the circulation is largely intensity-
dependent. An exponential rise in plasma epinephrine, norepinephrine and growth hormone 
concentrations occurs with increasing exercise intensity [117-119]. Plasma cortisol 
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concentration, however has been reported to only increase above exercise intensities of 
60% V̇O2max [120-122].  
 
Catecholamines 
The adrenal medulla is responsible for release of catecholamines; epinephrine and 
norepinephrine. Norepinephrine is also released by adrenergic neurons of the sympathetic 
nervous system. These two hormones are capable of affecting receptors in the 
cardiovascular, respiratory, gastrointestinal, and immune systems, in addition to endocrine 
glands, adipose tissue, and muscle. These catecholamines are strong responders to emotion 
stimuli and form the basis for the “fight or flight” hypothesis [123]. By binding to 
adrenergic receptors on target tissues, a stress-induced release of epinephrine and 
norepinephrine are hypothesized to prepare the body for danger. Adrenergic receptors can 
be further defined as alpha or beta (α1 and α2; β1, β2, and β3). Through the secondary 
messenger mechanism binding of these hormones to different adrenergic receptors can 
illicit inhibitory or excitatory effects [124]. Changes in circulating concentrations of 
epinephrine and norepinephrine appear to be largely intensity-dependent. An exponential 
rise in plasma epinephrine and norepinephrine concentrations occurs with increasing 
exercise intensity [117, 119]. 
β-adrenoceptors are located on T-cells, B-cells, NK cells, neutrophils and macrophages 
with the exception of Type 2 T-helper cells [125]. During exercise epinephrine and 
norepinephrine plasma concentration’s increase linearly with duration and exponentially 
with exercise intensity [126, 127]. Consequently, this hormone increase greatly affects the 
subsequent immune response. It has been suggested by Pedersen et al. (1997) that the 
original increase in circulating blood cell concentration of neutrophils and lymphocytes is 
due to epinephrine and norepinephrine. Evidence of this was observed following brief, 
intense or endurance exercise in which the concentration of circulating lymphocytes and 
neutrophils each correlated positively with plasma concentrations of epinephrine and 
norepinephrine [122, 128, 129]. Further evidence that catecholamines influence leucocyte 
ingress into circulation was observed by analysing the effects of increasing exercise 
intensity on catecholamine, lymphocyte, and granulocyte concentrations in the blood. 
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Furthermore, β-antagonist propranolol use during exercise has demonstrated that 
catecholamines regulate changes in circulating lymphocyte concentrations. Finally, 
activation of the stress response by exercise or β-agonist infusion have demonstrated a 
dose-dependent increase in lymphocyte concentration in peripheral circulation [104]. 
However, the increase in neutrophil concentration following infusion of catecholamines is 
significantly less compared to exercise−induced neutrophilia (increase in blood neutrophil 
concentration), suggesting further stimuli are inducing this increase in neutrophils during 
exercise [115, 130].    
 
Cortisol  
The primary glucocorticoid released from the adrenal cortex is cortisol. Cortisol 
contributes to the maintenance of plasma glucose during fasting and prolonged exercise 
[131]. The release of cortisol is driven by the following; corticotrophic-releasing hormone 
is secreted from the hypothalamus, causing the anterior pituitary gland to release 
adrenocorticotropic hormone (ACTH) into circulation. Binding to receptors on the adrenal 
cortex, ACTH increases cortisol secretion into the blood [132]. Cortisol is released during 
exercise to stimulate free fatty acid mobilisation from adipose tissue, mobilisation of tissue 
protein to yield amino acids for gluconeogenesis, and decrease the rate of glucose 
utilisation in cells [133]. The cortisol response to exercise appears largely due to exercise 
duration, where exercise under an hour rarely evokes a cortisol response [126]. There is a 
time lag response of cortisol, which generally peaks a number of hours after the peak in 
exercise-induced catecholamine release.  
Compared to catecholamines, there appears to be a less consistent effect of cortisol on 
circulating leucocyte concentrations. Some studies report no relationship [128] or an 
inverse relationship [134] between plasma cortisol concentration and the number of 
circulating neutrophils after exercise. However, a number of studies have suggested 
cortisol concentration does alter neutrophil ingress into peripheral circulation following 
exercise [122, 135-137]. Additionally, infusion of cortisol causes lymphocytopenia, 
monocytopenia, eosinocytopenia and neutrophilia, peaking 4 h after administration [138, 
139]. This assists in explaining both the incomplete neutrophilia in response to 
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catecholamine injection and the lymphocytopenia that occurs a number of hours after 
exercise.  
 
Growth Hormone 
Growth hormone (GH) is secreted from the anterior pituitary gland and exerts effects on 
growth of all tissues. GH secretion is controlled by growth hormone-releasing hormone 
and hypothalamic somatostatin, both released from the hypothalamus. Release of GH can 
by driven by exercise, stress, low plasma glucose concentration, and sleep [140]. 
Functionally, during exercise, GH assists in maintaining plasma glucose concentration, and 
is predominantly related to peak exercise intensity [141]. In response to an injection of GH 
at a dose corresponding to levels during exercise, a large neutrophilia occurred, although 
there were no effects on other leucocytes and cytokines [116]. However, there is no clear 
evidence to indicate that growth hormone regulates the number of circulating neutrophils 
following exercise [134]. 
 
1.5.3 Neutrophils 
Exercise and other forms of stress are able to alter the concentration of neutrophils in 
peripheral circulation. A rapid, and profound neutrophilia during exercise is followed by a 
second, delayed increase in circulating neutrophil concentration a few hours later [142, 
143]. This is variable between individuals depending on the exercise intensity, duration, 
and the training status of the individual undertaking the exercise. It is thought the initial 
neutrophilia is due to demargination caused by shear stress and catecholamines, whereas 
the later increase in neutrophil concentration several hours later may be due to release from 
the bone marrow due to an rise in cortisol concentration post-exercise [128]. 
During exercise, the concentration of circulating leucocytes increases substantially, 
primarily due to an increase in neutrophil concentration. This is known as neutrophilia, and 
is common among all forms of exercise, but the degree of change in neutrophil 
concentration is dependent on exercise and subject characteristics such as training status 
[76]. Changes in circulating neutrophil concentration may significantly alter both the 
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immune and inflammatory responses. Neutrophil concentration increases following bouts 
of strenuous exercise such as endurance competition [144-147], during training sessions 
[148-152], and in predefined training conditions at a set threshold under laboratory 
conditions [1]. 
In a Japanese study, endurance-trained runners were monitored following a competitive 
marathon. All subjects (age 36.6 ± 5.1 years; body mass 60.4 ± 4.2 kg) had completed a 
previous marathon under 2 h 40 minutes. Neutrophil concentration increased significantly  
immediately following exercise [153]. Sampling points were only conducted before and 
immediately after exercise, limiting the data available to monitor the post-exercise immune 
recovery. In another study involving 14 male competitive cyclists and triathletes (age 25 ± 
5 years; body mass 72 ± 9 kg; V̇O2peak 67 ± 6 mL.kg-1.min-1) who cycled for 4 h on a 400 
m track at a given workload of 70% of the individual anaerobic threshold, neutrophil 
concentration increased significantly immediately after exercise, remained elevated for 1 h, 
and returned to resting levels by 19 h after exercise [150]. Similarly, in eight highly trained 
cyclists (age 38 ± 4 years; body mass 72.5 ± 7.0 kg; V̇O2peak 61.0 ± 8.8 mL.kg-1.min-1) 
who exercised on a cycle ergometer at an average of 100 W for 45 minutes, a significant 
increase was observed in neutrophil concentration from before to immediately after 
exercise. It is unknown when neutrophil concentration returned to the resting level due to 
lack of post-exercise sampling points [154]. In a study of 17 professional cyclists (age 22.3 
± 0.9 years; body mass 70.6 ± 1.3 kg; V̇O2peak 81.9 ± 2.6 mL.kg-1.min-1), circulating 
neutrophil concentration increased significantly from before to immediately after a 137.1 
km cycling race. At 3 h after exercise, neutrophil concentrations significantly decreased 
from immediately after exercise but were still significantly elevated above pre-exercise 
levels [145]. Finally, in ten highly trained male cyclists (age 24.2 ± 5.3 years; body mass 
73.8 ± 6.5 kg; V̇O2peak 65.9 ± 7.1 mL.kg-1.min-1) who exercised for 2 h at approximately 
75% V̇O2peak, neutrophil concentration increased significantly from before to immediately 
after exercise, and increased further at 2 h after exercise. Samples were taken until 8 h after 
exercise (at 2 h intervals), at which point they were still significantly elevated above pre-
exercise (resting) levels [1]. This showed that neutrophils have not returned to pre-exercise 
resting levels at 8 h after exercise, which potentially may have implications for immune 
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cell redistribution if a second bout of exercise were to be undertaken within this ‘recovery’ 
period.   
 
1.5.4 Lymphocytes 
Circulating lymphocyte concentration has a biphasic response to prolonged exercise [61]. 
During and immediately after an acute bout of exercise, a lymphocytosis (increase in 
circulating lymphocyte concentration) is observed. However, after exercise, lymphocyte 
concentration decreases below pre-exercise levels for approximately 2–4 hours post-
exercise [155], before steadily returning to resting values. This response varies depending 
on exercise intensity, duration and fitness of the subject [156, 157]. Many studies have 
found this biphasic effect during and after exercise (approximately from immediately after 
to 4 hours after exercise) for, T lymphocytes, B lymphocytes, and Natural Killer cells [1]. 
Ingress of lymphocytes into peripheral circulation is largely driven by the actions of 
epinephrine, both directly by increasing expression of cell adhesion molecules, and 
indirectly via sympathetically activation resulting in increases in cardiac output and shear 
stress associated with enhanced blood flow [158].  
A recent study monitored immune response at pre-exercise, immediately post-, 2 h, 4 h, 6 
h, 8 h, and 24 h post-exercise in highly trained cyclists (age 24.2 ± 5.3 years; body mass 
73.8 ± 6.5 kg; V̇O2peak 65.9 ± 7.1 mL.kg-1.min-1). Following 2 h of exercise at 
approximately 75% V̇O2peak the biphasic response of circulating lymphocytes did occur. 
This featured a significant increase in lymphocyte concentrations from before to 
immediately after exercise, followed by a significant decrease from immediately after to 2 
h after exercise. Lymphocyte concentration then significantly increased again to above pre-
exercise levels by 6 h after exercise, and remained elevated to 8 h after exercise, only 
returning to resting levels at 24 h after exercise [1]. These results indicate that lymphocyte 
concentration had not returned to resting levels 8 h after exercise, potentially having 
implications for immune function if a second bout of exercise were to be taken within this 
‘recovery’ period.   
Separating lymphocytes into their respective subsets reveals an interesting relationship 
with the stress response.  The greatest expression of β-adrenergic receptors is found on the 
 68 
surface of NK cells, followed by γδ T cells, then CD8+, and least of all on CD4+ cells [104, 
158]. The difference in effects of exercise on the relative magnitude of ingress of the 
lymphocyte subsets into circulation will be discussed below, and reflects this differential 
density of adrenergic receptor expression on the surface of these cell types.  
 
CD4+ and CD8+ T cells 
While CD4+ and CD8+ T cell redistribution won’t be the focus of this study, it is important 
to consider their functional characteristics and understand their role in the larger scheme of 
the stress response. It is well established that, CD4+ T helper cells, along with a number of 
other cells, are responsible for regulating the T helper cytokine responses, whereas, CD8+ 
cytotoxic T cells are predominately involved in termination of virally infected cells. As 
such, it is important to consider their role in and response to stress and exercise. Previous 
research has demonstrated a repeatable ingress of both CD4+ and CD8+ T cells into 
peripheral circulation, similar to that of total lymphocyte concentration. A slightly more 
aggressive ingress into circulation has been observed in CD8+ compared to CD4+ T cells 
[104] following a stressor, reflecting the β-adrenergic receptor density on the surface of 
these cell types [158]. This ingress was observed following psychological stress, low- and 
high-intensity, and prolonged exercise [104, 155]. Furthermore, β-agonist infusion also 
drives ingress of CD8+ but not CD4+ T cells [104]. As with total lymphocyte concentration, 
a biphasic change in the circulating concentration of CD4+ and CD8+ T cells is present. 
Interestingly, the decrease in T cell concentration after exercise is largely due to a decrease 
in the concentration of Type 1 T cells, while little effect is observed on changes in the 
percentage of circulating Type 2 T cells [155, 159]. 
 
γδ T cells 
Previous research has demonstrated that acute exercise and psychological stress drive 
ingress of γδ T cells with high cytotoxic capabilities, tissue homing potential, and the 
capacity for rapid, innate-like target recognition [104, 160]. A significant increase in total 
γδ T cell concentration in peripheral circulation [104, 161, 162], and both δ1 and δ2 
subsets [163], following short duration exercise (30 min at 35%Wmax and 85%Wmax), and 
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in response to psychological stress and β-agonist infusion has been demonstrated. When 
examined for surface receptors; CD11a, CD62L, and CD94 on γδ T cells, those cells 
featuring high cytotoxic capabilities (CD94+), tissue homing potential (CD11a+) were 
mobilised to a greater extent following psychological stress [163]. No research has 
examined this population, highly sensitive to stress, followed prolonged, heavy-intensity 
exercise, or in response to repeated exercise bouts. 
 
1.5.5 Dendritic Cells 
Few studies have been published regarding cellular redistribution of dendritic cells. 
Following a marathon run, mDC circulating concentration increased significantly, whereas 
pDC concentration in the blood decreased significantly below pre-exercise values 
immediately post-race [164]. Furthermore, following a 1-hour ice-hockey training session, 
concentrations of mDCs and pDCs in the peripheral circulation both increased significantly 
compared with rest after the session was completed [165]. Finally, a significant increase in 
total DC concentration in the blood was observed following surgery or an exercise stress 
test to exhaustion [105]. No studies to our knowledge have examined changes in DCs 
under conditions where exercise intensity and duration are controlled, nor in response to 
repeated exercise bouts. 
 
1.5.6  Th1/Th2 relationship 
One study has examined changes in the Th1/Th2 relationship to an acute bout of endurance 
exercise. Nine male runners (age 30 years; body mass 74.5 kg; V̇O2peak 60.1 mL.kg-1.min-
1) ran on a treadmill for 2.5 h at 75% V̇O2peak during which blood samples were taken 
before exercise, 30 min into exercise, immediately after, 2 h and 24 h after exercise. There 
was a significant decrease in the proportion of Th1 cells in the blood (percentage of IFN-γ 
and IL-2 producing CD3+ cells) whereas no change was found in the proportion of Th2 
cells (percentage of IL-4 producing CD3+ cells) [155]. This change in circulating 
proportions of Th1 and Th2 cells may have implications for the function of different 
immune cells. It is unclear whether these changes are due to apoptosis or, as seems more 
likely, egress of cells out of peripheral circulation to other compartments. A decrease in the 
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percentage of Type 1 CD4+ and CD8+ T cells alone does not necessarily indicate that 
defence against intracellular pathogens such as viruses is suppressed [111]. Importantly, 
glucocorticoids and catecholamines appear to influence Th cytokine release, principally by 
stimulating glucocorticoid and β2 adrenergic receptors, respectively [166]. In turn, these 
stress hormones influence the activity of cellular (Th1), humoral (Th2), and mucosal 
(Th17) branches of the immune response [166, 167]. Specifically, cortisol, epinephrine and 
norepinephrine may suppress cytokine release from APCs and Th1 cells, while up-
regulating cytokine production from Th2 cells, thereby causing a shift toward Th2 cytokine 
production [155, 168]. Further research is warranted to examine the effects of stress and 
exercise on the T helper cytokine response. Additionally, only one study has examined the 
Th17 cytokine response to exercise [169]. This study examined the effect of strenuous 
endurance exercise (marathon and half-ironman triathlon) on CD4+ lymphocyte 
subpopulations including Th17 cells. Endurance exercise induced a significant increase in 
Th17 cell concentration immediately post-exercise. Conversely, no study has examined the 
effect of exercise on Th17 cytokine production. More research is warranted as Th17 cells 
are involved early on in regulation of immune function during infection, and may 
potentially be compromised by the exercise−induced stress response.  
 
1.5.7  Stress Hormone/Cytokine Interaction 
The Th2 shift that is reported to occur during exercise can be explained by the stress 
hormone–T-helper cell interaction (Figure 1.4).  This process is driven by catecholamines 
and cortisol, and by stimulation and inhibition of APCs and T-helper cells [170]. 
Catecholamines act on the APCs and Th1 cells. APC release of IL-12 is suppressed by 
catecholamines, while release of IL-10 is increased [170]. Furthermore, Th1 cells are 
inhibited by catecholamines binding to β-adrenoceptors [171], while β-adrenoceptors are 
not expressed on Th2 cells [172]. These combined processes down-regulate differentiation 
of Th1 cells, as well as blocking inhibition of Th1 and APC-produced pro-inflammatory 
cytokines, which inhibit the Th2 pathway (IL-2, IL-12, IFN-γ and TNF). 
Cortisol suppression of the Type 1 pathway occurs through a number of mechanisms. 
Previous studies have shown that cortisol decreases the production of TNF, IFN-γ, IL-2 
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and IL-12 from APCs and Th1 cells [173, 174]. This down-regulation blocks the inhibition 
of pro-inflammatory cytokines in the Th1 pathway, resulting in an increase in IL-4 
production [175]. Additionally, cortisol causes a decrease IL-12 receptors on the cell 
surface of NK and T cells [176]. 
The combined effects of catecholamines and cortisol cause a shift of the Th1/Th2 balance 
towards Th2, causing a release in anti-inflammatory cytokines and further enhancing 
humoral immunity. This may have implications for suppression of the cellular immune 
system in the period following exercise. However, there is limited research examining the 
immune response to exercise and its influence on Th1/Th2/Th17 cytokine regulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Stress hormone effects on Th1/Th2 cytokine release (adapted from [100]) 
 
1.5.8 Repeat Bouts of Exercise 
Elite athletes undergo strenuous training programs sometimes involving multiple sessions 
of conditioning per day. Some previous research has examined immune system function 
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following successive exercise bouts [156, 177-188]. Of limited number of studies 
involving repeated exercise, a number examined exercise duration and intensity or 
recovery duration not comparable to the repeated prolonged heavy-intensity exercise focus 
of this thesis [180-185]. Below are those studies which fit within the context of this thesis. 
The effect of repeated exercise was measured in 10 healthy males (age 21.6 ± 0.4 years; 
body mass 78.0 ± 4.6 kg; V̇O2peak 54.0 ± 2.7 mL.kg-1.min-1) who exercised for 1 h sub-
divided into three 20 min segments (5 min at 50% V̇O2peak and 15 min at 70% V̇O2peak) 
on two occasions separated by 4 h. Both circulating neutrophil and lymphocyte 
concentrations were significantly higher after two bouts of exercise than after the single 
bout and NK cytotoxic activity was significantly higher following the second bout [187]. 
Two more studies monitored nine endurance trained athletes (age 21–27 years; body mass 
74.7 ± 5.4 kg; V̇O2peak 69.1 ± 3.7 mL.kg-1.min-1) who completed one or two bouts of 
cycling for 75 min at ~75% V̇O2peak separated by a 3 h rest period. Following the second 
bout of endurance exercise, there was a significant increase in circulating concentrations of 
neutrophils, lymphocytes, CD4+, CD8+, and CD56+ cells, epinephrine, norepinephrine, 
ACTH, cortisol, and growth hormone, and a significant decrease in testosterone compared 
to a single bout of endurance exercise [177, 179]. Furthermore, in the same subject group, 
two studies were undertaken involving the same exercise protocol, however one group was 
given a 6 h rest period rather than 3 h. A significantly larger neutrophilia and 
lymphocytopenia was seen in the group with the smaller rest period following the second 
bout of exercise. Additionally, interleukin-6 (IL-6) and interleukin-1 receptor antagonist 
(IL-1ra) circulating concentrations were found to be significantly higher following exercise 
with 3 h rest compared to 6 h [178, 189]. 
A number of these studies have highlighted a ‘carry-over’ or ‘additive’ effect of repeated 
exercise bouts on lymphocyte and neutrophil concentration changes in the peripheral 
circulation [177-179, 186-188]. These carry-over effects of repeated exercise have been 
hypothesised to lead to chronic suppression of immune function [76]. In concert with a 
pronounced peak in plasma catecholamine and cortisol concentrations during exercise, the 
resultant ingress of lymphocytes and neutrophils into circulation is more severe during and 
after repeated exercise [177, 179]. However, cellular ingress only describes half the story. 
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It is recognised that following stress-induced cellular ingress, egress of these cells out of 
peripheral circulation occurs [104]. This egress of cells involves movements to areas at 
greater risk of potential infection, such as the epithelial surfaces of skin, gastrointestinal, 
urinary, and respiratory tracts [106]. It is largely unknown how prior intense exercise alters 
the cellular immune system during and following a subsequent exercise bout. Presently, 
only neutrophils and lymphocytes (including CD4+, CD8+ and CD56+ cells) have been 
examined within this context [177-179, 186-188]. No research has investigated the effects 
of repeated bouts of exercise on a number of lymphocyte subsets or dendritic cells in the 
circulation. This may cause a compounding effect on the immune system, potentially 
increasing the severity of the exercise-induced stress. This is important to consider in the 
context of an increased rate of symptoms associated with URIs during periods of 
competition and heavy training [8, 13, 14, 26-28].  
 
1.5.9 Saw-Tooth Theory? 
Expanding on the concept of a ‘carry-over’ or ‘additive’ effect, a ‘saw-tooth’ theory has 
been put forward, hypothesising that if a single bout of exercise might cause a suppression 
of the immune system, will repeated exercise without adequate recovery cause greater 
immune suppression? This theory dates back to when the ‘open window’ theory was at the 
forefront of hypotheses in exercise immunology [76]. It has been suggested by Mackinnon 
(1999) that the cumulative effects of repeated exercise without complete recovery of the 
immune system may eventually lead to a chronic suppression, possible increasing the risk 
of URI in such athletes (see Figure 1.5). We now know that the increased rate of URIs is 
more complicated than a single variable, however it is still worth considering the influence 
of repeated exercise-induced stress without sufficient recovery. This is because an 
increased rate of symptoms associated with URIs are found predominately during periods 
of competition or heavy training [8, 13, 14, 26-28].  
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Figure 1.5. Model: Variation on ‘open window’ with repeated exercise (adapted from [76]) 
 
1.5.10 Influence of Feeding on the Immune System 
One variable bearing large influence on plasma cortisol concentration during exercise, is 
the presence or absence of a feeding protocol during the sample collection period. As 
previously discussed, leucocyte redistribution is dictated largely by plasma catecholamine 
and cortisol concentrations [104, 122, 128, 135-139]. Complicating matters, these stress 
hormones are heavily involved in maintaining blood glucose concentration at a normal 
homeostatic level during exercise and fasting [133, 140, 190]. Previous research has also 
demonstrated that inducing a stress response on subjects’ while in a fasted state results in 
no increase in salivary cortisol concentration, while a significant increase is observed in fed 
subjects [191, 192]. Salivary cortisol has a high correlation coefficient (r = 0.893) with 
plasma cortisol concentration [193]. Furthermore, while feeding appears to increase 
cortisol concentration [194], feeding during exercise appears to decrease it (compared to 
placebo) [195, 196]. Certain protocol designs may accentuate this effect, particularly in 
protocols including sampling for many hours after the end of exercise. While some studies 
did not feed their subjects for the duration of a sample collection protocol [186, 197], 
others have done the opposite [1, 177-179, 189, 198]. Importantly, in those studies with no 
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feeding permitted, subjects were without food for a maximum of twenty hours (including 
the overnight fast) and completed one or two prolonged heavy-intensity exercise bouts. 
Together, these two factors may have had a large influence on changes in leucocyte 
distribution during exercise and the post-exercise recovery period. Potentially, this effect 
may be further exacerbated in repeated exercise protocols. Previous research examining 
repeated, prolonged, heavy-intensity exercise effects on immune cell redistribution has 
highlighted that subjects were not adequately replenished to allow fulfilment of a repeated 
exercise protocol [186]. This was likely due to combined effects of the depletion of 
carbohydrate stores, and an exercise intensity that would require the consumption of such a 
substrate. Of course, control of feeding is employed to limit variables when designing a 
study. However, this protocol design does not reflect recommended post-exercise recovery 
protocols, and may result in changes which would not occur during optimal training.  
 
1.5.11 Other Factors Affecting Immune Response to Acute Exercise 
Although not the direct focus of this thesis, it is important to discuss a number of factors 
that can affect immune response to acute exercise. Specifically, infection history, age, 
gender, and certain environmental factors can affect how a person’s immune system 
responds to a bout of exercise.  
Infection history can affect the immune response to exercise. Specifically, viral 
reactivation can have an impact on the rate of presentation of URI-associated symptoms in 
athletes. Persistent reactivating herpesviruses that are prevalent among humans include 
herpes simplex virus (HSV-1, HSV-2), Epstein-Barr virus (EBV), varicella zoster virus 
(VZV), and cytomegalovirus (CMV) [199]. One study examining the profile of infections 
of elite athletes experiencing recurrent URS associated with long-term fatigue and poor 
performance identified a high percentage as having herpes group viruses (e.g. CMV) or 
evidence of EBV reactivation [17]. Epstein Barr viral reactivation has also been 
demonstrated in association with URS in some endurance sports [17, 24].  
Immunosenescence is the overarching term that has been used to describe the biological 
ageing and progressive dysfunction of systemic immunity. This age-related diminution of 
the immune system is characterized by poor vaccine efficacy, lowered immune vigilance, 
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and greater morbidity and mortality as a result of infectious disease [200, 201]. This 
senescence is associated with reactivation of herpesviruses.  
There remain a number of gender difference in the immune-endocrine response to exercise 
[202].  Although data are limited, some sex-based differences in immune responses to 
endurance exercise have been observed [203, 204]. Women have shown a greater 
lymphocyte response to prolonged cycling exercise than men [204], although this may be 
specific to woman who are physically trained since gender does not appear to influence 
lymphocyte apoptosis in response to maximal endurance exercise in untrained subjects 
[205].  Furthermore, women also demonstrate an attenuated inflammatory response to 
muscle damaging exercise than men, even when muscle damage is similar [206]. While 
limited studies exist, there appears to be some gender differences in the immune system 
response to exercise. 
Environmental factors can influence the way the immune system responds to acute 
exercise. Potential adverse conditions include extremes of heat and humidity, cold, high 
altitude, and air pollutants, although it remains a controversial suggestion that physical 
activity performed in stressful environments poses a greater than normal threat to immune 
function [207]. Exercising in hot versus thermoneutral conditions (core temperature ≥1°C 
higher in hot conditions) augments circulating stress hormones, catecholamines, and 
cytokines with associated increases in circulating leukocytes [208, 209]. However, exercise 
in the heat appears to elicit limited effect on neutrophil function, monocyte function, 
natural killer cell activity, and mucosal immunity [207, 210-217]. Therefore, most of the 
available evidence does not support the argument that exercising in the heat poses a greater 
threat to immune function (vs thermoneutral conditions). However, due to ethical 
committee restrictions, most laboratory studies have evoked modest core temperature 
responses (<39°C), rather than what can be reached during exercise in the field (~39.5°C) 
[218], or during heat stroke (core temperature >40.6°C) [219]. Studies investigating the 
effects of cold and high altitude on immunity and infection incidence are often hindered by 
extraneous stressors (e.g. isolation) [207]. Of the available evidence, previous research 
does not support the popular belief that short- or long-term cold exposure, with or without 
exercise, suppresses immunity and increases infection incidence [134, 211, 212]. Some 
evidence shows that ascent to high altitude increases infection incidence [220-222]. Studies 
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have reported suppressed cell-mediated immunity in mountaineers at high altitude [221]; 
however, the impact of this finding on resistance to infection remains unclear. When 
designing studies in exercise immunology, it is necessary to consider the environment in 
which participants are undertaking exercise, as the immune response can be altered by 
altitude, temperature and humidity; to what degree remains a contentious issue.  
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1.6 Flow Cytometry 
Flow Cytometry is a laser-based biotechnology that utilizes light scattering and 
fluorescence emission to quantitatively analyse the properties of individual particles, such 
as cells. The flow cytometer is capable of passing suspended cells in a stream of fluid 
through a laser [223], demonstrated in Figure 1.6. Quantitative measurement of parameters 
is obtained by several systems working in unison. A single stream of particles is 
transported and focused by a hydrodynamic fluidics system. This stream is guided through 
a laser beam for interrogation [223]. The biological sample undergoing analysis is injected 
into a stream of sheath fluid, located in the flow chamber. Differences in the density and 
velocity of the two fluids allow them to form a two-layer stable flow (laminar flow) that 
does not interact [223]. Difference between the velocities of flow of the two fluids allows 
the sample fluid to be restricted to the centre of the flow chamber. This control of the fluids 
allows suspended cells in the sample fluid to be directed through the laser beam. In 
addition to the laser, the optical system consists of a series of focusing lenses which direct 
light generated following interaction of the laser with particles in the flow stream, and a 
series of dichroic mirrors and band-pass filters which direct specific wavelengths of light to 
the appropriate photo-detector for signal processing [223, 224]. A photo-detector produces 
a small current when light is detected from sample particles interaction with the laser. The 
amplitude of the current is proportional to the total number of light photons received by the 
detector [223]. Via a series of linear and logarithmic amplifiers, the electrical current is 
amplified and then converted to a voltage pulse. This voltage pulse is assigned a digital 
value by the Analog-to-Digital Converter (ADC). Each voltage pulse generated represents 
data from a single particle. Within the range of 0-1000mV, the ADC converts the pulse to a 
digital number representing 0-1000mV channels [223]. Data is stored and displayed via 
computer software to allow for analysis and comparison of samples [223, 224]. 
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Figure 1.6. Model: A diagram illustrating the fluidics and optical systems of a flow cytometer 
 
1.6.1 Light Scatter 
In the context of cell counting and sorting, light scatter is paramount in identifying 
populations of cells. When sample particles are passed through the laser beam, deflected 
laser light scatters in all directions. The forward scatter channel (FSC) collects light 
scattered in a forward direction. It is measured at an approximate 20o offset from the axis 
of the laser beam by a type of photo-detector called a photodiode. Light collected by the 
FSC is proportional to a particle’s surface area and equates to a particle’s size [223]. 
Conversely, side scatter light reflects cellular granularity or the internal complexity of 
sample particles. This side scatter light collected in the side scatter channel (SSC), is 
measured perpendicular to the axis of the laser beam, by a photomultiplier tube detector 
[223].  
 
1.6.2 Fluorescence  
Fluorescence is used in flow cytometry to identify specific proteins on the surface, or 
located inside of cells, or found in solution via the use of fluorochromes. Travelling in 
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waves, light is a form of electromagnetic energy [225]. The energy content of a light beam 
is what determines the colour of light. Additionally, this energy content is directly 
proportional to the light beam’s wave frequency and inversely proportional to its 
wavelength [225]. A fluorescent compound is capable of absorbing light energy within a 
specific wavelength range. This absorption of light causes excitation of the electrons within 
that compound, raising the electrons to an unstable higher energy state [223]. Some energy 
is then released as heat by the fluorescent compound, undergoing a conformational change 
to return to a more stable state [223]. The subsequent release of the remaining energy as 
light, emitted at a longer wavelength to the light source which originally excited the 
compound, is referred to as fluorescence [225].  
In addition to identifying forward and side scatter characteristics of cells, lasers are used to 
focus light consisting of a single wavelength on the individual particles of a sample [223-
225]. As mentioned above, fluorochromes are used to analyse specific cellular parameters. 
These fluorochromes are maximally excited by the flow cytometer within a specific 
wavelength to target specific cellular antigens or intracellular molecules. Light emitted by 
these fluorochromes allows for the quantification of the biological and biochemical 
properties of the target molecule. This is because the amount of fluorescent signal detected 
by the flow cytometer is proportional to the number of fluorochrome molecules on the 
particle [223, 225].  Flow cytometers use separate fluorescence channels to detect the 
specific wavelength of light emitted from fluorochromes allowing for multiple identifying 
markers to be analysed in a single sample.   
 
1.6.3 Data Analysis  
Computer software allows the data collected above to be graphed and analysed statistically 
[223, 224]. Histograms, dot plots, contour plots or density plots can be used to visualise 
one or two parameters at once. This visualisation of data can facilitate the identification of 
various cell populations which are associated with specific antibodies, or forward or side 
scatter characteristics [223].  
During the data collection process, digital conversion of a light scatter or fluorescent signal 
can be processed by either linear or logarithmic amplification of the electrical current 
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produced by a photo-detector [223]. Linear data is reported on a 1024 channel scale in 
proportion to the intensity of collected light and displayed graphically on axes with linear 
values. This linear scale is used for analysis of parameters in which a narrow range of 
signal intensity is expected, such as forward scatter and side scatter light [226]. 
Conversely, the logarithmic amplified data is reported on a 1024 channel scale with the 
digital channel number proportional to the log of the original light intensity. This 
logarithmic amplification is normally used to display data of fluorescent parameters as it 
compresses strong signals which range up to hundreds or thousands of times the intensity 
the intensity of weak signals, allowing such data to be displayed graphically [223, 226]. 
Analysis of the relative intensities of logarithmically amplified signals is achieved by 
converting the channel values to a number that corresponds to the fluorescent intensity of 
the original light signal. All values are displayed graphically on a four log decade scale 
(100 – 104) corresponding to linear values in the range of 1 – 10,000 [227]. 
Cells are often analysed for the presence or absence of a given marker to better define and 
categorise the cell type [228]. A negative control sample is required to accurately 
distinguish between positive and negative data sets [228]. Negative isotype controls are 
commonly used as control samples, providing non-specific staining for an antibody of a 
particular isotype conjugated to a particular fluorochrome and biological comparison 
controls. This provides relevant comparison conditions to determine the presence or 
absence of a given marker [228].  
Analysis of different cell populations can be achieved by analysing both forward and side 
scatter, and the presence or absence of conjugated fluorochromes. This can be assisted by 
the use of ‘gating’. Computer software allows for subsets of collected data to be analysed 
in isolation. Numerical or graphical boundaries are created by “gates”. “Gates” are utilised 
to identify cells of interest while excluding data from unwanted cells [223]. These 
boundaries define the characteristics of particles to be included in further analysis [223]. 
This is used to target specific cell populations [223]. Granulocytes, monocytes and 
lymphocytes can be visualized by graphing forward scatter and side scatter parameters on a 
dot plot. Once gated according to size and granularity, identification of specific CD 
molecules can be used to further define different cell types.  
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In addition to cellular identification, flow cytometry can be used in protein quantification. 
A cytometric bead array (CBA) allows for the quantification of multiple proteins 
simultaneously [229]. In general, a CBA assay consists of a mixture of beads uniform in 
size (7.5 µm) but containing different fluorescence intensities of a red-emitting dye. A 
different capture antibody against each specific protein (such as a cytokine) is covalently 
coupled to each type of bead. Cytokines bound to these antibodies are detected by use of 
antibodies labelled with phycoerythrin. The fluorescence intensity measured with 
phycoerythrin is proportional to the cytokine concentration in the sample and is quantified 
from a calibration curve [230]. CBA provides an adequate supplement to an enzyme-linked 
immunosorbent assay (ELISA), allowing for multiple analytes to be quantified in a single 
sample.  
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1.7 Mitogen Stimulation 
 
Mitogen stimulation is used for in vitro assessment of cellular immunity for research 
purposes, in addition to examining patients with immunodeficiency [231], autoimmunity 
[232], infectious diseases [233], and cancer [234], reflecting immune function in vivo. 
Stimulating isolated cells allows a functional representation of a cellular population at rest, 
or while under pre-determined controlled conditions. Common mitogens used for 
stimulation include phytohaemagglutinin (PHA), phorbol 12-myristate 13-acetate (PMA) 
and ionomycin, and anti-CD3/anti-CD28 coated beads [235, 236]. 
 
1.7.1 Phytohaemagglutinin 
Phytohaemagglutinin is a lectin extracted from red kidney beans (Phaseolus vulgaris) [237, 
238]. The protein consists of two molecular species, a leucoagglutinin (PHA-L) and an 
erythroagglutinin (PHA-E) [239, 240].  PHA-M is the mucoprotein form and is a crude 
extract used for the stimulation of cell proliferation and cytokine production in in vitro 
lymphocyte culture for subsequent detection in immunoassays, either by ELISA [241], 
cytometric bead array [242, 243], intracellular cytokine identification [241]. PHA can also 
be used as a stimulant in leucocyte proliferation assays [244].   
Although, a large amount of literature exists on PHA-stimulation of immune cells to induce 
proliferation following exercise [244-253], few studies have examined PHA-stimulated 
cytokine production following prolonged exercise. Of those exercise-related studies, a 
PHA stimulation assay was used to analyse T helper cytokines (TNF, IFN-γ, IL-10, IL-6, 
IL-4, and IL-2) released from isolated PBMCs of endurance athletes [242]. Blood samples 
were collected at rest and incubated with or without the addition of bovine colostrum. 
Cytokines were quantified by cytometric bead array. The results demonstrated bovine 
colostrum is able to modulate in vitro cytokine production of human PBMCs [242]. Of 
those studies examining PHA-stimulation of PBMCs following exercise, conflicting results 
are apparent.  In one study, IFN-γ concentration significantly increased from pre-exercise 
to 24 h following moderate, but not exhaustive exercise, whereas no significant change was 
reported in IL-2 concentration [254]. Furthermore, no significant change was apparent in 
IFN-γ or IL-2 production following PHA-stimulation of PBMCs after cycling for 60 min at 
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75 % of V̇O2peak [255]. Conversely, following cycling for both, 60 min at 60 % of 
V̇O2peak, and a 19 min exhaustive effort, PHA-stimulation of PBMCs resulted in a 
significant decrease in IL-2 production [250, 256]. To our knowledge, no other cytokines 
have been analysed following PHA-stimulation of PBMCs following prolonged, heavy-
intensity exercise.  
 
1.7.2 Phorbol 12-myristate 13-acetate & ionomycin 
Another common cell stimulation cocktail used in immunology research combines phorbol 
12-myristate 13-acetate (PMA) and ionomycin [235]. Treatment with PMA and ionomycin 
is sufficient to induce activation of many cell types to produce cytokines [236, 257]. This 
cocktail can be used to induce cytokine production in in vitro cell culture for subsequent 
detection in immunoassays, either by ELISA, cytometric bead array [258], or intracellular 
cytokine identification [155]. PMA is a small organic compound which diffuses through 
the cell membrane into the cytoplasm, where it directly activates protein kinase C (PKC). 
Activation of PKC triggers calcium ion release and mobilisation, resulting in a cascade of 
additional cellular responses mediating T-cell activation [259]. Ionomycin, a calcium 
ionophore produced by the bacterium Streptomyces conglobatus , is used in addition to 
PMA to trigger calcium release, which is required for nuclear factor of activated T-cell 
(NFAT) signalling [260]. Stimulation with these compounds bypasses the TCR complex 
and will lead to activation of several intracellular signalling pathways [261]. This 
activation results in a rapid up-regulation of cytokine production.   
Previously, the combined stimulation of PMA and ionomycin was used in analysis of 
intracellular cytokines following a 2.5 h bout of cycling [155, 159], and a 1.5 h bout of 
running [159]. Both studies demonstrated exercise-induced changes in type 1 cytokine-
producing T cells as described in Chapter 1.4.5. 
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1.8 Exercise Physiology 
It is necessary to consider a number of physiological variables related to exercise when 
examining immune changes due to exercise-induced stress. As outlined above, stress 
hormone release in dictated by both exercise intensity and duration. As such, when 
designing a study to examine the influence of a set exercise intensity, it is paramount to 
understand the physiological effects of exercise of varying intensity on the stress response. 
Below are a number of variables important to consider when prescribing a bout of exercise.  
  
1.8.1 Oxygen Consumption 
Oxygen consumption/uptake is a measure of metabolic demand. Changes in oxygen 
consumption are driven by changes in underlying metabolic processes, as the consumption 
of oxygen is necessary for sustain production of adenosine triphosphate (ATP) from 
substrates (e.g. glucose, free fatty acids) [131]. When exercise begins, the increase in 
energy production is used to provide ATP for contracting skeletal muscles. This ATP is 
provided by an increase in aerobic metabolism, driving greater consumption of oxygen. 
This oxygen consumption can be measured by open-circuit spirometry to accurately 
determine resting metabolic rate, and changes in oxygen consumption and carbon dioxide 
production during rest and exercise [262].    
 
1.8.2 V̇O2max/V̇O2peak 
Maximal oxygen uptake is an important measure for when quantifying exercise intensity. It 
is defined as the highest oxygen uptake that an individual can obtain during exercise using 
large muscle groups [263]. The maximal capacity to transport and utilise oxygen during 
exercise is considered by many to be the most valid measurement of cardiovascular fitness 
and has a high correlation with aerobic performance [132]. The most accurate means to 
determine V̇O2max is by direct laboratory measurement. This is generally performed in the 
form of an incremental (or graded) exercise test in a laboratory using a motorised treadmill 
or cycle ergometer, and open-circuit spirometry used to measure pulmonary gas-exchange. 
The terms peak oxygen uptake (V̇O2peak) and maximal oxygen uptake (V̇O2max) are both 
used in this thesis. The difference in terms is dictated by whether the subject reaches 
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specific criteria for maximum oxygen consumption. The primary criterion for reaching 
V̇O2max is a plateau in V̇O2 (<200 mL.min-1 change) with increasing work rate. 
Additionally, secondary criteria for reaching V̇O2max include; 1) a maximal heart rate 
within 5% of their age predicted maximal heart rate (220 beats.min-1 - age), 2) a blood 
lactate concentration of >11.0 mmol/L collected 5 min post-exercise, and 3) respiratory 
exchange ratio of ≥1.10 [264]. If these criteria are not met, then the highest oxygen 
consumption result would be defined as V̇O2peak. 
 
1.8.3 LT/AT/VT1 
An even more accurate measure of exercise intensity is by comparing workload in relation 
to the lactate threshold (LT) – also known as the anaerobic threshold (AT), or the first 
ventilatory threshold (VT1). It is thought that below the lactate threshold, ATP production 
used to provide energy for muscle contraction comes from aerobic sources [262, 265]. 
However, as exercise intensity increases, so does reliance on anaerobic metabolism [266-
268]. As such, an exponential rise in blood lactate concentration occurs, defined as the LT. 
Depending on the method of identification, the point at which this occurs can be described 
as the LT, AT, or VT1. While, LT is defined by analysis of blood lactate concentrations 
during an incremental exercise test, AT and VT1 are identified using respiratory exchange 
data from the same protocol. As blood lactate concentration, blood pH, CO2 production, 
and ventilation (V̇E) are closely related, gas exchange data can be used to non-invasively 
identify these points [269]. To determine AT, the relationship between V̇O2 and V̇CO2 is 
examined by regression analysis, called the V-slope method [270]. The highest work rate 
prior to the systematic departure from a linear relationship between V̇O2 and V̇CO2 is 
defined as AT, which occurs secondary to an excess CO2 production from non-metabolic 
sources, thus increasing V̇CO2 [270, 271]. To determine VT1, the ventilatory equivalents 
for O2 (V̇E/V̇O2) and CO2 (V̇E/V̇CO2) are plotted against work rate. VT1 is then defined as 
the exercise intensity at which V̇E/V̇O2 exhibited a systematic increase without a 
concomitant increase in V̇E/V̇CO2.  
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1.8.4 MLSS/RCT/VT2 
Another term commonly used in relation to changes in lactate concentration with 
increasing exercise intensity is the “maximal lactate steady state” (MLSS). This is defined 
as the highest exercise intensity at which blood lactate concentration, while elevated 
compared with rest, may attain a steady-state value and remains at equilibrium for the 
remainder of the exercise [272]. Teamed with this increase in blood lactate are a number of 
changes in V̇E and V̇CO2, allowing this point to be identified by gas exchange data [273-
275]. As with the thresholds above, the respiratory compensation threshold (RCT) and 
second ventilatory threshold (VT2) can be determined by analysis of V̇E/V̇O2 and V̇E/V̇CO2. 
This point corresponds to the exercise intensity at which an increase in V̇E/V̇O2 is 
accompanied by an increase of V̇E/V̇CO2 [267]. This point can also be defined as the work 
rate associated with the second non-linear increase of V̇E and V̇CO2 [270].  
 
1.8.5 Exercise Intensity Domains 
Exercise intensity domains are used to define the points between different thresholds. This 
provides insight into exercise intensity, and how sustainable such a bout of exercise would 
be. These domains can be divided into “moderate”, “heavy”, “severe”, and “extreme” 
[276]. Any exercise intensity correspond to an oxygen uptake between rest and that 
corresponding to LT/AT/VT1 is defined as the moderate intensity domain. Exercise 
intensities above LT/AT/VT1 but less than MLSS/RCT/VT2 are defined within the heavy-
intensity domain. Any exercise intensity performed above MLSS/RCT/VT2 and less than 
V̇O2max is defined as the severe intensity domain. Finally, extreme-intensity is above 
MLSS but V̇O2peak is not achieved as fatigue occurs before V̇O2 reaches asymptote [276]. 
As a guide, both the moderate and heavy-intensity domains are sustainable for a prolonged 
time period, whereas exercising in the severe domain would result in an upward drift of 
V̇O2 towards maximal values, at which point, exhaustion would occur.  
 
1.8.6 Prolonged, Heavy-Intensity Exercise 
As this term is mentioned throughout the current thesis, it is necessary to define “prolonged 
heavy-intensity exercise”. For the purpose of the following studies, prolonged heavy-
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intensity exercise is defined as sustainable exercise of duration greater than 1.5 h, at work 
rates above the anaerobic threshold. Previous research has highlighted a significant 
increase in training volume (both; proportion (%), and absolute volume (km)) in the heavy-
intensity domain when transitioning from the off-season to pre-competition, and 
competition phases of a season in professional cyclists [20]. Sustainable power at the upper 
limit of the heavy-intensity domain is correlated to time trial performance [277]. 
Furthermore, during “le Tour de France”, cyclists averaged ~60% of a climb’s duration 
(hors, first, and second category climbs) at or above the heavy-intensity domain [278]. 
Cyclists are regularly training and racing at this exercise intensity for prolonged periods of 
time, as such it was deemed appropriate that our studies mirror such an exercise dose.  
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1.9 Aims of the Current Study 
The overall aim of this thesis is to analyse the immune system response and subsequent 
recovery period following prolonged heavy-intensity exercise in highly trained individuals 
under various conditions. More specifically: 
 To analyse the effect of a single bout of prolonged heavy-intensity exercise on a 
number of novel markers of immune system function including, dendritic cells, γδ 
T cells, and T helper cytokines. Focus will be placed both on the immediate 
exercise effect and the subsequent immune recovery period after exercise. 
 To determine the effect of prior exercise on the immune system response and 
recovery period following a second bout of exercise with minimal recovery 
between sessions, by examining a number of novel markers of the immune system.  
Below are the specific aims and hypotheses for Studies I, II, and III. 
The aim of Study I is to examine the effect of prolonged heavy exercise on plasma cortisol 
concentration, and Th1, Th2, and Th17 cytokine release following exercise and recovery. 
We hypothesised that the exercise-induced stress would increase plasma cortisol 
concentration after exercise, resulting in the release of IL-17 and a shift from secretion of 
Th1 to Th2 cytokines, returning to resting level several hours after the cessation of 
exercise. 
The aim of Study II is to examine the effect of prolonged heavy exercise on circulating 
concentrations of lymphocyte and dendritic cells and their subsets following exercise and 
recovery. We hypothesised that the exercise-induced stress would increase circulating 
concentrations of cell subsets following exercise, with those cell subsets presenting more 
effector characteristics highlighting ingress into circulation at a higher degree than those 
cell subsets with more naïve cell functions, returning to resting level several hours after the 
cessation of exercise. 
The aims of Study IIIA and Study IIIB are to examine the effect of repeated, prolonged 
heavy exercise on Th1, Th2, and Th17 cytokine release, in addition to lymphocyte and 
dendritic cells and their subsets following exercise and recovery. We hypothesised that 
repeated exercise would result in a ‘carry on’ or additive effect compared to a single bout 
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of exercise. This would manifest itself in a greater peak in cell concentrations post-
exercise, a greater release of IL-17 and a more pronounced shift from secretion of Th1 to 
Th2 cytokines.  
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1.10 Significance 
The multifaceted nature of the immune system, and the varying influence of exercise and 
stress on the immune function, there is a great deal that is unknown in the field of exercise 
immunology. Fortunately, this leaves many niches of the immune system unexplored in its 
response to many forms of exercise and stress. Because of variability between studies in 
training status of the subjects, exercise protocols, analysis, and sampling, many areas can 
be explored. The immune system represents a hugely complex, communicating, fine-tuning 
system in which the stress response has large influence over its function. More research is 
warranted to explore the relationships between stress, exercise, and immune function. In 
the present study, this involves examining rarely tested markers (such as γδ T cells , 
dendritic cells and T helper cytokines), under controlled conditions, and circumstances that 
may be expected to produce greater, potentially more harmful effects on the immune 
system, both during the stress, and during the subsequent recovery period.  
The exercise protocols employed for the present studies have been designed to mirror the 
heavy training intensity and duration experienced by elite cyclists. The results may provide 
a more complete understanding of the effects heavy prolonged exercise have on the 
immune system in athletes who include repeat training sessions in their regimes. The 
results of this study may help identify contributing factors accounting for the illness that 
some athletes experience during phases of intense training combined with short recovery 
periods. Additionally, it is hoped this research may help identify when the immune system 
has recovered, potentially indicating when it is safe – in an immune health context – for an 
athlete to return to training. 
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2. METHODOLOGY 
2.1 Study Design 
Three studies were proposed to investigate cellular and cytokine changes in response 
prolonged heavy-intensity exercise. A large focus was placed on the temporal 
characteristics and kinetics during the recovery period of the dependant variables. Analysis 
included a number of immune system variables, and the inclusion of both single and 
repeated exercise protocols. 
 
2.1.1 Study I  
Study I aimed to examine the effect of a single two-hour bout of prolonged heavy-intensity 
exercise on stimulated Th1/Th2/Th17 cytokine concentrations in peripheral blood. The 
post-exercise recovery period was of key interest, featuring six sampling points after the 
completion of exercise.   
 
Figure 2.1. Time-line of blood sampling and meal schedule Study I. Time points include pre-exercise, 
immediately post-exercise, 2 h, 4 h, 6 h, 8 h, and 24 h post-exercise. 
 
2.1.2 Study II  
The aim of Study II was to examine the effects a single two-hour bout of prolonged heavy-
intensity exercise on total dendritic cell concentrations and dendritic cell subsets, and γδ T 
cell concentrations, γδ T cell phenotypes in peripheral blood. The focus was to analyse the 
immediate effect of the exercise and the subsequent changes during the post-exercise 
period. 
Time (24-h) 
Meals 
Exercise 
Blood Sampling 
Ex. 
  7       8        9       10      11     12       13    14      15      16      17     18        7        8 
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Figure 2.2. Time-line of blood sampling and meal schedule Study II. Time points include pre-exercise, 
immediately post-exercise, 1 h, 2 h, 4 h, and 6 h post-exercise. 
 
2.1.3 Study III  
Study III aimed to examine the effect of repeated ninety-minute exercise bouts on 
perturbations in the immune system following prolonged heavy-intensity endurance 
exercise. Analyses included full blood count (FBC), stimulated Th1/Th2/Th17 cytokine 
concentrations, total dendritic cell concentrations and dendritic cell subsets, and γδ T cell 
concentrations, γδ T cell phenotypes in peripheral blood.  
 
 
 
 
Time (24-h) 
Meals 
Exercise 
Blood Sampling 
Ex. 
  7       8        9       10      11     12      13     14      15     16 
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Figure 2.3. Exercise, blood collection, and meal schedule for the Single and Repeat bout data collection 
protocols (Study III).  
 
  
Time (24-h) 
Meals 
Single bout (SB) 
Blood Sampling 
Repeat bout (RB) 
p.m. 
a.m. p.m. 
6        7       8        9       10      11     12      13      14     15      16      17     18      19           6        7 
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2.2 Ethics 
Ethical clearance for each study was obtained from the Bond University Human Research 
Ethics Committee (RO-955/RO-1145). Ethical approval of Study I (RO-955) was 
originally applied for in 2009. A number of amendments were added to RO-955 in 2011 to 
allow Study II to proceed. Finally, Study III ethical approval was obtained in RO-1145. 
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2.3 Subjects 
Ten highly trained ‘A’ grade club-level male cyclists were recruited from various cycling 
clubs in South-East Queensland with the assistance of Cycling Australia for each study 
(total n = 30).  
 
2.3.1 Power Calculations  
Power calculations to predict recommended subject numbers were completed for repeated 
measures ANOVA. Effect size was calculated from reported F-statistics and degrees of 
freedom (df) published by Anane et al., 2009 and Anane et al., 2010 examining 
lymphocytes and specific lymphocyte subsets in response to short duration psychological 
stress task or a 16-min cycle bout at 85%Wmax [104, 163]. Effect size was calculated online 
using the website; lyonsmorris.com/ma1/. F statistic, between groups df, within groups df, 
and the number of subjects were entered. Effect size was calculated for the following 
variables:  
Table 2.1. Calculated effect size of psychological stress and acute exercise 
Immune Variable Psychological 
Stress 
Acute Exercise 
Lymphocyte concentration 0.3652 0.4296 
NK cell concentration  0.3893 0.4317 
γδ T cell concentration 0.3091 0.3803 
δ1 T cell concentration 0.2902  
δ2 T cell concentration 0.3024  
 
Sample size was calculated using G*Power software for ANOVA with repeated measures, 
within-factors interaction, for Study I and Study II. For the above variables, statistical 
power was set at 0.8, alpha set at 0.05, sample size was calculated as follows: 
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Table 2.2. Calculated sample size from effect size calculations for Study I and Study II 
Immune Variable Psychological 
Stress 
Acute Exercise 
Lymphocyte concentration 8 6 
NK cell concentration  7 6 
γδ T cell concentration 11 8 
δ1 T cell concentration 12  
δ2 T cell concentration 11  
 
 
Sample size was calculated using G*Power software for ANOVA with repeated measures, 
within-between interaction, for Study III. For the above variables, statistical power was set 
at 0.8, alpha set at 0.05, sample size was calculated as follows: 
Table 2.3. Calculated sample size from effect size calculations for Study III 
Immune Variable Psychological 
Stress 
Acute Exercise 
Lymphocyte concentration 6 6 
NK cell concentration  6 6 
γδ T cell concentration 8 6 
δ1 T cell concentration 8  
δ2 T cell concentration 8  
 
When using the effect size of previous research, it should be noted that these studies used 
short-duration, acute psychological stress and a 16-minute cycle bout at 85%Wmax. 
Compared to prolonged, heavy-intensity exercise of this proposed thesis, the interventions 
used by Anane et al., would likely elicit a response of reduced magnitude compared to 
prolonged exercise. This can be seen when comparing the acute psychological stress to the 
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16-minute cycle bout at 85%Wmax. Additionally, previous research in exercise immunology 
have indicated groups of 9 – 10 subjects are adequate to demonstrate significant changes in 
immune variables including cortisol concentration, lymphocyte concentration (including 
subsets CD4+ T cells, CD8+ T cells, NK cells), neutrophil concentration, and T helper 
cytokine concentrations [155, 177-179, 187, 189, 195-197, 279-282]. Based upon the 
results from these previous studies and the results from the power calculations above, a 
subject population of 10 subjects were recruited for each study.  
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2.4 Subject Screening 
A pre-participation health screening was performed to ensure volunteers were able to 
undertake a maximal exercise test and prolonged heavy-intensity exercise. The 
Explanatory Statements and Consent Forms for Studies I, II, and III are located in the 
appendices (Appendix C to Appendix F). Potential participants completed a medical 
history questionnaire (Appendix G), exercise history questionnaire (Appendix H), and 
physical activity readiness questionnaire - PARQ (Appendix I). Further screening tests 
included; a pulmonary function test, a resting electrocardiogram (ECG) and blood pressure 
measurements, a finger prick blood test for blood glucose, total cholesterol, LDL 
cholesterol, and HDL cholesterol concentrations. The combination of the screening 
questionnaires and tests were used to detect potential pulmonary, cardiovascular, metabolic 
and immunological conditions. Data from the subject screening are presented in Tables 2.1, 
2.2, and 2.3. 
 
Table 2.4. Physical characteristics data collected during pre-screening for Study I 
Subject Characteristics (n=10) Mean ± SD 
Age (years) 24.2 ± 5.3 
Height (m) 1.82 ± 0.07 
Body mass (kg) 73.8 ± 6.5 
BMI (kg.m-2) 22.2 ± 1.3 
FVC (L) 5.98 ± 0.49 
FEV1 (L) 4.85 ± 0.40 
FEV1/FVC (%) 81.2 ± 2.4 
Supine HR (beats.min-1) 48.5 ± 11.2 
Supine BP (mm Hg) 120.4 / 77.3 ± 5.9 / 4.8 
Training (km/week) 292.5 ± 89.8 
Data are mean ± standard deviation. BMI: body mass index. FVC: forced vital capacity. FEV1: volume 
exhaled at end of first second of forced expiration. HR: heart rate. BP: blood pressure. Training: volume in 
kilometres performed during training per week. 
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Table 2.5. Physical characteristics data collected during pre-screening for Study II 
Subject Characteristics (n=10) Mean ± SD 
Age (years) 24.0 ± 4.1 
Height (m) 1.81 ± 0.05 
Body mass (kg) 73.3 ± 5.8 
BMI (kg.m-2) 22.3 ± 1.4 
Fasting glucose (mmol.L-1) 4.4 ± 0.6 
HDL (mmol.L-1) 1.26 ± 0.32 
LDL (mmol.L-1) 2.90 ± 0.94 
Total cholesterol (mmol.L-1) 3.77 ± 1.06 
HDL/Cholesterol 0.35 ± 0.1 
FVC (L) 6.08 ± 0.62 
FEV1 (L) 4.90 ± 0.31 
FEV1/FVC (%) 81.1 ± 5.1 
Supine HR (beats.min-1) 46.0 ± 6.2 
Supine BP (mm Hg) 119.2 / 73.6 ± 7.3 / 5.4 
Training (km/week) 348 ± 57 
Data are mean ± standard deviation. BMI: body mass index. HDL: high-density lipoprotein. LDL: low-
density lipoprotein. FVC: forced vital capacity. FEV1: volume exhaled at end of first second of forced 
expiration. HR: heart rate. BP: blood pressure. Training: volume in kilometres performed during training per 
week. 
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Table 2.6. Physical characteristics data collected during pre-screening for Study III 
Subject Characteristics (n=10) Mean ± SD 
Age (years) 23.2 ± 3.2 
Height (m) 1.82 ± 0.06  
Body mass (kg) 74.8 ± 6.2 
BMI (kg.m-2) 22.5 ± 1.5 
Fasting glucose (mmol.L-1) 4.2 ± 0.8 
HDL (mmol.L-1) 1.46 ± 0.57 
LDL (mmol.L-1) 2.83 ± 1.08 
Total cholesterol (mmol.L-1) 3.64 ± 0.70 
HDL/Cholesterol 0.39 ± 0.11 
FVC (L) 5.74 ± 0.30 
FEV1 (L) 4.72 ± 0.56 
FEV1/FVC (%) 82.3 ± 7.8 
Supine HR (beats.min-1) 48.5 ± 11.2 
Supine BP (mm Hg) 120.4 / 77.3 ± 5.9 / 4.8 
Training (km/week) 316 ± 75 
Data are mean ± standard deviation. BMI: body mass index. HDL: high-density lipoprotein. LDL: low-
density lipoprotein. FVC: forced vital capacity. FEV1: volume exhaled at end of first second of forced 
expiration. HR: heart rate. BP: blood pressure. Training: volume in kilometres performed during training per 
week. 
 
A risk stratification matrix was employed to determine a potential participant’s suitability 
for exercise [283]. This matrix examined positive risk factors including: age (≥ 45 years), 
family history (myocardial infarction, coronary revascularisation, or sudden death, in 
parents or other first degree relatives), cigarette smoking (current cigarette smoker, or those 
who quit within the previous 6 months), sedentary lifestyle (at least 30 minutes of 
moderate intensity physical activity, on at least three days of the week, for at least three 
months), obesity (body mass index ≥ 30 kg.m-2 or waist girth > 102 cm), hypertension 
(systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg), 
dyslipidemia (LDL cholesterol ≥ 3.37 mmol.L-1, or HDL cholesterol < 1.04 mmol.L-1, or 
total cholesterol ≥ 5.18 mmol.L-1), and pre-diabetes (fasting plasma glucose ≥ 5.5 mmol.L-
1), and negative risk factor of high HDL cholesterol (≥ 1.55 mmol.L-1). If a potential 
participant exhibited two or more risk factors, they were excluded from participation in the 
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research. Additional exclusion criteria included; 1) any contraindications to exercise (such 
as recent injuries and/or overt contraindicators for performing maximal exercise), 2) 
thyroid and/or other autoimmune diseases, and 3) immune deficiencies. Finally, potential 
participants were required to; 1) be between the ages of 18-35 years, 2) having a minimum 
of one year racing experience, and 3) currently racing in A Grade club racing or Elite A 
Open Grading.  
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2.5 Test Sessions 
Subjects visited the exercise laboratory for a screening and familiarisation session, an 
incremental exercise test, and the experimental trial or trials for each study. An overview of 
the protocols used during these sessions is provided below. 
 
2.5.1 Screening and Familiarisation Session 
Once the screening process was completed (as described above), the participants 
underwent a familiarisation with the incremental exercise test protocol. This involved 
preparation of the cycle ergometer (Lode Excalibur Sport, Groningen, The Netherlands) 
with assistance from the subject to determine their preferred bicycle setup. Ten electrodes 
were attached to each participant to examine the 12-lead ECG and record cardiac rate and 
rhythm, and a mouth-piece and pneumotachograph was positioned in the subject mouth to 
record gas exchange analysis (Ultima CardiO2, Medical Graphics Corp., St Paul, MN). 
The subjects then underwent the incremental exercise test protocol (including 4-min warm-
up at 90 W, increasing 15 W every 30-sec thereafter) until they reached a heart rate of 120 
beats.min-1, at which point the test was terminated. Subjects were monitored for cardiac 
arrhythmias and abnormalities via ECG, and any further contraindications to exercise and 
signs of poor perfusion such as injury, confusion, ataxia, pallor, cyanosis, nausea, or cold 
and clammy skin. Subjects were able to stop the test at any time. During this session, 
preferred cycling cadence was determined by the subject and researchers, which was 
subsequently used during incremental exercise test and experimental trials. All trials 
(screening and familiarisation, incremental exercise test, and experimental trials) were 
performed in a laboratory with the temperature controlled at 20-22°C. 
 
2.5.2 Incremental Exercise Test 
The incremental exercise test was used to determine each subject’s individual ventilatory 
thresholds and V̇O2peak. Following completion of the pre-screening and familiarisation 
process (as described above), subjects undertook the incremental exercise test. Immediately 
before the test, the metabolic cart was calibrated according to the manufacturer’s 
instructions. The pressure-differential pneumotachograph was calibrated before each test 
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by using a syringe of known volume (3.0 L) over a range of flows. Oxygen and carbon 
dioxide gases were then calibrated before each test using a precision-analysed gas mixture. 
The cycle ergometer was prepared according to the previously determined preferred 
cycling position to ensure consistency between all exercise bouts. Once the subjects were 
prepared with the 12-lead ECG, mouth-piece and nose clip, they were invited to sit on the 
bike. The incremental exercise test involved a 4-min warm-up at 90 W. Following the 
warm-up the resistance applied on the cycle ergometer increased at a rate of 15 W every 
30-sec. Subjects were required to remain at the same cadence throughout the test. Data 
collected included cardiac rate and rhythm, blood pressure and gas exchange data. Gas 
exchange data was collected breath-by-breath, with 30-sec and 60-sec averages recorded 
post-hoc. Criteria for termination of the test included any heart abnormalities, faintness, 
and any further contraindications to exercise as listed above. Furthermore, subjects were 
permitted to end the test at any time for any reason. If the participant’s cadence decreased 
15 revolutions.min-1 below the predetermined preferred cadence, despite verbal 
encouragement, the test was terminated. Each subject’s individual V̇O2peak was 
determined by their highest V̇O2 value from 30-sec averaged V̇O2 data. Criteria for reaching 
V̇O2max included: 1) a plateau in V̇O2 (<200 mL.min-1 change) with increasing work rate, 
2) a maximal heart rate within 5% of their age predicted maximal heart rate (220 beats.min-
1 - age), and 3) respiratory exchange ratio of ≥1.10 in which any two of the above three 
criteria indicate reaching V̇O2max [264]. 
 
Threshold Determination 
Each subject’s ventilatory thresholds (VT1/VT2) were determined by their gas-exchange 
data collected during the incremental exercise test using the following criteria. The first 
ventilatory threshold (VT1) was defined as the exercise intensity at which V̇E/V̇O2 
exhibited a systematic increase without a concomitant increase in V̇E/V̇CO2. The second 
ventilatory threshold (VT2) corresponded to the exercise intensity at which the increase in 
V̇E/V̇O2 was accompanied by an increase of V̇E/V̇CO2 [267]. Thresholds were further 
defined as the work rates associated with a first and a second nonlinear increase of V̇E and 
V̇CO2 [270]. According to the criteria outlined above, two independent investigators 
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reviewed the plots of each index and made individual determinations of VT1 and VT2. If 
the investigators did not agree on a particular workload for VT2 by two or more workload 
levels, a third investigator was consulted. If the investigators chosen workload for VT2 
were one workload apart, an average of the two was taken. 
 
2.5.3 Experimental Trials 
Subjects were asked to train normally in the lead up to the test sessions, however it was 
requested that the subjects refrained from high intensity exercise during the two days prior 
to each experimental trial and avoid exercise for 24 h prior to visiting the laboratory. 
Furthermore, subjects were asked to avoid the use of large-dose vitamin/mineral 
supplements (above 100% of recommended dietary allowances), nutritional supplements, 
ergogenic aids, herbs, and medications known to affect immune function for one week 
prior to the test sessions.  
All exercise bouts were performed at the same intensity and duration for each subject, 
consisting of a 5-min warm-up period at 50% of V̇O2peak, immediately followed by either 
a 90-min (Study III) or 120-min (Study I and Study II) cycling bout at the predetermined 
workload (90% of the each individual’s second ventilatory threshold) at the subject’s 
previously determined preferred cadence. Gas exchange was measured for 4 min at 20-min 
intervals during the exercise bout to ensure the workload remained consistent. Once the 
exercise trial was complete, subjects were asked to sit while blood samples were taken.  
The subjects were under supervision for the entirety of the sampling, except overnight. 
While under supervision, subjects were given the option to read, listen to music, watch TV 
or work on their computer. Subjects were not permitted to sleep during the day of the 
experimental trial. 
 
Meal Protocol 
Total energy requirements per subject were calculated for the day of the experimental trial. 
These total requirements were sub-divided into main meals plus snacks at specific times 
(Figure 2.1, Figure 2.2, Figure 2.3). As used in previous studies [195, 196], to ensure 
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adequate carbohydrate intake, all meals consisted of a minimum of 60% carbohydrates. 
While under supervision, all meals were provided.  
 
2.5.4 Blood Sample Collection 
A qualified phlebotomist was employed to draw blood at each time point. Blood was 
drawn from an antecubital vein by venepuncture or cannulation. Blood collection points 
varied between studies, as previously described above (Figure 2.1, Figure 2.2, and Figure 
2.3). 
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2.6 Flow Cytometry 
2.6.1 Th1/Th2/Th17 Cytokines 
Th1/Th2/Th17 cytokines were assessed using the Human Th1/Th2/Th17 Cytokine Kit 
(Becton Dickson (BD) Bioscience, California, USA). The test kit quantitatively measured 
the concentration of selected circulating cytokines in the blood [229, 284]. It contained 
antibodies specific to IL-2, IL-4, IL-6, IL-10, TNF, IFN-γ and IL-17A proteins. The 
cytometric bead array system was employed to assess and quantitatively measure the 
concentration of plasma cytokines from peripheral blood mononuclear cells (PBMCs) and 
whole blood. Two different mitogens and stimulation methods were employed. Stimulation 
of PBMCs by PHA was used in Study I, whereas stimulation of whole blood by PMA and 
ionomycin was used for Study III. The decision to change mitogen was reached before 
Study III, as the results from Study I proved difficult to interpret. It was deemed a more 
broad-spectrum approach via PMA-stimulation of whole blood to the examine T helper 
cytokines may provide a response more indicative of immune function compared to the 
more narrow view provided by isolated PBMC analysis. The large difference in incubation 
time described in detail below; 72 h with PHA and 4 h with PMA and ionomycin, is due to 
the severity in which these individual mitogens act. Previous research has suggested a 
range of 48 to 72 h for PHA stimulation and 4 to 6 h for PMA [235, 236, 241, 243, 285-
287].   
The protocol for Study I involved the following; 10 mL of blood was collected into lithium 
heparin tubes (BD Bioscience) and layered over Ficoll-Paque PLUS (GE Healthcare Life 
Sciences, Milan, Italy). Following centrifugation at 400 x g for 40 min, cells were 
resuspended in RPMI-1640 culture medium containing 5% foetal bovine serum (FBS) and 
then counted (Countess® Automated Cell Counter, Life Technologies, Carlsbad, CA). 
Isolated PBMCs were mitogenically stimulated with or without 1 µg of 
phytohaemagglutinin (PHA) at a concentration of 1x106 cells/mL at 37°C with 5% CO2 for 
72 hours. Following incubation, the supernatant was removed and stored at 80°C for 
subsequent analysis.  
The protocol employed for Study III differed to Study I. Briefly, 5 mL of blood was 
collected into lithium heparin tubes. Two tubes were prepared per sample, each containing 
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a volume of 1 mL of whole blood and 1 mL of RPMI medium. To the stimulated sample, 
PMA (25 ng/mL) and ionomycin (1 µg/mL) were added, whereas nothing more was added 
to the unstimulated sample. All samples were mixed and then incubated for 4 h at 37°C. 
Following incubation, the supernatant was removed and stored at 80°C for subsequent 
analysis.  
Table 2.7. Lower limits of detection of Th1, Th2, and Th17 cytokines 
Cytokine Limit of detection (pg/mL) 
IL-2 2.6 
IL-4 4.9 
IL-6 2.4 
IL-10 4.5 
TNF 3.8 
IFN-γ 3.7 
IL-17A 18.9 
 
Th1, Th2 and Th17 cytokine concentrations were quantified using a commercially 
available cytometric bead array kit (BD Pharmingen, San Diego, CA) to measure the 
concentrations of IL-2, IL-4, IL-6, IL-10, TNF, INF-γ and IL-17A from supernatant of 
stimulated samples. In the absence of stimulation with PHA or PMA and ionomycin, the 
concentrations of these cytokines were not within the limits of detection. Limits of 
detection are included in Table 2.4. The range of standards for each cytokine were prepared 
as follows; 0 pg/mL, 20 pg/mL, 40 pg/mL, 80 pg/mL, 156 pg/mL, 312.5 pg/mL, 625 
pg/mL, 1250 pg/mL, 2500 pg/mL, and 5000 pg/mL. Samples were diluted as a ratio of 1:4 
with assay diluent. Next, 50 µL of each unknown sample was mixed with 50 µL of Human 
Th1/Th2/Th17 PE detection reagent and allowed to incubate for 3 hours. Following 
incubation, samples were washed with wash buffer, and then resuspended for acquisition.  
Prior to sample analysis, the BD CBA Dual-Laser Instrument Setup template for 
acquisition of cytokines using the BD Cytometric Bead Array Human Th1/Th2/Th17 
Cytokine kit were downloaded from bdbioscience.com/cbatemplates and installed onto the 
flow cytometer. Instructions for setup of the correct acquisition template and instrument 
settings were available at the website; 
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bdbioscience.com/documents/CBA_HumanTh1Th2Th17_Kit_Manual.pdf. Briefly, 
cytometer setup beads were prepared with the inclusion of FITC and PE Positive Controls. 
SSC, FSC, FL1, and FL2 PMT voltages were optimised to gate the desired bead 
population.  
Acquisition of samples was set at 2100 gated events as per the kit instructions. All 
standards were acquired, followed by the unknown samples. Analysis of Human 
Th1/Th2/Th17 Cytokine data was completed using FCAP Array software. Instructions for 
analysis were available at; 
bdbioscience.com/docs/FCAP_Array_analysis_of_CBA_Kits.pdf. Briefly, bead groups 
were defined for each cytokine analysed. Next, standards, unknown samples, and the 
dilution factor were defined. Finally, standard curves were produced and unknown sample 
concentrations were calculated.  
 
2.6.2 γδ T cell subset 
Total γδ T cells, δ1 and δ2 subsets, memory phenotypes, and surface molecules were 
determined using the following antibodies; CD3 PerCP (BD Biosciences), Vδ-1 TCR FITC 
(Thermo Scientific), γδ TCR PE, Vδ-2 TCR APC, CD27 FITC, CD27 PE, CD45RA APC, 
CD11a FITC, CD62L PE, CD94 FITC (BD Pharmingen) [163]. Briefly, 100 µL whole 
blood was incubated with appropriate amounts of antibody (as determined by titration, 
Table 2.5) for 30 min in the dark at room temperature. Volumes used, and tube 
arrangement of each antibody used are included in Table 2.5. Erythrocytes were 
subsequently lysed using FACS lysing solution (BD Bioscience). Following lysis, samples 
were centrifuged (350  g, 5 min, at room temperature). Samples were then washed and 
fixed in 1% paraformaldehyde. Fixed preparations were analysed immediately, collecting a 
minimum of 100,000 events from each sample.  
 
Appropriate, matched isotype controls were used to set negative staining criteria. 
Fluorescence-minus-one (FMO) controls were not required to asses spill-over as four 
colour flow cytometry was being used [228, 288]. The FACS-Calibur flow cytometer (BD 
Biosciences) was calibrated weekly using Calibrite beads (BD Biosciences). Total 
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lymphocytes were gated using the forward versus side scatter plot to identify the target 
population. γδ T cells were then gated as the CD3+ γδ TCR+ population, δ1 T cell were 
gated as CD3+Vδ1+ and δ2 T cells were gated as CD3+ Vδ2+. Additional information on 
the gating strategy is presented in Appendix A. Lymphocyte subset concentrations were 
quantified using the percentage values obtained from each lymphocyte subset gate. The 
total lymphocyte concentration was obtained from the full blood count. 
 
Table 2.8. γδ T cell assay antibody volumes and tube assignment 
Antibody Fluorochrome Volume (µL) Tube 
CD3 PerCP 10 A, B, C, D 
Vδ-1 TCR FITC 5 A 
Vδ-2 TCR PE 5 B 
γδ TCR APC 5 C, D 
CD27 FITC 10 B 
CD27 PE 10 A 
CD45RA APC 10 A, B 
CD11a FITC 10 C 
CD62L PE 10 C 
CD94 FITC 10 D 
 
 
2.6.3 Dendritic cell phenotypes 
Total dendritic cells (tDCs), dendritic cell phenotypes (pDCs, mDCs, CD14-/lowCD16+ 
DCs), and total monocytes were identified by the combination of HLA-DR PerCP, lineage 
cocktail-2 FITC (CD3, CD14, CD19, CD20, CD56), CD123 PE (BD Bioscience), CD33 
APC, CD11c PE and CD16 APC (BD Pharmingen) antibodies. Briefly, 100 µL whole 
blood was incubated with appropriate amounts of antibody (as determined by titration, 
Table 2.6) for 30 min in the dark at room temperature. Volumes used, and tube 
arrangement of each antibody used are included in Table 2.6. 
 
Expression of CD33 and HLA-DR and absence of the lineage cocktail-2 antibodies with 
intermediate forward and side scatter characteristics located between those of lymphocytes 
 117 
and monocytes was used to determine tDCs. Dendritic cells were further defined into three 
subpopulations: (1) a subset of CD123dim/CD33high/CD16- cells, with strong expression of 
HLA-DR–mDCs; (2) a subset of CD123inter/CD33inter/CD16+ cells–CD14-/lowCD16+ DCs 
and (3) CD123high/CD33-/dim/CD16- cells–pDCs, both with intermediate expression of 
HLA-DR [289]. Additional information on the gating strategy is presented in Appendix B. 
Cell concentrations were quantified using percentage values obtained from each 
lymphocyte and monocyte subset gate. The total monocyte concentration was obtained 
from the full blood count. 
 
Table 2.9. Dendritic cell assay antibody volumes and tube assignment 
Antibody Fluorochrome Volume (µL) Tube 
HLA.DR  PerCP 10 A, B 
Lineage cocktail-2 FITC 10 A, B 
(CD3, CD14, CD19, CD20, CD56)    
CD33 APC 10 A 
CD123 PE 10 A 
CD16 APC 10 B 
CD11c PE 10 B 
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2.7 Additional Analysis 
2.7.1 Plasma Cortisol 
Samples for cortisol analysis were collected in EDTA anti-coagulation blood collection 
tubes. Samples were spun at 5000 x g for 10 min. Plasma was removed and stored at -80°C 
until analysis. Analysis was completed as previously described [290]. Samples were 
analysed by ultra-high-performance liquid chromatography tandem mass spectrometry 
(UHPLC MS/MS) described elsewhere [290]. Briefly, plasma samples were treated with 1 
M HCl at room temperature to displace cortisol and cortisone from binding proteins. To 
each sample, the multi-analyte internal standard (d4-dexamethasone, d2-11-deoxycortisol 
and d2-cortisone) and H2O were added before loading onto activated Oasis HLB 1 cc (30 
mg) solid phase extraction cartridges (Waters, Milford, USA). Samples were eluted with 
100 % ethyl acetate, dried at 50°C and reconstituted in 45 % methanol with 2 mmol/L 
ammonium acetate and 0.1 % formic acid. The flow rate of the UHPLC analysis was 0.4 
ml/min, sample injection volume 20 μl, and column temperature 50°C. The tandem mass 
spectrometer was operated in positive mode electron spray ionisation. The total analytical 
run time on the UHPLC MS/MS was 3 min. 
 
2.7.2 Full Blood Counts 
Full blood counts were performed using a five-part differential haematology analyser 
(Beckman Coulter AcT 5 diff AL Hematology Analyzer, California, USA). The 
haematology analyser utilised a sequential dilution system and dual-focused flow fluid 
dynamics technologies employing the Coulter Principle of impedance to count and size the 
cells. Plasma volume calculations and adjustments were conducted for all studies according 
to Dill and Costill [291]. Data presented has been adjusted for plasma volumes shifts. No 
significant change in plasma volume was evident in any study.  
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2.8 Statistical Analysis 
Due to the divergent statistical analyses employed for each study, the statistical 
methodology is described in detail in each individual chapter.  
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Abstract 
Endurance exercise can cause immunosuppression and increase the risk of upper 
respiratory illness. The present study examined changes in the secretion of T helper (Th) 
cell cytokines following endurance exercise. Ten highly-trained road cyclists (mean ± 
SEM: age 24.2 ± 1.7 yr; height 1.82 ± 0.02 m; body mass 73.8 ± 2.0 kg; peak oxygen 
uptake 65.9 ± 2.3 ml.kg-1.min-1) performed 2 h of cycling exercise at 90 % of the second 
ventilatory threshold. Peripheral blood mononuclear cells were isolated, and stimulated 
with phytohaemagglutinin. Plasma cortisol concentrations and the concentration of 
Th1/Th2/Th17 cell cytokines were examined. Data were analysed using both traditional 
statistics and magnitude-based inferences. Results revealed a significant decrease in plasma 
cortisol at 4 h to 24 h post-exercise, compared to pre-exercise values. Qualitative analysis 
revealed post-exercise changes in concentrations of plasma cortisol, IL-2, TNF, IL-4, IL-6, 
IL-10, and IL-17A compared to pre-exercise values. A Th1/Th2 shift was evident 
immediately post-exercise. Furthermore, for multiple cytokines including; IL-2 and TNF 
(Th1), IL-6 and IL-10 (Th2), and IL-17 (Th17) no meaningful change in concentration 
occurred until more than 4 hours post-exercise, highlighting the duration of exercise-
induced changes in immune function. These results demonstrate the importance of 
considering ‘clinically’ significant versus statistically significant changes in immune cell 
function following exercise.   
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Introduction 
Prolonged endurance exercise is associated with increased incidence of symptoms 
associated with upper respiratory illnesses (URIs) in elite athletes [29, 31, 32, 292]. This 
increased rate of URIs may be observed following acute bouts of prolonged heavy- to 
severe-intensity exercise (e.g., marathon running, triathlon, road cycling) and periods of 
increased training load, potentially inducing a chronic stress response [108]. The aetiology 
of exercise-induced URIs appears to be multifactorial, as the associated stress response 
involves many different cell types, pathways and proteins of the immune system [111].  
 
Stress-related changes in immune system function are typically mediated through 
activation of the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal 
axis. Activation of the SNS induces catecholamine release, with a delayed release of 
glucocorticoids. These stress hormones alter immune function after acute exercise and 
during periods of heavy training [107], in response to acute and chronic psychological 
stress [293], and following surgery [294]. The effects of exercise-induced stress hormones 
on T helper cell function during and after prolonged heavy-intensity exercise has not been 
fully elucidated.  
 
Glucocorticoids and catecholamines influence T helper cell (Th) cytokine release, 
principally by stimulating glucocorticoid and β2 adrenergic receptors, respectively [166]. In 
turn, these stress hormones influence the activity of cellular (Th1), humoral (Th2), and 
mucosal (Th17) branches of the immune response [166, 167]. Specifically, cortisol, 
epinephrine and norepinephrine may suppress cytokine release from antigen presenting 
cells and Th1 cells, while up-regulating cytokine production from Th2 cells, thereby 
causing a shift toward Th2 cytokine production [155, 168]. The balance between Th1 and 
Th2 immunological responses is very important in maintaining optimum immune health. 
The Th1 pathway primarily acts against intracellular pathogens, particularly viruses and 
bacteria, while the Th2 pathway is believed to protect against extracellular pathogens such 
as parasites [101]. Previous research has extensively examined changes in the balance of 
Th1 and Th2 cytokines in plasma in the first 12 h after exercise [295]. By contrast, there 
is less research published concerning changes in T helper cytokine secretion (including 
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Th17 cytokines) during recovery from prolonged heavy exercise. While these changes are 
transient, it may have implications related to potential immune suppression following 
prolonged heavy-intensity exercise [296].  
 
Exercise-induced glucocorticoid release occurs during prolonged exercise [107]. An 
increase in glucocorticoid concentration after exercise may influence T helper cytokine 
secretion differently to exercise of moderate duration and intensity, due to the large effect 
of changes in cortisol on immune function [107, 111]. Th17 cells play a key role in 
mucosal host defence of the upper respiratory and gastrointestinal tracts against a myriad 
of airborne antigens [297-299]. Functioning as part of the “first line of defence” in the 
mucosa, Th17 cytokines have been linked to increased polymeric immunoglobulin receptor 
(pIgR) expression, saliva sIgA and human β-defensin 2 release [300-303]. These results 
demonstrate that Th17 cytokine pathways are influential in the innate immune response in 
the mucosa. However, there is little evidence available about changes in Th17 cytokines 
after exercise. 
 
The aim of the present study was to examine the effect of prolonged heavy exercise on 
plasma cortisol concentration, and Th1, Th2, and Th17 cytokine release. We hypothesised 
that the exercise-induced stress would increase plasma cortisol concentration after exercise, 
resulting in the release of IL-17 and a shift from secretion of Th1 to Th2 cytokines.    
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Methods 
Subjects  
Ten well-trained male cyclists volunteered to participate in the present study (mean ± 
SEM: age 24.2 ± 1.7 yr; height 1.82 ± 0.02 m; body mass 73.8 ± 2.0 kg; peak oxygen 
uptake 65.9 ± 2.3 ml.kg-1.min-1).  Subjects were excluded if they exhibited any 
cardiovascular, metabolic, neurological, immunological or autoimmune disorders. The 
cyclists provided written informed consent for participation in the study, which was 
approved by the Bond University Human Research Ethics Committee. 
 
Experimental Design 
The cyclists visited the laboratory on three occasions; for a screening/familiarisation 
session, a maximal exercise test, and a constant load test with blood sampling before and 
after exercise. Peak oxygen consumption (V̇O2peak) was determined during a graded 
exercise test in which the cyclists were allowed to choose a preferred cadence within the 
range of 70–90 rev.min-1. The test was performed on an electromagnetically-braked cycle 
ergometer (Lode Excalibur Sport, Groningen, Netherlands). The cyclists commenced 
cycling at 90 W for 4 min; thereafter intensity increased by 30 W/min until volitional 
fatigue and/or when cadence could not be maintained at a minimum 70 rev.min-1. The 
criteria to determine maximal efforts at the end of a test were: a plateau in V̇O2 (defined as 
an increase in V̇O2 values of less than 1.5 ml.kg-1.min-1 between two consecutive 1-min 
periods in the final part of the test), a maximal value of respiratory exchange ratio ≥ 1.1, a 
maximal heart rate value above 95 % of the age-predicted maximum (220-age) [304]. Each 
cyclist’s second ventilatory threshold (VT2) was determined from the gas-exchange data 
collected during incremental exercise (ParvoMedics' TrueOne® 2400, Utah, USA), using 
the ventilatory equivalents methods [267].  
 
The cyclists refrained from exercise for 48 h prior to the maximal exercise test and 
experimental trial, and avoided consumption of alcohol or caffeine in the previous 24 h, 
and during the exercise and post-exercise sample period. Pre-exercise blood samples were 
collected from the cyclists after an overnight fast. The cyclists then consumed a 
standardised breakfast (2000 kJ) of cereal, milk, and juice and commenced the exercise 
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trial at 0800 hrs. The cyclists performed exercise for 2 h at 90 % VT2 (Monark Ergomedic 
828 E, Sweden). Cardiac rate and rhythm were monitored continuously throughout 
exercise, and cardiac rate was recorded each minute. Pulmonary gas exchange was sampled 
for 4 min at 20-min intervals to ensure that the cyclists were exercising at the work rate 
associated with 90 % VT2 and that no drift in oxygen uptake occurred. The cyclists were 
allowed to drink water ad libitum during exercise. The cyclists were provided with a 
standardised meal (4500 kJ) of sandwiches, and a milkshake at 2.5 h post-exercise. 
 
Blood collection 
Venous blood samples were collected pre-exercise, immediately post-exercise, 2 h, 4 h, 6 
h, 8 h, and 24 h post-exercise. Blood was collected into tubes containing K3EDTA (Becton 
Dickinson, New Jersey, USA). One tube was immediately centrifuged at 1000  g for 15 
min. Plasma was stored in aliquots at -80°C. The remaining blood sample was used for the 
cytokine stimulation assay.  
 
Plasma cortisol analysis 
Plasma cortisol was analysed by ultra-high-performance liquid chromatography tandem 
mass spectrometry described elsewhere [290]. Briefly, plasma samples were treated with 1 
M HCl at room temperature to displace cortisol and cortisone from binding proteins. To 
each sample, the multi-analyte internal standard (d4-dexamethasone, d2-11-deoxycortisol 
and d2-cortisone) and H2O were added before loading onto activated Oasis HLB 1 cc (30 
mg) solid phase extraction cartridges (Waters, Milford, USA). Samples were eluted with 
100 % ethyl acetate, dried at 50°C and reconstituted in 45 % methanol with 2 mmol/L 
ammonium acetate and 0.1 % formic acid. The flow rate of the UHPLC analysis was 0.4 
mL/min, sample injection volume 20 μL, and column temperature 50°C. The tandem mass 
spectrometer was operated in positive mode electron spray ionisation. The total analytical 
run time on the UHPLC MS/MS was 3 min. 
 
 131 
Flow cytometry 
Peripheral blood mononuclear cells (PBMC) were isolated using Ficoll-Paque PLUS (GE 
Healthcare Life Sciences, Milan, Italy) and then counted (Countess® Automated Cell 
Counter, Life Technologies, Carlsbad, CA). Cells were cultured at a concentration of 1 × 
106 cells/mL and stimulated with 1 μg/mL of the mitogen phytohaemagglutinin (PHA) for 
72 h. Following incubation, the supernatant was removed and stored at 80°C for 
subsequent analysis. Th1, Th2 and Th17 cytokine concentrations were quantified using a 
commercially available cytometric bead array kit (BD Pharmingen, San Diego, CA) to 
measure the concentrations of IL-2, IL-4, IL-6, IL-10, TNF, INF-γ and IL-17A from 
supernatant of stimulated samples. In the absence of stimulation with PHA, the 
concentrations of these cytokines was below the detection limit of the assay.  
 
Statistics 
Prior to statistical analysis, all data were tested to determine if they were normally 
distributed. Data that were normally distributed (Figure 3.1) were analysed using one-way 
ANOVA with repeated measures to determine any change over time, with a Bonferroni 
correction applied post hoc when significance was evident. These data are presented as 
mean  SEM. Data that were not normally distributed (Table 3.3) were analysed using the 
non-parametric Friedman’s ANOVA and Wilcoxon signed-rank test. These data are 
presented as median  interquartile range. The Bonferroni correction was used for all 
multiple comparisons, with significance set at p < 0.008 (p < 0.05 divided by the number of 
time points). All statistical analyses were performed using SPSS software version 19.0 
(SPSS Inc., Chicago, USA). Data was further analysed for ‘clinical’ significance using 
magnitude-based inferences [305]. All qualitative analyses based on effect size were 
conducted using a modified statistical spreadsheet (available at 
www.sportsci.org/resource/stats/xPostOnlyCrossover.xls) [306]. Measures were log-
transformed before analysis to symmetrically distribute the non-normally distributed data.  
Magnitudes of effects were determined by standardisation of the log-transformed variable. 
Between-time point standardized differences and effect sizes for all values were calculated 
using the pooled standard deviation [307]. Threshold values for Cohen Effect Size statistics 
were > 0.2 (small), > 0.5 (moderate), and > 0.8 (large). For between-time point 
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comparisons, probabilities were calculated to establish whether the true (unknown) 
differences were lower, similar or higher than the smallest worthwhile difference or 
change. The smallest worthwhile difference for each variable was derived by 
standardisation: 0.20 multiplied by the pooled between-subject standard deviations at each 
time point compared to pre-exercise, based on Cohen’s Effect Size principle [307]. 
Quantitative chances of higher or lower differences were evaluated qualitatively as 
follows: < 1 %, almost certainly not; 1–5 %, very unlikely; 5–25 %, unlikely; 25–75 %, 
possible; 75–95 %, likely; 95–99 %, very likely; > 99 %, almost certain. If the chance of 
higher or lower differences was > 5 %, the true difference was assessed as unclear. 
Otherwise, the change was interpreted as the observed chance [305].  
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Results 
Physical characteristics and exercise values 
Physical characteristics of the cyclists are presented in Table 3.1. Mean heart rate for the 2 
h exercise bout was 161 ± 3 beats.min-1, and mean exercise intensity associated with 90 % 
VT2 occurred at 75.1 ± 0.9 % of V̇O2peak.    
 
Table 3.1. Physical characteristics and aerobic capacity of the cyclists 
Subject Characteristics (n=10) Mean ± SEM 
Age (years) 24.2 ± 1.7 
Height (m) 1.82 ± 0.02 
Body mass (kg) 73.8 ± 2.0 
BMI (kg.m-2) 22.2 ± 0.4 
Absolute V̇O2peak (L.min-1) 4.83 ± 0.1 
Relative V̇O2peak (mL.kg-1.min-1) 65.9 ± 2.3 
Training (km/week) 292.5 ± 28.4 
Data are mean ± standard error of the mean. BMI: body mass index. V̇O2peak: peak oxygen uptake. Training: 
volume in kilometres performed during training per week. 
 
Plasma cortisol 
Figure 3.1 displays plasma cortisol concentration following prolonged heavy-intensity 
exercise. There was no statistically significant change immediately or 2 h post-exercise. 
Plasma cortisol concentration significantly decreased 4 h post-exercise (p < 0.001), when 
compared with the resting pre-exercise concentration, and remained significantly decreased 
at 6 h post-exercise (p < 0.01), 8 h post-exercise (p < 0.001) and 24 h post-exercise (p < 
0.01).   
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Figure 3.1. Plasma cortisol concentration before and after prolonged heavy-intensity cycling. Data represent 
mean ± SEM. *, significantly change compared to ‘Pre-Exercise’ (p < 0.05) 
 
Magnitude-based inferences revealed that compared to pre-exercise, plasma cortisol 
concentration was likely higher immediately post-exercise. The chances that the true 
difference in cortisol was higher/trivial/lower were 94/5/1%. Cortisol was very likely lower 
at 2 h post-exercise (1/2/97 %). Furthermore, compared to pre-exercise, cortisol was almost 
certainly lower at 4 h (0/0/100 %), 6 h (0/0/100 %), and 8 h (0/0/100 %). At 24 h post-
exercise, cortisol was likely lower (4/12/84 %) than pre-exercise values (Table 3.2). 
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Table 3.2. Qualitative analysis of changes in cortisol concentration following prolonged heavy-intensity exercise 
Data presented as percentage difference compared to the pre-exercise concentration. CL: Confidence level. 
 
Table 3.3. T helper cytokine release before and after a bout of prolonged heavy-intensity exercise 
Th1 cytokines: IL-2, TNF, IFN-γ. Th2 cytokines: IL-4, IL-6, IL-10. Th17 cytokine: IL-17A. Data represent median (1st and 3rd quartile).  
 Pre – Post Pre – 2 h Pre – 4 h Pre – 6 h Pre – 8 h Pre – 24 h 
 
% Difference  
(90% CL) 
 
39.4  
(13.2; 65.6) 
 
-24.6  
(-39.8; -9.5) 
 
-58.3  
(-64.7; -52.0) 
 
-63.0  
(-76.7; -49.3) 
 
-70.0  
(-76.8, -63.3) 
 
-38.8  
(-48.0; -29.6) 
Effect Size 1.3 (large) -1.4 (large) -4.2 (large) -3.2 (large) -5.1 (large) -2.2 (large) 
% Chance for value to be 
higher/trivial/lower than Pre  
94/5/1 1/2/97 0/0/100 0/0/100 0/0/100 4/12/84 
Qualitative inference Likely higher Very likely lower Almost certainly 
lower 
Almost certainly 
lower 
Almost certainly 
lower 
Likely lower 
 Pre-exercise Post-exercise 2 h 4 h 6 h 8 h 24 h P value 
 
IL-2 
 
18.9 (3.9, 59.8) 
 
11.5 (2.8, 24.0) 
 
11.2 (2.5, 51.7) 
 
65.8 (8.0, 110.0) 
 
50.7 (10.6, 107.0) 
 
47.4 (13.6, 96.3) 
 
7.1 (1.7, 162.0) 
 
0.141 
TNF 2.0 (1.5, 2.4) 1.8 (1.4, 2.0) 1.8 (1.5, 2.1) 2.3 (2.0, 3.3) 2.9 (1.7, 3.9) 2.0 (1.6, 2.6) 1.9 (1.4, 2.8) 0.488 
IFN-γ 1.1 (1.1, 1.3) 1.1 (1.0, 1.2) 1.2 (1.1, 1.4) 1.3 (1.1, 2.4) 1.6 (1.2, 2.3) 1.8 (1.1, 4.8) 1.1 (1.0, 1.4) 0.103 
 
IL-4 
 
2.0 (1.9, 2.1) 
 
2.1 (2.0, 2.2) 
 
2.1 (1.9, 2.3) 
 
2.0 (1.9, 2.2) 
 
2.0 (1.9, 2.1) 
 
2.0 (2.0, 2.2) 
 
1.9 (1.9, 2.0) 
 
0.227 
IL-6 347.7 (14.3, 835.8) 142.7 (32, 1061.8) 98.3 (30.5, 433.4) 249.9 (112, 706.2) 458.4 (125, 1006) 718.2 (95.7, 990.3) 131.7 (49.9, 606.0) 0.039 
IL-10 4.4 (1.8, 7.5) 2.7 (1.8, 7.2) 4.6 (1.8, 7.4) 5.2 (2.2, 16.1) 11.5 (2.7, 17.0) 6.6 (2.2, 19.3) 3.7 (1.5, 30.0) 0.126 
 
IL-17A 
 
2.8 (2.8, 3.0) 
 
2.9 (2.5, 3.3) 
 
2.7 (2.7, 3.2) 
 
2.8 (2.8, 3.2) 
 
2.8 (2.6, 3.1) 
 
3.0 (2.7, 3.1) 
 
2.8 (2.6, 3.0) 
 
0.500 
T helper cell cytokines  
There were no statistically significant changes in PHA-stimulated production of the T 
helper 1 cytokines IL-2, TNF, and IFN-γ, T helper 2 cytokines IL-4 and IL-10, and T 
helper 17 cytokine IL-17A following exercise (Table 3.3). A significant time effect was 
observed for IL-6; however, post hoc analysis revealed no significant change at individual 
time points after exercise compared with the pre-exercise IL-6 concentration. 
 
Table 3.4 displays changes in Th1 cytokine concentrations. Compared with pre-exercise 
values, the concentration of IL-2 was likely higher than pre-exercise at 4 h (85/15/0 %) and 
8 h (90/10/0 %) post-exercise. The concentration of TNF was also likely higher than pre-
exercise values at 4 h post-exercise (82/17/1 %). Changes in IFN-γ concentration were 
unclear at every time point post-exercise. 
 
Compared to pre-exercise, the concentration of IL-4 was likely higher immediately post-
exercise (79/18/3 %), while the difference in IL-4 during the remaining recovery period 
were unclear (Table 3.5). Compared to pre-exercise, the IL-6 concentration was possibly 
higher at 4 h (68/29/3 %), possibly lower at 6 h (4/42/54 %), and likely higher at 8 h post-
exercise (94/6/0 %). Compared to pre-exercise, IL-10 concentration was likely higher at 4 
h post-exercise (77/23/0 %). 
 
IL-17A concentration compared to pre-exercise was possibly higher than pre-exercise at 8 
h post-exercise (73/25/2 %) (Table 3.6).  
  
Table 3.4. Qualitative analysis of changes in Th1 cytokine concentrations following prolonged heavy-intensity exercise 
 Pre – Post Pre – 2 h Pre – 4 h Pre – 6 h Pre – 8 h Pre – 24 h 
IL-2  
% Difference  
(90% CL)  
 
69.3 
(-75.7; 214.4) 
 
-4.0 
(-33.0; 25.1) 
 
162.2 
(42.5; 281.9) 
 
142.4 
(64.0; 220.7) 
 
115.3 
(34.0; 196.5) 
 
132.6 
(-41.5; 306.6) 
Effect Size (rating) -0.1 (trivial) 0.04 (trivial) 0.5 (moderate) 0.5 (moderate) 0.3 (small) 0.5 (moderate) 
% Chance for value to be 
higher/trivial/lower than Pre  
7/49/44 1/77/22 85/15/0 26/59/15 90/10/1 4/94/2 
Qualitative inference Unclear Trivial Likely higher Unclear Likely higher Trivial 
TNF  
% Difference 
(90% CL) 
 
-3.2 
(-24.7; 18.2) 
 
80.7 
(-55.9; 217.4) 
 
45.4 
(-1.1; 92.0) 
 
145.2  
(-43.8; 334.3) 
 
11.4 
(-9.4; 32.2) 
 
20.5 
(-17.4; 58.4) 
Effect Size (rating) -0.4 (small) 0.5 (moderate) 0.6 (moderate) 0.7 (moderate) 0.1 (trivial) 0.2 (small) 
% Chance for value to be 
higher/trivial/lower than Pre  
6/47/47 56/31/14 82/17/1 69/21/11 44/46/10 60/26/14 
Qualitative inference Unclear Unclear Likely higher Unclear Unclear Unclear 
IFN-γ  
% Difference  
(90% CL) 
 
5.2 
(-32.7; 43.2) 
 
7.3 
(-28.2; 42.8) 
 
11.8 
(-11.9; 35.5) 
 
25.5 
(-4.6; 55.6) 
 
77.0 
(-0.0; 154.1) 
 
21.8 
(-35.5; 79.2) 
Effect Size (rating) -0.5 (moderate) -0.4 (small) -0.2 (small) -0.1 (trivial) 0.2 (small) -0.03 (trivial) 
% Chance for value to be 
higher/trivial/lower than Pre  
11/28/61 11/47/42 18/77/6 45/50/5 50/43/7 33/54/14 
Qualitative inference Unclear Unclear Unclear Unclear Unclear Unclear 
Data presented as percentage difference compared to the pre-exercise concentration. CL: Confidence level. 
Table 3.5. Qualitative analysis of changes in Th2 cytokine concentrations following prolonged heavy-intensity exercise 
 Pre – Post Pre – 2 h Pre – 4 h Pre – 6 h Pre – 8 h Pre – 24 h 
IL-4 
% Difference  
(90% CL)  
 
5.4 
(-0.4; 11.2) 
 
5.1 
(-3.2; 13.4) 
 
4.2 
(-3.6; 11.9) 
 
-0.1 
(-4.3; 4.0) 
 
2.6 
(-3.9; 9.2) 
 
-3.4 
(-8.9; 2.0) 
Effect Size (rating) 0.5 (moderate) 0.4 (small) 0.3 (small) -0.1 (trivial) 0.2 (small) -0.6 (moderate) 
% Chance for value to be 
higher/trivial/lower than Pre  
79/18/3 66/23/10 62/28/11 33/26/41 21/43/35 14/23/62 
Qualitative inference Likely higher Unclear Unclear Unclear Unclear Unclear 
IL-6 
% Difference 
(90% CL) 
 
250.8 
(79.8; 581.3) 
 
159.2 
(-123.0; 441.4) 
 
640.3 
(-195.6; 1476.1) 
 
397.5 
(109.1; 686.0) 
 
461.1 
(87.8; 834.5) 
 
359.7 
(-75.3; 794.7) 
Effect Size (rating) 0.1 (trivial) -0.6 (moderate) -0.2 (small) 0.2 (small) 0.4 (small) 0.04 (trivial) 
% Chance for value to be 
higher/trivial/lower than Pre  
39/54/7 11/60/29 68/29/3 4/42/54 94/6/0 35/64/1 
Qualitative inference Unclear Unclear Possibly higher Possibly lower Likely higher Trivial 
IL-10 
% Difference  
(90% CL) 
 
10.9 
(-27.8; 49.7) 
 
46.7 
(-28.5; 121.8) 
 
63.7 
(19.0; 108.4) 
 
116.5 
(3.9; 229.1) 
 
139.7 
(49.5; 229.8) 
 
153.0 
(10.2; 295.8) 
Effect Size (rating) -0.1 (trivial) 0.4 (small) 0.5 (moderate) 0.6 (moderate) 0.8 (large) 0.9 (large) 
% Chance for value to be 
higher/trivial/lower than Pre  
7/69/25 26/70/4 77/23/0 46/43/11 46/53/0 25/72/3 
Qualitative inference Unclear Trivial Likely higher Unclear Trivial Trivial 
Data presented as percentage difference compared to the pre-exercise concentration. CL: Confidence level. 
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Table 3.6. Qualitative analysis of changes in Th17 cytokine IL-17A concentration following prolonged heavy-intensity exercise 
 Pre – Post Pre – 2 h Pre – 4 h Pre – 6 h Pre – 8 h Pre – 24 h 
IL-17A 
% Difference  
(90% CL)  
 
1.9  
(-3.8; 7.7) 
 
-1.2  
(-10.3; 7.9) 
 
5.2 
(-6.4; 16.9) 
 
4.8 
(-6.5; 16.0) 
 
8.4 
(-5.3; 22.0) 
 
-2.0 
(-11.4; 7.4) 
Effect Size (rating) 0.1 (trivial) -0.1 (trivial) 0.3 (small) 0.2 (small) 0.4 (small) -0.4 (small) 
% Chance for value to be 
higher/trivial/lower than Pre  
29/62/9 15/42/44 51/35/15 17/30/53 73/25/2 31/32/37 
Qualitative inference Unclear Unclear Unclear Unclear Possibly 
higher 
Unclear 
Data presented as percentage difference compared to the pre-exercise concentration. CL: Confidence level. 
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Discussion 
This is the first study to analyse changes in Th1, Th2 and Th17 cytokine production during 
recovery from exercise. It is established that exercise intensity and duration influence the 
cortisol response to exercise. Previously, cycle exercise of comparable intensity (~75 % 
V̇O2peak) and duration (2 h) resulted in a significant increase in cortisol concentration 
immediately post-exercise [308]. Although traditional data analysis in the present study did 
not reveal any statistically significant increase in plasma cortisol immediately post-
exercise, quantitative methods used suggested an increase in plasma cortisol concentration 
was likely, and given results of previous research of similar exercise duration and intensity, 
this result would be expected. 
 
Plasma cortisol concentration decreased below pre-exercise levels from 4 h to 24 h post-
exercise. While the initial decrease (which occurred early in the afternoon) may be 
explained by diurnal variation [309], plasma cortisol concentration remained below resting 
values at 24 h post-exercise. This low plasma cortisol concentration may be clinically 
important when considering the repetitive nature of endurance training day after day. This 
result may indicate that the cyclists were well rested following the exercise bout, and 
would have been able to respond positively to an additional bout of exercise on the second 
morning.   
 
Using traditional data analysis, there were no statistically significant changes in T helper 
cell cytokine secretion at any time point during the post-exercise period in the present 
study (Table 3.3). However, analysis using magnitude-based inferences suggested a 
multitude of changes following exercise. Compared to pre-exercise, IL-2 (Th1) production 
was likely higher at 4 h and again at 8 h post-exercise (Table 3.4), while TNF (Th1) 
production was likely higher at 4 h post-exercise (Table 3.4). IL-4 (Th2) production was 
likely higher immediately post-exercise (Table 3.5), while IL-6 (Th2) production was 
possibly higher at 4 h, possibly lower at 6 h, and likely higher at 8 h post-exercise (Table 
3.5). IL-10 (Th2) production was likely higher at 4 h post-exercise (Table 3.5), while IL-
17A (Th17) production was possibly higher at 8 h post-exercise (Table 3.6).  
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Previously, intracellular cytokines IL-2 (Th1), IFN-γ (Th1), and IL-4 (Th2) produced by 
CD4+ T cells were used to define T helper cell types and their functional changes. Using 
this method, a Th1-to-Th2 shift was described following exercise and hormone infusion 
[155, 167, 168, 310]. This ‘shift’ occurs when IL-2- and/or IFN-γ-producing T helper cells 
(Th1) decrease in cell concentration, while IL-4-producing T helper cells (Th2) remain 
unchanged. In the present study, no change in IL-2 and IFN-γ occurred immediately post-
exercise (Table 3.4), while IL-4 concentration increased at the same time point (Table 3.5). 
Hence, a shift towards Th2 was observed immediately post-exercise.  
 
Although single intracellular cytokine analysis of T helper cells provides a concise 
explanation of the Th response to exercise, it neglects to consider the magnitude of 
cytokines involved in the T helper cell network. Cytokines are not solely secreted from T 
helper cells, but include cytotoxic T cells, natural killer cells, dendritic cells, macrophages 
and even skeletal muscle [311, 312]. In the present study, stimulated cytokine secretion 
both increased and decreased occurred immediately following exercise (IL-4), and up to 8 
hours post-exercise (IL-2, IL-6 and IL-17A). This presents an intricate pattern of changes 
to consider. In particular, at 4 h post-exercise, the Th1 cytokines IL-2 and TNF, and the 
Th2 cytokines IL-6 and IL-10 were all increased. This concomitant increase and balancing 
of Th1 and Th2 cytokines has been observed previously by measuring intracellular 
cytokine production from unstimulated peripheral blood mononuclear cells following 30 
min of moderate-intensity cycling [312]. In contrast, the present study examined the 
functional ability of peripheral blood mononuclear cells to respond to a stimulus (PHA). 
Interestingly, the release of multiple cytokines was elevated at 4 h post-exercise. These 
responses demonstrate that exercise-induced stress can prime peripheral blood 
mononuclear cells to respond to stimulation [313].    
 
Recently, analysis by magnitude-based inference has received greater use in exercise 
science and clinical settings. As previously stated, using traditional data analysis, there 
were no statistically significant changes in stimulated T helper cell cytokine secretion at 
any time point during the post-exercise period in the present study (Table 3.3). However, 
analysis using magnitude-based inferences suggested various changes following exercise, 
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which may prove clinically significant. This approach may provide insights into what are 
clinically important, yet statistically non-significant results in physiological and 
immunological processes. This study assists in highlighting the importance of considering 
non-traditional methods for data analysis when dealing with small sample sizes, with high 
between-subject variability.  
 
Finally, regarding changes in individual cell populations within the isolated PBMC 
population; previous research has demonstrated changes in circulating concentrations of 
PBMC subsets in response to exercise [1]. The proportion of different cell types making up 
the isolated PBMC population may change at different time points following exercise, 
potentially impacting on the results. Changes in the proportion of discrete cell subtypes 
with exercise could have altered the number of cells capable of responding to the mitogen 
and secreting cytokines. PBMCs consist of monocytes (10 – 30%), dendritic cells (1 – 2%), 
and primarily of lymphocytes (70 – 90%). T cells (45 – 70% of PBMCs), B cells (up to 
15% of PBMCs), and NK cells (up to 15% of PBMCs) make up the predominant portions 
of the lymphocyte population [47]. Whereas, those cells excluded during PBMC isolation 
consist of polymorphonuclear cells (PMNs) such as neutrophils and eosinophils [49]. Of 
the PBMC populations, NK cells are the most responsive to the stress response, followed 
by T cells, monocytes, dendritic cells, and then B cells [104, 111]. As such, with a set 
number of cells collected at each time point (1 × 106 cells/mL), it is likely that following 
exercise the proportion of NK and T cells increased, while the proportion of monocytes, 
dendritic cells and B cells decreased, reaching a peak difference between immediately, and 
2 h post-exercise. This may have an effect on cytokine release, as different cells produce 
different cytokines [314]. It could be argued that changes in cytokine production are less 
due to the direct effect of catecholamines and cortisol on cellular function, rather the 
change in representation in circulating cell types driving the change in perceived 
function/cytokine release. 
 
The changes that occurred in T helper cell cytokine release suggest a multifactorial, 
prolonged response to heavy endurance exercise. The fluctuations in cytokine production 
that occurred during recovery from exercise could have important implications for 
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resistance to illness in athletes. While intracellular cytokine analysis following stimulation 
provides a concise explanation of the Th1/Th2 shift, the current study suggests a much 
more complex response to exercise.  
 
Acknowledgements 
We would like to thank James Keane and Sharni Hardcastle for their technical assistance; 
and Dr Sue Hooper for her advice and support.  
 
Author Disclosure Statement 
No competing financial interests exist. 
 
Funding 
This work was supported by Bond University and the Queensland Academy of Sport 
Centre of Excellence in Applied Sports Science Research.  
  
 145 
4. STUDY II – DENDRITIC CELL AND γδ T CELL RESPONSES TO PROLONGED HEAVY 
ENDURANCE EXERCISE 
 
Abstract 
The purpose of this study was to assess alterations in circulating dendritic cell sub-
populations, γδ T cell sub-populations and memory phenotypes after prolonged heavy-
intensity exercise. Ten well-trained endurance cyclists (mean ± SD: age 24.0 ± 4.1 years; 
height 1.81 ± 0.05 m; body mass 73.3 ± 5.8 kg; peak oxygen uptake 60.7 ± 4.6 mL.kg-
1.min-1) performed 2 h of cycling exercise at 90% of their second ventilatory threshold. 
Blood samples were collected before exercise, immediately post-exercise, 1 h, 2 h, 4 h, and 
6 h post-exercise. Flow cytometry was used to examine γδ T cell subsets, dendritic cell 
phenotypes, memory phenotypes and receptor expression. A significant decrease in cell 
concentration was evident in γδ T cells and the δ2 subset up to 4 h post-exercise. 
Phenotypical differentiation revealed a significant decrease in naïve and central memory δ2 
cells. Additional analysis revealed preferential egress of γδ T cells expressing CD11ahigh 
and CD62Lhigh. Finally, a significant decrease was evident in total dendritic cells at 1 h 
post-exercise, together with decreases in myeloid dendritic cells and CD14-/lowCD16+ 
dendritic cells up to 2 h post-exercise. These results suggest an exercise-stress-induced 
egress of γδ T cells from the circulation with greater propensity for tissue and lymph node 
homing for a period of 4 h after intense exercise.   
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Introduction 
Stress-induced leucocyte redistribution is a well-documented phenomenon [102]. The rapid 
ingress of neutrophils and lymphocytes into circulation in response to stressors such as 
psychological stress [104], exercise [1], and surgery [105] follows a distinct pattern. This 
involves a redistribution of cells from areas of storage into the blood vessels (ingress) and 
out to the tissues (egress) [106, 107]. Specifically, prolonged heavy-intensity exercise—
defined here as sustainable exercise of duration > 1.5 h, above the anaerobic threshold—
induces cell redistribution of lymphocyte and granulocytes from immediately, until up to 8 
h, following exercise [1, 107]. Changes in cellular redistribution and function of 
neutrophils, T cells, B cells, and natural killer cells have been thoroughly characterized 
during the immediate response to, and recovery from, prolonged heavy-intensity exercise 
[1, 197, 308]. This research has led to the ‘open window’ hypothesis of risk of illness with 
exercise [107]. To date, changes in γδ T cells and dendritic cells in response to exercise 
have received less attention, and may provide further information as to the cellular 
response to exercise.  
 
γδ T cells have been labelled ‘the bridge between innate and adaptive immunity’ [78]. 
These cells perform MHC-independent activation, T cell receptor-dependent recognition of 
conserved antigens, and can act as professional antigen presenting cells. They also have 
protective memory and reactive memory capabilities [78, 79]. Two major subsets (δ1 and 
δ2)—which are further divided into four memory phenotypes (according to presence of 
CD45RA and CD27)—are used to distinguish the specific roles of γδ T cells [79]. 
Alterations in naïve (CD45RA+/CD27+), central memory (CD45RA-/CD27+), effector 
memory (CD45RA-/CD27-) and terminally differentiated effector memory 
(CD45RA+/CD27-) phenotypes can be characterized. Previously, acute exercise bouts of 20 
to 30 minutes caused egress of γδ T cells immediately post-exercise [104, 160]. More 
detailed phenotypical analysis revealed psychological stress mobilises cells with high 
cytotoxic capabilities, tissue homing potential, and the capacity for rapid, innate-like target 
recognition [163]. These previous studies examined short duration stress and exercise, with 
the immediate ingress of cell subsets into circulation. The present study aimed to analyse 
changes in these cell types following a much more prolonged stress stimulus, and monitor 
the redistribution (ingress and egress) during the 6-hour period following exercise.  
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Dendritic cells (DCs) functioning as professional APCs in the blood appear to have 
immature/precursor characteristics, because they undergo a maturation process after 
entering the tissue [63]. As such, exercise-induced redistribution may have considerable 
effects on dendritic cell function. Myeloid DCs (HLA.DR+/lin-/CD11c+) are able to 
stimulate allogen- and antigen-specific T cell responses. By contrast, plasmacytoid DCs 
(HLA.DR+/lin-/CD123+) are closely involved in regulatory T cell and cytotoxic T cell 
activation, and regularly migrate to secondary lymphoid organs. CD16+ DCs 
(HLA.DR+/lin-/CD11c+/CD16+) are derived from monocytes, and activate T helper cells in 
an allogeneic fashion [65, 74]. Together, these cells play a crucial role in initiating and 
regulating both cellular and humoral immune responses. Previous research has revealed 
that following a marathon, myeloid DCs increase significantly, while plasmacytoid DCs 
decreased significantly below pre-exercise values [164]. Following a 1-hour ice-hockey 
training session, both myeloid and plasmacytoid DCs increased significantly immediately 
after exercise [165]. Neither of these studies examined CD16+ DCs, and included only pre-, 
post-, and 24 h post-exercise samples to examine redistribution. Further research is 
warranted to identify and understand changes in redistribution of this rarely examined cell 
type during the early phase of recovery from exercise. 
 
Very little research is currently in the literature examining exercise- or stress-induced 
changes in γδ T cells and dendritic cells. Importantly, these cells are involved heavily in 
regulation, antigen presentation and innate recognition. Prolonged heavy-intensity exercise, 
in the form of single acute bouts or extended periods of heavy training, has been suggested 
to induce short term immune suppression [1, 296]. As such, the aim of the study was to 
analyse γδ T cell and dendritic cell redistribution following an acute stressor of prolonged 
heavy-intensity exercise.  
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Methods 
Subjects  
Ten well-trained male cyclists volunteered to participate in the present study.  Physical 
characteristics of the cyclists are presented in Table 4.1. Subjects were excluded if they 
exhibited any cardiovascular, metabolic, neurological, immunological or autoimmune 
disorders. The cyclists provided written informed consent for participation in the study, 
which was approved by the Bond University Human Research Ethics Committee. 
 
Table 4.1. Physical characteristics, aerobic capacity, threshold performance data, and physiological variables 
during exercise of the cyclists 
Subject Characteristics (n=10) Mean ± SD 
Age (years) 24.0 ± 4.1 
Height (m) 1.81 ± 0.05 
Body mass (kg) 73.3 ± 5.8 
BMI (kg.m-2) 22.3 ± 1.4 
Absolute V̇O2peak (L.min-1) 4.4 ± 0.4 
Relative V̇O2peak (mL.kg-1.min-1) 60.7 ± 4.6 
Peak Power (W) 445 ± 41 
Peak Power-to-weight (W/kg) 6.1 ± 0.5 
VT1 Power (W) 287 ± 28 
VT1 Power-to-weight (W/kg) 3.9 ± 0.3 
VT2 Power (W) 346 ± 27 
VT2 Power-to-weight (W/kg) 4.7 ± 0.4 
Training (km/week) 
Mean HR (beats.min-1) 
Mean V̇O2 (L.min-1) 
Mean Cadence (revolutions.min-1) 
Mean Power output (W) 
348 ± 57 
153 ± 11 
3.4 ± 0.3 
94 ± 4 
296 ± 18 
Data are mean ± standard deviation. BMI: body mass index. V̇O2peak: peak oxygen uptake. VT1: first 
ventilator threshold. VT2: second ventilator threshold. Training: volume in kilometres performed during 
training per week. HR: heart rate. 
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Experimental Design 
The cyclists visited the laboratory on three occasions; for a screening/familiarization 
session, a maximal exercise test, and a constant load test with blood sampling before and 
after exercise. Each session was separated by at least three days during which time they 
were permitted to train as normal. Throughout the testing period, cyclists were required to 
report any upper respiratory or gastrointestinal symptoms. Peak oxygen consumption 
(V̇O2peak) was determined during a graded exercise test in which the cyclists were allowed 
to choose their preferred cadence within the range of 70–90 rev.min-1. The test was 
performed on an electromagnetically braked cycle ergometer (Lode Excalibur Sport, 
Groningen, Netherlands). The cyclists commenced cycling at 90 W for 4 min; thereafter 
intensity increased by 30 W/min until volitional fatigue and/or when the cyclists could not 
maintain their cadence above 70 rev.min-1. The criteria to determine maximal effort at the 
end of a test were: a plateau in V̇O2 (defined as an increase in V̇O2 values of less than 1.5 
ml.kg-1.min-1 between two consecutive 1-min periods in the final part of the test), a 
maximal value of respiratory exchange ratio ≥ 1.1, a maximal heart rate value above 95% 
of the age-predicted maximum (220-age) [304]. Each cyclist’s first (VT1) and second 
(VT2) ventilatory threshold was determined from the gas-exchange data collected during 
incremental exercise (Medgraphics® 2400, Utah, USA), using the ventilatory equivalents 
methods [267].  
 
The cyclists refrained from exercise for 48 h prior to the maximal exercise test and the 
experimental trial, and avoided consumption of alcohol or caffeine in the previous 24 h, 
and during the exercise and post-exercise sample period. Pre-exercise blood samples were 
collected from the cyclists after an overnight fast. The cyclists then consumed a 
standardized breakfast (2000 kJ) of cereal, milk, and juice and commenced the 
experimental trial at 8 a.m. hrs. The cyclists performed exercise for 2 h at 90% VT2 on a 
stationary cycle ergometer (Monark Ergomedic 828 E, Sweden). Heart rate was monitored 
continuously throughout the exercise. Pulmonary gas exchange was sampled for 4 min at 
20-min intervals to ensure that the cyclists were exercising at the work rate associated with 
90% VT2 and that no drift in oxygen consumption occurred. The cyclists were allowed to 
drink water ad libitum during exercise. Immediately after exercise, a venous blood sample 
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was collected. Additional blood samples were collected 1 h, 2 h, 4 h, and 6 h post-exercise. 
The cyclists were provided with a standardized meal following the blood collection at 2 h 
post-exercise. The meal consisted of sandwiches and a milkshake (4500 kJ). 
 
Flow cytometry 
Venous blood was sampled from an antecubital vein and collected into blood collection 
tubes containing K3EDTA (BD Vacutainer, New Jersey, USA). Samples were analysed to 
determine a full blood cell count (Coulter HmX Hematology Analyzer, Beckman Coulter). 
Cells were identified by immunofluorescent antibody staining of whole blood using four-
color flow cytometry (FACS-Calibur, BD Biosciences). Flow cytometric analysis was 
completed within six hours of blood collection. 
 
Lymphocyte subsets 
Total γδ T cells, δ1 and δ2 subsets, memory phenotypes, and surface molecules were 
determined using the following antibodies; CD3 PerCP (BD Biosciences), Vδ-1 TCR FITC 
(Thermo Scientific), γδ TCR APC, Vδ-2 TCR APC, CD27 FITC, CD27 PE, CD45RA 
APC, CD11a FITC, CD62L PE, CD94 FITC (BD Pharmingen) [163]. Briefly, 100 µL 
whole blood were incubated with appropriate amounts of antibody (as determined by 
titration) for 30 min in the dark at room temperature. Erythrocytes were subsequently lysed 
using FACS lysing solution (BD Bioscience). Following lysis, samples were centrifuged 
(350  g, 5 min, at room temperature). Samples were then washed and fixed in 1% 
paraformaldehyde. Fixed preparations were analysed immediately, collecting a minimum 
of 100,000 total events from each sample. Appropriate, matched isotype controls were used 
to set negative staining criteria. The FACS-Calibur flow cytometer (BD Biosciences) was 
calibrated weekly using Calibrite beads (BD Biosciences). Total lymphocytes were gated 
using forward versus side scatter. γδ T cells were then gated as the CD3+ γδ TCR+ 
population, δ1 T cell were gated as CD3+Vδ1+ and δ2 T cells were gated as CD3+ Vδ2+. 
Lymphocyte subset numbers were quantified using the percentage values obtained from 
each lymphocyte subset gate. The total lymphocyte concentration was obtained from the 
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full blood count. Percentage values of subsets were multiplied by the total lymphocyte 
concentration to determine absolute concentrations of target lymphocyte subsets. 
 
Dendritic cell phenotypes 
Total dendritic cells (tDCs), dendritic cell phenotypes (pDCs, mDCs, CD14-/lowCD16+ 
DCs), and total monocytes were identified by the combination of HLA-DR PerCP, lineage 
cocktail 2 FITC (CD3, CD14, CD19, CD20, CD56), CD123 PE (BD Bioscience), CD33 
APC, CD11c PE and CD16 APC (BD Pharmingen) antibodies. Expression of CD33 and 
HLA-DR and absence of the lineage cocktail 2 with intermediate forward (FSC) and side 
scatter (SSC) between those of lymphocytes and monocytes was used to determine tDCs. 
Dendritic cells were further defined into three subpopulations: (1) a subset of 
CD123dim/CD33high/CD16- cells, with strong expression of HLA-DR–mDCs; (2) a subset 
of CD123inter/CD33inter/CD16+ cells–CD14-/lowCD16+ DCs and (3) CD123high/CD33-
/dim/CD16- cells–pDCs, both with intermediate expression of HLA-DR. Monocytes were 
identified as expressing CD33, CD14 and HLA-DR and by their forward and side scatter 
characteristics [289]. Absolute counts were quantified using percentage values obtained 
from each lymphocyte and monocyte subset gate. The total monocyte concentration was 
obtained from the full blood count. 
 
Statistics 
All statistical analyses were performed using SPSS software version 19.0 (SPSS Inc., 
Chicago, USA).  Data at each time point were compared using one-way ANOVA with 
repeated measures. Bonferroni correction was applied post hoc when significance was 
evident. Normally distributed data are presented as the mean and standard deviation (SD). 
The criterion for significance was set at p<0.05. Non-normally distributed data (as defined 
by testing the assumptions of normality, homogeneity of variance and sphericity) were 
analysed using Friedman’s ANOVA. In the result of significant main effect (p<0.05), 
Wilcoxon signed-rank test was employed post hoc for comparisons between pre-exercise 
and subsequent time points. The criterion for significance was adjusted for multiple time 
points to p<0.01. Non-normally distributed data are presented as the median ± 1st and 3rd 
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quartile. To examine the effect of resting concentration on cellular egress; data for 
lymphocyte and dendritic cell subsets were also divided into “low” and “high” 
concentration groups according to their resting concentration. Percentage changes from 
pre-exercise to nadir values were included. Additionally, the relationship between pre-
exercise cell concentration and nadir cell concentration was explored using Spearman rank 
data correlation analysis to test for correlations. P<0.05 was accepted as significant. 
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Results 
Physiological variables during exercise 
Mean heart rate for the 2 h exercise bout was 153 ± 11 beats.min-1, while mean power was 
296 ± 18 W with a mean V̇O2 of 3.4 ± 0.3 L.min-1 corresponding to 76.5 ± 2.5 % of 
V̇O2peak.    
  
Full Blood Count 
A significant time effect was evident for total lymphocytes; however post hoc analysis did 
not reveal a significant change between pre-exercise and any time point (Figure 4.1). 
Prolonged heavy exercise induced a significant increase in the concentration of circulating 
granulocytes (Figure 4.2). To examine cellular egress, data for total lymphocytes are also 
presented in “low” and “high” concentration groups according to resting concentration. 
The “low” and “high” concentration groups decreased by 4.14% and 21.07%, respectively 
from pre-exercise to nadir at 2 h post-exercise. When examining pre-exercise lymphocyte 
concentration versus the difference between pre-exercise and nadir values, there was a 
significant negative relationship (r = -0.80, p<0.01). Furthermore, changes in granulocyte 
and monocyte ingress were examined by dividing into “low” and “high” concentration 
groups according to their resting concentrations. For granulocytes, “low” and “high” 
concentration groups increased by 198.6% and 169.3%, respectively from pre-exercise to 
peak at 1 h post-exercise. When examining pre-exercise granulocyte concentration versus 
the difference between pre-exercise and peak values, no significance was found (r = 0.16, 
p=0.66). For monocytes, “low” and “high” concentration groups increased by 32.0% and 
39.0%, respectively from pre-exercise to peak at 2 h post-exercise. When examining pre-
exercise monocyte concentration versus the difference between pre-exercise and peak 
values, no significance was found (r = 0.02, p=0.95). 
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Figure 4.1. Total lymphocyte concentration (A), and lymphocyte concentration presented as individual 
samples divided into “low” and “high” concentration groups (B) before and after a bout of prolonged heavy-
intensity exercise. Time effect: p <0.001. 
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Figure 4.2. Total granulocyte (A) and monocyte (B) concentrations before and after a bout of prolonged 
heavy-intensity exercise. Data represent mean ± SD. Time effect: Granulocytes; p <0.001, Monocytes; 
p=0.178. *, significantly different from pre-exercise, p<0.05. 
 
Total γδ T cells 
Prolonged heavy exercise reduced the concentration of circulating γδ T cells (Figure 4.3). 
A significant time effect was evident for both γδ T cells (Figure 4.3) and the δ2 subsets 
(Figure 4.5). Post hoc analysis revealed that both γδ T cells and the δ2 subsets were 
significantly lower than pre-exercise values at 1 h, 2 h, and 4 h post-exercise (p<0.01). 
There were no significant changes in the δ1 subset at any time point. Data for total γδ T 
cells, and δ1 and δ2 subsets are also presented in “low” and “high” concentration groups. 
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The “low” and “high” concentration groups decreased by 37.9% and 47.7% (Total γδ), 
6.9% and 39.1% (δ1), and 45.1% and 56.8% (δ2), respectively from pre-exercise to nadir 
values. When examining pre-exercise concentration versus the difference between pre-
exercise and nadir values, there was a significant relationship in total γδ (r = -0.93, 
p<0.001), δ1 (r = -0.83, p<0.01), and δ2 (r = -0.95, p<0.001). 
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Figure 4.3. Total γδ T cell concentration (A), and individual concentrations of γδ T cells divided into “low” 
and “high” concentration groups (B) before and after a bout of prolonged heavy-intensity exercise. Data 
represent median (1st and 3rd quartile). *, significantly different from pre-exercise, p<0.01. 
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Figure 4.4. δ1 γδ T cell subset concentration (A), and individual concentrations of δ1 γδ T cells divided into 
“low” and “high” concentration groups (B) before and after a bout of prolonged heavy-intensity exercise. 
Data represent median (1st and 3rd quartile).  
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Figure 4.5. δ2 γδ T cell subset concentration (A), and individual concentrations of δ2 γδ T cells divided into 
“low” and “high” concentration groups (B) before and after a bout of prolonged heavy-intensity exercise. 
Data represent median (1st and 3rd quartile). *, significantly different from pre-exercise, p<0.01. 
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Figure 4.6. δ1 naïve (A), central memory (B), CD45RA+ effector memory (C) and effector memory (D) 
phenotype concentrations before and after a bout of prolonged heavy-intensity exercise. Data represent 
median (1st and 3rd quartile). NA: naïve. CM: central memory. EM: effector memory. EMRA: CD45RA+ 
effector memory.  
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δ1 and δ2 memory phenotypes 
Both δ1 and δ2 γδ T cell subsets were further divided into four memory phenotypes, 
according to expression of CD45 and CD27 antigens. A significant time effect was evident 
for changes in naïve, central memory and effector memory δ2 γδ T cell memory 
phenotypes (Figure 4.7). Post hoc analysis revealed that naïve δ2 cell concentration was 
significantly lower than pre-exercise values at 1 h, 2 h, and 4 h post-exercise , while central 
memory δ2 γδ T cell concentration was significantly lower than pre-exercise values at 1 h 
and 2 h post-exercise (p<0.01). 
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Figure 4.7. δ2 naïve (A), central memory (B), CD45RA+ effector memory (C) and effector memory (D) 
phenotype concentrations before and after a bout of prolonged heavy-intensity exercise. Data represent 
median (1st and 3rd quartile). NA: naïve. CM: central memory. EM: effector memory. EMRA: CD45RA+ 
effector memory. *, significantly different from pre-exercise, p<0.01. 
 
 160 
CD11a, CD62L and CD94 expression 
γδ T cells were defined by expression of adhesion molecules (CD11a and CD62L) and the 
NK receptor CD94. CD11a γδ T cells were separated into CD11ahigh and CD11alow subsets. 
A significant time effect was evident for changes in CD11ahigh γδ T cells, with post hoc 
analysis revealing a significant decrease from pre-exercise to 1 h, 2 h, and 4 h post-exercise 
(p<0.01) (Figure 4.8). CD11a expression on γδ T cells are also presented in “low” and 
“high” concentration groups according to total γδ T cells resting concentration. The “low” 
and “high” groups decreased by 5.6% and 18.4% (CD11alow), 38.6% and 45.5% 
(CD11ahigh), respectively to nadir values. In examining pre-exercise concentration versus 
the difference between pre-exercise and nadir values, there was a significant relationship in 
CD11ahigh (r = -0.91, p<0.001), but not in CD11alow (r = -0.30, p=0.41). 
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Figure 4.8. High (A) and low (C) expression of CD11a on γδ T cells, and individual concentrations of these 
subsets divided into “low” and “high” concentration groups (B and D) before and after a bout of prolonged 
heavy-intensity exercise. Data represent median (1st and 3rd quartile). All data non-normally distributed. *, 
significantly different from pre-exercise, p<0.01. 
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CD62L expression reflects lymph node-migratory potential, and can be divided into 
CD62Lhigh and CD62Llow γδ T subsets. There was a significant time effect evident for 
changes in the both subsets. Post hoc analysis revealed that CD62Lhigh γδ T cell 
concentration  was significantly lower than pre-exercise values at 1 h, 2 h, and 4 h post-
exercise, while CD62Llow/- γδ T cell concentration was significantly lower than pre-
exercise values at 1 h post-exercise (p<0.01) (Figure 4.9). Data for expression of CD62L 
on γδ T cells are also presented in “low” and “high” concentration groups according to the 
resting concentration of total γδ T cells. The “low” and “high” concentration groups 
decreased by 38.1% and 44.8% (CD62Llow), and 37.5% and 44.8% (CD62Lhigh), 
respectively from pre-exercise to nadir values. When examining pre-exercise concentration 
versus the difference between pre-exercise and nadir values, there was a significant 
positive relationship in CD62Llow (r = 0.95, p<0.001), and CD62Lhigh (r = 0.82, p<0.01). 
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Figure 4.9. High (A) and low (C) expression of CD62L on γδ T cells, and individual concentrations of these 
subsets divided into “low” and “high” concentration groups (B and D) before and after a bout of prolonged 
heavy-intensity exercise. Data represent median (1st and 3rd quartile). All data non-normally distributed. *, 
significantly different from pre-exercise, p<0.01. 
 
CD94 γδ T cells were defined as CD94+ and CD94- in relation to innate recognition of 
aberrant MHC expression on infected and cancerous cells. A significant time effect was 
evident in both CD94+ and CD94- cells. Post hoc analysis revealed that both CD94+ and 
CD94- γδ T cell concentrations were significantly lower than pre-exercise values at 1 h, 2 
h, and 4 h post-exercise (p<0.01) (Figure 4.10). Data for expression of CD94 on γδ T cells 
are also presented in “low” and “high” concentration groups according to the pre-exercise 
concentration of total γδ T cells. The “low” and “high” concentration groups decreased by 
10.5% and 39.0% (CD94+), and 49.5% and 52.5% (CD94-), respectively from pre-exercise 
to nadir values. When examining the relationship between pre-exercise concentration and 
the difference between pre-exercise and nadir values, there was a significant relationship in 
CD94+ (r = -0.84, p<0.01), and CD94- (r = -0.93, p<0.001). 
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Figure 4.10. Positive (A) and negative (C) expression of CD94 on γδ T cells, and individual concentrations of 
these subsets divided into “low” and “high” concentration groups (B and D) before and after a bout of 
prolonged heavy-intensity exercise. Data represent median (1st and 3rd quartile). All data non-normally 
distributed. *, significantly different from pre-exercise, p<0.01. 
 
Dendritic cell phenotypes 
Exercise stimulated changes in total dendritic cells and cell phenotypes. A significant time 
effect was evident for changes in tDCs (Figure 4.11), mDCs (Figure 4.12), pDCs (Figure 
4.13) and CD14-/lowCD16+ DCs (Figure 4.14). Post hoc analysis revealed that mDC and 
CD14-/lowCD16+ DC concentrations were significantly lower than pre-exercise values at 1 
and 2 h post-exercise (p<0.01). Data for total DCs, and its phenotypes are also presented in 
“low” and “high” concentration groups according to the resting concentration of total DCs. 
The “low” and “high” concentration groups decreased by 31.7% and 29.3% (tDCs), 21.7% 
and 35.4% (pDCs), 33.1% and 25.4% (mDCs), and 54.4% and 61.2% (CD16+DCs), 
respectively from pre-exercise to nadir values. When examining pre-exercise concentration 
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versus the difference between pre-exercise and nadir values, there was a significant 
positive relationship in tDCs (r = -0.64, p<0.05), pDCs (r = -0.85, p<0.001), and 
CD16+DCs (r = -0.93, p<0.001), but not in mDCs (r = -0.55, p=0.1). 
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Figure 4.11. Total dendritic cell concentration (A), and individual concentrations divided into “low” and 
“high” concentration groups (B) before and after endurance exercise. Data (A) represent median (1st and 3rd 
quartile). *, significantly different from pre-exercise p<0.01. 
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Figure 4.12. Myeloid dendritic cell concentration (A), and individual concentrations divided into “low” and 
“high” concentration groups (B) before and after endurance exercise. Data (A) represent median (1st and 3rd 
quartile). *, significantly different from pre-exercise p<0.01. 
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Figure 4.13. Plasmacytoid dendritic cell concentration (A), and individual concentrations divided into “low” 
and “high” concentration groups (B) before and after endurance exercise. Data (A) represent median (1st and 
3rd quartile). *, significantly different from pre-exercise p<0.01. 
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Figure 4.14. CD14-/lowCD16+ dendritic cell concentration (A), and individual concentrations divided into 
“low” and “high” concentration groups (B) before and after endurance exercise. Data (A) represent median 
(1st and 3rd quartile). *, significantly different from pre-exercise p<0.01. 
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Discussion  
The present study examined changes in γδ T cell and dendritic cell subsets in peripheral 
blood in response to prolonged heavy-intensity exercise. Results revealed a significant 
decrease in the concentration of γδ T cells, due to redistribution of the δ2 subset that 
persisted up to 4 h post-exercise. Specifically, naïve (CD45RA+/CD27+), and central 
memory (CD45RA-/CD27+) γδ T cells were predominantly responsible for the decrease in 
the δ2 subset.  Furthermore, data was divided into “high” and “low” concentration groups. 
This provided information on the specific cell types mobilised during exercise-induced 
stress, and the influence of resting cell concentration on the cellular redistribution. These 
data highlight the transient, biphasic change in circulating γδ T cells following acute 
exercise. A significant time effect was also evident in some cell types (e.g., total 
lymphocytes, δ2 EM, pDCs), changes in the concentrations of these cells were not 
statistically significant (p<0.01) at any specific time point following exercise. 
 
The decrease in γδ T cell concentration occurred despite no significant changes in total 
lymphocyte concentration. This phenomenon suggests aggressive egress of γδ T cells out 
of the circulation, compared with T and B cells.  The absence of any significant change in 
lymphocyte concentration differs from some previous research [1, 107, 315]. However, in 
response to a 2.5-h treadmill run at 75 % of maximal oxygen uptake, there was no 
significant change in lymphocyte concentration immediately post-exercise, while midway 
through the exercise bout, a significant increase occurred [155]. This may reflect the 
duration of the bout and the well trained status of the individuals recruited. As part of the 
immunological response to stress, ingress of lymphocytes into the circulation occurs 
followed by egress out of the blood to target organs such as the skin and lung, or sites of 
immune activation, or back to compartments from which the cells were originally 
mobilised (e.g., the marginated pool, spleen, and bone marrow) [106]. Egress of γδ T cells 
out of circulation in the present study contrasts with the ingress of γδ T cells into 
circulation previously observed following acute psychological stress, 20-min bouts of low- 
and high-intensity exercise, and β-agonist infusion [104]. This difference in redistribution 
of γδ T cells between the present study and that of Anane et al. likely reflects differences in 
the types of stress, the elapsed time between initial activation of the stress response, and 
subsequent timing of blood samples [156].  
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While the δ1 subset remained unchanged, the δ2 subset decreased significantly in 
concentration during the post-exercise period (Figure 4.4, 4.5). This difference may reflect 
differences in the functions of the two subsets. The δ2 subset accounts for the majority of 
γδ T cells in circulation [79]. These cells function importantly in the role of TCR-
dependent activation by phosphoantigens, enabling them to respond to a large range of 
pathogens [79]. Conversely, the δ1 subset is predominantly found in the mucosa, the skin 
and intestines, representing only a minor proportion of γδ T cells in peripheral circulation. 
These δ1 γδ T cells exert important functions in local epithelial immune surveillance, and 
assist in local wound healing [316]. Different changes in these subsets have also been 
reported following psychological stress, when there was a trend towards greater ingress of 
δ2 into circulation [163]. Caution is advised when comparing cell ingress versus cell 
egress, because the magnitude of initial cell ingress does not always reflect the degree of 
delayed cell egress [106]. Naïve and central memory γδ T cells were largely responsible for 
the decrease in the δ2 subset concentration that we observed after exercise. It would seem 
at odds that naïve and central memory phenotypes are preferentially redistributed, when 
both effector memory phenotypes possess immediate effector functions [317]. Perhaps, the 
ability for rapid cell expansion in response to antigen or cytokine stimulation provides a 
distinct innate advantage compared to cells with immediate specific effector responses 
(e.g., effector memory and effector memory RA γδ T cells) [85]. 
 
Differentiation of cell phenotype through cell surface antigen expression further 
highlighted the functional diversity of the γδ T population. A significant decrease was 
observed in CD11ahigh γδ T cell concentration up to 4 h post-exercise. This may be 
expected, because CD11a functions in cellular adhesion, is typically up-regulated on 
endothelial cells in the proximity of inflamed tissues [92], and is highly sensitive to 
catecholamine secretion [162]. Additionally, psychological stress triggers selective ingress 
of γδ T cells that express high levels of CD11a [163]. Both CD62Lhigh and CD62Llow γδ T 
cells decreased significantly following the 2 h cycling bout. CD62Llow reached a nadir at 1 
h post-, while CD62Lhigh remained significantly below pre-exercise concentration until 4 h 
post-exercise. The discrepancy between ‘high’ and ‘low’ CD62L expression following 
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stress has been observed in T helper cells, cytotoxic T cells, NK cells and B cells [106, 
318], and likely reflects the successive decrease in CD62L expression with the progressive 
increase in phenotype maturity [79, 86]. Finally, both CD94+ and CD94- γδ T cell 
concentrations were significantly lower than pre-exercise values up to 4 h post-exercise. 
Both subsets are mobilised following psychological stress [163], and it appears there is no 
preference as to cytotoxic capability when undergoing egress following exercise-induced 
stress.  
 
Total dendritic cell concentration significantly decreased from pre-exercise to 1 h post-
exercise. This was highlighted by a significant decrease in mDCs and CD14-/lowCD16+ DCs 
up to 2 h post-exercise. Because dendritic cells undergo a maturation process after entering 
the tissue [63], the effects of stress-induced redistribution may have important implications 
for immune surveillance in the periphery [319]. Previous research has reported that 
dendritic cell concentration increases acutely following surgery, or a treadmill exercise test 
to exhaustion, with an equal rise in mDCs and pDCs [105]. Furthermore, immediately 
following a marathon race, mDC concentration increases, while pDC concentration 
decreases [164]. Collectively, these results may reflect cellular redistribution as observed 
following acute stress in mice [319]. The difference in egress between mDCs and pDCs 
reflects specific functions of these cell types. mDCs are characteristically first responders 
to pathogens and other causes of inflammation and are able to stimulate allogen- and 
antigen-specific T cell responses [74]. The ability of these cells to respond to stress and be 
redistributed to areas of infection is likely important and reflective of the results in the 
present study. Additionally, mDCs are reported to mainly trigger a Th1-immune response 
[320], whereas pDCs trigger a Th2-immune response [321]. The decrease in Th1-related 
mDCs and no change in Th2-related pDCs is a similar response to changes in Th1 and Th2 
cells in circulation following a 2.5-h treadmill run, where type 1 cells decreased while type 
2 cells remained unchanged 2 h after exercise [155]. Similar to mDCs, CD16+ DCs are 
involved in T cell activation through allogeneic stimulation and type 1 cytokine responses 
[65, 322]. The result of the present study confirms that mDCs and CD16+ DCs also share 
similar characteristics of cellular redistribution following exercise-induced stress. 
Together, these results demonstrate an exercise-induced redistribution of dendritic cells, 
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which features selective egress of those cells with greater ability to stimulate Th1 
responses.  
 
In addition to conventional analysis, individuals were divided into “high” vs “low” 
concentration groups according to circulating cell concentration at rest. The concept of 
sorting subjects into “high” and “low” and/or “non” responder groups has been used in 
research previously, such as when examining the effectiveness of a training program or 
intervention on individuals, either healthy populations [323, 324], diseased populations 
[325, 326], or the highly trained [327]. The concept in the present study is slightly 
different, rather examining the influence of resting cell concentration in peripheral 
circulation on cellular ingress (granulocytes and monocytes) and egress (lymphocytes, γδ T 
cells, and dendritic cells). This is of interest, as i) an acute stressor can cause divergent 
responses in the severity of leucocyte redistribution between individuals, and ii) low 
resting concentrations of cell subsets have been of interest in athletic populations 
previously [328, 329]. A number of interesting observations were identified. Subjects were 
sub-divided into “high” and “low” concentration groups on the basis of the resting 
concentrations of granulocytes, monocytes, lymphocytes, γδ T cells (δ1 and δ2 subsets, and 
CD11a, CD62L, and CD94), and tDCs (mDCs, pDCs, and CD16+ DCs). Although 
statistical analysis did not uncover any significant difference between the “high” and “low” 
concentration groups (n = 5 per group), a number of interesting observations were detected. 
While some subsets appeared to have quite a uniform response between “low” and “high” 
regardless of initial resting concentration, others demonstrated a much more divergent 
response. Concerning cellular ingress; granulocytes and monocytes appeared to feature 
similar changes in cell concentration from rest to peak values, regardless of initial 
concentration. Furthermore, Pearson’s correlation coefficients were r = 0.16 and r = 0.02 
for granulocytes and monocytes, respectively suggesting a small to no correlation between 
resting and peak concentration. For cellular ingress, results varied between cell types. For 
lymphocytes, total γδ T cells, δ1, δ2, CD62L (both low and high subsets), CD11a (both 
low and high subsets), CD94 (both positive and negative subsets), mDCs, and CD16+ DCs 
the “low” resting concentration group resulted in a lower percentage concentration change 
to nadir compared to the “high” resting concentration group. Conversely, tDCs and pDCs 
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saw a higher percentage change in the “low” resting concentration group. Furthermore, 
there was a significant large (0.7 to 1.0) negative correlation between resting and the 
decrease to nadir concentrations for lymphocytes, total γδ T cells, δ1, δ2, CD62L (both low 
and high subsets), CD11ahigh (not low), CD94 (both positive and negative subsets), mDCs, 
and pDCs. For these subsets, it appeared that those individuals with a higher resting 
concentration pre-exercise experienced a greater drop to nadir values during the post-
exercise period, whereas those individuals with a lower resting cell concentration 
experienced less of a drop, and in some cases, an increase in cell concentration. Potentially, 
the magnitude of egress in relation to resting leucocyte concentration may have 
implications for the effectiveness of cellular redistribution following the stress response. It 
is recognised in previous research that elite athletes experience leucopenia at rest driven 
primarily by neutropenia [328, 329]. Furthermore, a high-intensity training block resulted 
in impaired redistribution of CD8+ T lymphocytes in elite cyclists following exercise [330]. 
Questions remain wether this is due to decreased resting concentration of leucocytes or a 
more efficient stress response mounted by the athlete due to regularly experiencing such 
efforts. A previous study has suggested that it may be the latter [329], however this 
research was examining resting concentrations rather than in response to an acute stressor. 
The present study has provided more evidence to suggest resting peripheral cell circulating 
and cellular redistribution are closely linked phenomenon.  
 
Finally, the present study decided not to include a 24 h post-exercise time point. It was 
determined that the 24-h sample was the least important sample, compared to sampling 
closer to the end of the bout of exercise. While countless studies have included time points 
at immediately post-, 1 h post-, and 24 hours post-exercise [104, 105, 150, 153, 155, 159, 
163, 165, 308, 331], very few have examined the period between immediately post- and 6 
h post-exercise [1, 195-197, 332]. This time period was considered more important, both 
within the context of the ‘Open Window’ Theory [44], and when considering athletes 
completing multiple bouts of exercise on the same day. Furthermore, many studies, 
including my Honours research highlighted most immune subsets had returned to resting 
level 24 hours post-exercise, even following repeated exercise [1, 150, 155, 177-179, 187, 
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189], this has also been highlighted in a recent position statement review article [111]. 
Thus more focus was placed on time points from immediately post-, to 6 h post exercise.  
 
In summary, the present study provides novel and detailed insights into the time course of 
changes in γδ T cell subsets and dendritic cells during recovery from prolonged, intense 
physical stress. It has been proposed that an ‘open window’ transiently exists in the hours 
after exercise, whereby individuals are potentially more susceptible to contracting upper 
respiratory illnesses [107]. In the present study, the circulating concentration of most cell 
types decreased during the post-exercise period. Rather than reflecting a decline in 
immunocompetence, it is more likely that this response reflects a change in 
immunosurveillance, whereby cells move selectively to regions of the body where they 
may encounter pathogens (e.g., skin, lungs and gastrointestinal tract) [333]. Alternatively, 
some T cells may also be redistributed to bone marrow, where they could play a role in 
regulating the production of granulocytes [333]. Future research could investigate whether 
alterations in the distribution of γδ T cell subsets and dendritic cells in blood following 
exercise is associated with changes in their capacity to respond to infectious challenges, 
and changes in cellular function. 
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5. STUDY IIIA – THE EFFECT OF REPEATED PROLONGED HEAVY EXERCISE ON T 
HELPER CYTOKINE PROFILES 
 
Abstract 
The purpose of this study was to investigate the effects of prior heavy-intensity exercise on 
whole blood T helper cytokine profiles during recovery from a second bout of exercise. 
Ten well-trained endurance cyclists (mean ± SD: age 23.2 ± 3.2 years; height 1.82 ± 0.06 
m; body mass 74.8 ± 6.2 kg; peak oxygen uptake 59.0 ± 4.3 mL.kg-1.min-1) performed two 
exercise trials on different occasions. On the first occasion, they cycled in the morning and 
afternoon for 1.5 h at 90% of their second ventilatory threshold, with 4 h separating the two 
bouts. On the second occasion, they cycled for 1.5 h at the same intensity, but only in the 
afternoon. Blood samples were collected throughout the recovery period post-exercise. 
Whole blood was stimulated by phorbol 12-myristate 13-acetate (PMA) and ionomycin, 
and a cytometric bead array was used to quantify Th1/Th2/Th17 cytokine production. 
There were significant increases in cytokine production from pre-exercise of Th1 cytokine; 
IL-2, and Th2 cytokines; IL-4 and IL-10. When adjusted according to total leucocyte 
concentration at each time point, a significant increase from pre-exercise was observed in 
Th1 cytokines; IL-2, TNF, and IFN-, and Th2 cytokines; IL-4 and IL-10. However, there 
was no significant difference between the single and repeat exercise bout trials at any time 
point. Importantly, a significant time x trial effect was present in IL-17A production, 
suggesting a potential effect of repeated exercise on the ability to produce IL-17A which 
may be important considering its role in rapid response to infection. 
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Introduction 
Training of endurance athletes typically features repeated exercise bouts of heavy-intensity 
and prolonged duration. Such exercise results in transient changes in circulating leucocyte 
concentrations, and potentially changes in immune function and an increased risk of 
symptoms associated with upper respiratory illnesses (URIs) [1-5]. While acute stress 
(such as regular exercise) exhibits positive effects on the immune system, chronic stress is 
considered harmful, increasing the occurrence of opportunistic infections [102, 108]. 
During a typical exercise training schedule, endurance athletes regularly activate the stress 
response, sometimes without adequate recovery between stressors. This regular stress-
induced immunological challenge can alter the balance between a healthy immune system 
and training-induced immunosuppression [34, 36, 334]. The reported increased incidence 
of symptoms associated with URIs in elite athletes regularly occurs during periods of 
heavy training and competition [3-5, 24, 32, 335]. It has been proposed that repeated 
exercise without sufficient recovery may suppress immune function, which may in turn 
increase susceptibility to URIs [76, 108, 336].  
 
Some previous research has examined immune system function following successive 
exercise bouts [156, 177-188]. Of these studies, a number have examined immune 
variables unrelated to plasma cytokines [156, 177-185, 187, 188]. Furthermore, while these 
studies do examine repeated exercise, the duration of the exercise and/or the recovery 
period or the intensity of the exercise is not comparable to the current study [180-185]. Of 
the previous studies, a number of these have highlighted a ‘carry-over’ or ‘additive’ effect 
of repeated exercise bouts on lymphocyte and neutrophil concentration changes [177-179, 
186-188]. This ‘additive’ effect of repeated exercise in combination with inadequate 
recovery has been hypothesised to lead to chronic suppression of immune function [76]. 
Two studies have examined plasma cytokine concentrations, IL-6 and IL-1ra with repeated 
exercise [186, 189]. While one study highlighted this ‘carry-over’ effect [189], the other 
did not find any significant difference between single and repeat exercise protocols [186]. 
Importantly, these studies examined plasma cytokine concentrations, whereas no previous 
study has examined cytokine production following mitogen stimulation.  
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Mitogen stimulation is used for in vitro assessment of cellular immunity for research 
purposes, in addition to examining patients with immunodeficiencies [231], autoimmunity 
[232], infectious diseases [233], and cancer [234], and is thought to reflect immune 
function in vivo. Stimulating isolated leucocytes allows a functional representation of a 
cellular population at rest, or while under pre-determined controlled conditions. A common 
cell stimulation cocktail used in immunology research combines phorbol 12-myristate 13-
acetate (PMA) and ionomycin [235]. Treatment with PMA and ionomycin is sufficient to 
induce activation of many cell types to produce cytokines [236, 257]. This cocktail can be 
used to induce cytokine production in in vitro cell culture for subsequent detection in 
immunoassays, either by ELISA, cytometric bead array [258], or intracellular cytokine 
identification [155]. PMA is a small organic compound which diffuses through the cell 
membrane into the cytoplasm, where it directly activates protein kinase C (PKC). 
Activation of PKC triggers calcium ion release and mobilisation, resulting in a cascade of 
additional cellular responses mediating T-cell activation [259]. Ionomycin, a calcium 
ionophore produced by the bacterium Streptomyces conglobatus, is used in addition to 
PMA to trigger calcium release, which is required for nuclear factor of activated T-cell 
(NFAT) signalling [260]. Stimulation with these compounds bypasses the TCR complex 
and will lead to activation of several intracellular signalling pathways [261]. This 
activation results in a rapid up-regulation of cytokine production. Previously, the combined 
stimulation with PMA and ionomycin was used in analysis of intracellular cytokines 
following a 2.5 h bout of cycling [155, 159], and a 1.5 h bout of running [159]. Both 
studies demonstrated exercise-induced changes in type 1 cytokine-producing T cells. 
 
Exercise-induced stress alters glucocorticoid and catecholamine concentrations. 
Importantly, these stress hormones influence T helper cell function, altering cytokine 
release, principally by stimulating glucocorticoid and β2 adrenergic receptors, respectively 
[166]. In turn, these stress hormones influence the activity of cellular (Th1), humoral 
(Th2), and mucosal (Th17) branches of the immune response [166, 167]. Specifically, 
cortisol, epinephrine and norepinephrine may suppress cytokine release from antigen 
presenting cells and Th1 cells, while up-regulating cytokine production from Th2 cells, 
thereby causing a shift toward Th2 cytokine production [155, 168]. The balance between 
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Th1 and Th2 immunological responses is very important in maintaining optimum immune 
health. Furthermore, Th17 cells play a key role in mucosal host defence of the upper 
respiratory and gastrointestinal tracts against a myriad of airborne antigens [297-299]. 
Functioning as part of the “first line of defence” in the mucosa, Th17 cytokines have been 
linked to increased polymeric immunoglobulin receptor (IgR) expression, saliva sIgA and 
human β-defensin 2 release [300-303]. The effect of repeat exercise may alter this 
relationship. Previous research has highlighted a ‘compounding’effect of repeated exercise 
on circulating epinephrine, norepinephrine and cortisol concentrations [177]. However, it is 
unknown how the T helper system would be affected by this increasing response. Previous 
research has examined changes in the balance of Th1 and Th2 cytokines in plasma in the 
first 12 h after a single prolonged exercise bout [295]. However, no research has 
examined changes in T helper cytokine secretion (including Th17 cytokines) following 
repeat bouts of prolonged heavy-intensity exercise.  
 
Mitogen stimulation is an effective method of analysing immune function. Very little is 
known about the mitogen-stimulated T helper cytokine response to exercise, especially the 
influence of repeated exercise with limited recovery. The present study examined the effect 
of repeated prolonged heavy exercise on plasma cortisol concentration, and Th1, Th2, and 
Th17 cytokine release.  
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Methods 
Subjects  
Ten highly-trained male cyclists volunteered to participate in the present study.  Physical 
characteristics of the cyclists are presented in Table 5.1. Subjects were excluded if they 
exhibited any cardiovascular, metabolic, neurological, or autoimmune disorders. The 
cyclists provided written informed consent for participation in the study, which was 
approved by the Bond University Human Research Ethics Committee. 
 
Table 5.1. Physical characteristics, aerobic capacity, and threshold performance data 
Subject Characteristics (n=10) Mean ± SD 
Age (years) 23.2 ± 3.2 
Height (m) 1.82 ± 0.06 
Body mass (kg) 74.8 ± 6.2 
BMI (kg.m-2) 22.5 ± 1.6 
Absolute V̇O2peak (L.min-1) 4.4 ± 0.3 
Relative V̇O2peak (mL.kg-1.min-1) 59.0 ± 4.3 
Peak Power (W) 411 ± 28 
Peak Power-to-weight (W/kg) 5.5 ± 0.5 
VT1 Power (W) 287 ± 23 
VT1 Power-to-weight (W/kg) 3.8 ± 0.3 
VT2 Power (W) 342 ± 30 
VT2 Power-to-weight (W/kg) 4.6 ± 0.4 
Training (km/week 316 ± 75 
Data are mean ± standard deviation. BMI: body mass index. V̇O2peak: peak oxygen uptake. VT1: first 
ventilator threshold. VT2: second ventilator threshold. Training: volume in kilometres performed during 
training per week. 
 
Experimental Design 
Each cyclist visited the laboratory on four occasions; for a screening/familiarization 
session, a maximal exercise test, and two experimental exercise sessions. The experimental 
exercise sessions (Figure 5.1) involved each cyclist completing both a morning (A.M.-Ex) 
and afternoon (P.M.-Ex) bout of exercise (Repeat Trial - REP), and on a separate occasion, 
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only an afternoon bout of exercise (Single Trial - SIN).  The two experimental trials were 
separated by a minimum of seven days, during which time the cyclists were permitted to 
train as normal. Participants completed the SIN and REP trial in a counter-balanced order. 
Throughout the testing period, cyclists were required to report any upper respiratory or 
gastrointestinal symptoms. All cyclists refrained from exercise for 48 h prior to both the 
maximal exercise test and the experimental trials. Alcohol or caffeine consumption was 
avoided during the exercise and post-exercise sample period. 
  
Peak oxygen consumption (V̇O2peak) was determined during a graded exercise test in 
which the participants cycled at their preferred cadence within the range of 70–100 
rev.min-1. The test was performed on an electromagnetically-braked cycle ergometer (Lode 
Excalibur Sport, Groningen, Netherlands). The cyclists commenced the graded exercise 
test at 90 W for 4 min, after which the work rate increased by 30 W/min until volitional 
fatigue and/or when the cyclists could not maintain their cadence above 70 rev.min-1 
despite strong verbal encouragement. The criteria used to determine maximal effort at the 
end of a test were: a plateau in V̇O2 (defined as an increase in V̇O2 values of less than 2 
mL.kg-1.min-1 between two consecutive 1-min periods in the final stages of the test), a 
maximal respiratory exchange ratio ≥ 1.1 and/or a maximal heart rate within 5% of their 
individual age-predicted maximum (220-age) [304]. Each cyclist’s first (VT1) and second 
(VT2) ventilatory thresholds were determined from the gas-exchange data collected during 
incremental exercise (ParvoMedics' TrueOne® 2400, Utah, USA), using the ventilatory 
equivalents methods [267].  
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Figure 5.1. Exercise, blood collection, and meal schedule for the Single and Repeat bout data collection 
protocols.  
 
On arrival for the SIN or REP trials, the cyclists consumed a standardised breakfast (2,000 
kJ) of cereal, milk, and juice. Pre-exercise blood samples were collected from the cyclists 
following breakfast. On the day of the REP trial, the cyclists exercised for 1.5 h at 90% 
VT2 on a stationary cycle ergometer (Monark Ergomedic 828 E, Sweden) beginning at 
7:00 a.m. (A.M.-Ex) and again at 12:30 p.m. (P.M.-Ex). For the SIN trial, the cyclists also 
exercised for 1.5 h at 90% VT2, but only once, beginning at 12:30 p.m. (P.M.-Ex). Heart 
rate was monitored continuously throughout exercise. Pulmonary gas exchange was 
sampled for 4 min at 20-min intervals during the exercise bouts to ensure that the cyclists 
were consistently exercising at the work rate associated with 90% VT2, and that no drift in 
V̇O2 occurred. The cyclists ingested water ad libitum during exercise. Immediately after 
exercise, a venous blood sample was collected. In total, eight blood samples were collected 
at 6.30 a.m. (rest), 8.30 a.m. (post A.M.-Ex), 12.00 p.m. (pre P.M.-Ex), 2.00 p.m. (post 
P.M.-Ex), 3.00 p.m. (1-h post P.M.-Ex), 4.00 p.m. (2-h post P.M.-Ex), 6.00 p.m. (4-h post 
P.M.-Ex) and 6.30 a.m. (24-h post rest) on the subsequent day. A post-exercise snack was 
provided at 8.45 a.m. and 2.15 p.m. consisting of breakfast cereal, milk and honey (1,500 
kJ), while larger meals were provided to the cyclists at 11.30 a.m. and 4.15 p.m. consisting 
of sandwiches and a milkshake (4,500 kJ). 
 
TIME 
Meals 
Single bout (SB) 
Blood Sampling 
Repeat bout (RB) 
p.m. 
a.m. p.m. 
6        7       8        9       10      11     12       1       2        3       4        5        6        7            6        7 
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Flow cytometry & Analysis 
Briefly, 5 mL of blood was collected into lithium heparin tubes. Two tubes were prepared 
per sample, each containing a volume of 1 mL of whole blood and 1 mL of RPMI medium. 
To the stimulated sample, PMA (25 ng/mL) and ionomycin (1 µg/mL) were added, 
whereas nothing more was added to the unstimulated sample. All samples were mixed and 
then incubated for 4 h at 37°C. Following incubation, the supernatant was removed and 
stored at 80°C for subsequent analysis. Th1, Th2 and Th17 cytokine concentrations were 
quantified using a commercially available cytometric bead array kit (BD Pharmingen, San 
Diego, CA) to measure the concentrations of IL-2, IL-4, IL-6, IL-10, TNF, IFN-γ and IL-
17A from supernatant of stimulated samples. In the absence of stimulation with PMA and 
ionomycin, concentrations of these cytokines were below the detection limit of the assay. 
The software program FCAP Array v3.0 (BD Bioscience) was used to produce standard 
curves, and determine unknown concentrations of all seven cytokines.  
 
Statistics 
All data are presented as mean ± standard deviation. All statistical analyses were 
performed using SPSS software version 22.0 (SPSS Inc., Chicago, USA).  Performance 
measures (heart rate, cadence, power output) across the three exercise trials were compared 
using one-way ANOVA with repeated measures. All immunological data were analysed 
using a 2 (single and repeated exercise bouts) x 8 (times of measurement) repeated 
measures ANOVA. Data were assessed for the assumptions of normality, homogeneity of 
variance and sphericity. If the assumption of sphericity was violated, the degrees of 
freedom were adjusted using the Greenhouse-Geisser correction. The time  trial 
interaction effect is reported. Where significant effects between trials were found (p<0.05), 
separate paired t-tests with Bonferroni corrections for multiple comparisons were 
performed between each time point across the two trials (SIN versus REP trial). If 
significant time effects were found (p<0.05), separate paired t-tests with Bonferroni 
corrections for multiple comparisons were performed to compare the pre-exercise resting 
sample to each subsequent time point. The association between individual cytokine 
concentrations, and between SIN and REP cytokine concentrations during recovery were 
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explored using Pearson’s correlation analysis to test for correlations. P<0.05 was accepted 
as significant.  
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Results 
Physiological variables during exercise 
Mean power output, heart rate and cycling cadence did not differ between exercise trials 
(Table 5.2).  
 
Table 5.2. Physiological variables during exercise  
 SIN P.M.-Ex REP A.M.-Ex REP P.M.-Ex P value 
Mean HR (beats.min-1) 151 ± 11 150 ± 11 150 ± 10 0.359 
Mean Cadence (revolutions.min-1) 87.9 ± 7.7 87.3 ± 7.8 87.7 ± 7.9 0.089 
Mean Power Output (W) 297.0 ± 28.5 297.4 ± 27.4 294.5 ± 27.0 0.143 
Data are mean ± standard deviation. HR: heart rate. SIN: single exercise trial. REP: repeated exercise trial. 
P.M-Ex: afternoon exercise bout. A.M.-Ex: morning exercise bout. 
 
Leucocyte concentrations 
Difference between trials. Immediately post-A.M.-Ex leucocyte concentration was 
significantly higher in the REP trial, compared to the SIN trial. The leucocyte 
concentration of the REP trial continued to be significantly above the SIN trial at pre-P.M.-
Ex.  
Effect of exercise. When trials were examined individually, all exercise bouts resulted in a 
significant increase in leucocyte concentration from pre- to post-exercise (p<0.001, Figure 
5.2).  
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Figure 5.2. Total leucocyte concentration before and after single and repeat bouts of prolonged heavy-
intensity exercise. Data represent mean ± SD. Time x trial interaction: Main effect of time: Main effect of 
trial. Leucocytes: 0.172; <0.001; 0.001. The first p value represents the trial (single versus repeat) x time 
interaction; the second p value represents the main effect of time; the third p value represents the main effect 
of trial. *, Signifies a significant difference between trials at time point. #, signifies a significant difference 
from pre- to immediately post-exercise for the REP trial. +, signifies a significant difference from pre- to 
immediately post-exercise for the SIN trial. 
 
Th 1 cytokines  
Difference between trials. There was no significant time x trial interaction or main effect of 
trials present for production of IL-2, TNF or IFN-γ. There was a trend towards significance 
in the time x trial interaction of IL-2 concentration (p=0.07). 
Effect of exercise. A significant increase was observed in IL-2 concentration from pre-
exercise to post-P.M.-Ex in the SIN trial, both in absolute concentration (Figure 5.3.A) and 
when adjusted according to leucocyte concentration (Figure 5.3.B). Furthermore, a 
significant increase was observed in TNF concentration from pre-exercise to post-P.M.-Ex 
in the SIN trial when adjusted according to leucocyte concentration (Figure 5.4.B). Finally, 
a significant increase was observed in IFN-γ concentration from pre-exercise to post-P.M.-
Ex in the SIN trial when adjusted according to total leucocyte concentration (Figure 5.5.B). 
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Figure 5.3. IL-2 (Th1) concentration (A) and IL-2 production normalised to WBC concentration (B) before 
and after single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x 
trial interaction: Main effect of time: Main effect of trial. A: 0.070; 0.011; 0.412. B: 0.261; 0.027; 0.712. The 
first p value represents the trial (single versus repeat) x time interaction; the second p value represents the 
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main effect of time; the third p value represents the main effect of trial. *, significantly different from pre-
exercise in single trial, p<0.01. 
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Figure 5.4. TNF (Th1) concentration (A) and TNF production normalised to WBC concentration (B) before 
and after single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x 
trial interaction: Main effect of time: Main effect of trial. A: 0.154; 0.020; 0.095. B: 0.142; 0.014; 0.297. The 
first p value represents the trial (single versus repeat) x time interaction; the second p value represents the 
main effect of time; the third p value represents the main effect of trial. *, significantly different from pre-
exercise in single trial, p<0.01. 
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Figure 5.5. IFN-γ (Th1) concentration (A) and IFN-γ production normalised to WBC concentration (B) 
before and after single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. 
Time x trial interaction: Main effect of time: Main effect of trial. A: 0.676; 0.510; 0.463. B: 0.290; 0.050; 
0.091. The first p value represents the trial (single versus repeat) x time interaction; the second p value 
represents the main effect of time; the third p value represents the main effect of trial. *, significantly 
different from pre-exercise in single trial, p<0.01. 
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Th 2 cytokines  
Difference between trials. There was no significant time x trial interaction present for 
production of IL-4, IL-6 or IL-10. There was a trend towards significance in IL-4 
concentration (p=0.062). 
Effect of exercise. A significant increase was observed in IL-4 concentration from pre-
exercise to pre-P.M.-Ex, post-P.M.-Ex, 1 h, 2 h, and 4 h post-P.M.-Ex in the SIN trial, and 
from pre-exercise to pre-P.M.-Ex, post-P.M.-Ex, and 2 h post-P.M.-Ex in the REP trial 
(Figure 5.6.A). When adjusted according to leucocyte concentration a significant increase 
was observed in IL-4 from pre-exercise to pre-P.M.-Ex, post-P.M.-Ex, 1 h, and 4 h post-
P.M.-Ex in the SIN trial, and from pre-exercise to pre-P.M.-Ex in the REP trial (Figure 
5.6.B). No significant time effect was present in IL-6 at any time point. Additionally, a 
significant increase was observed in IL-10 concentration from pre-exercise to 1 h, and 4 h 
post-P.M.-Ex in the SIN trial, and from pre-exercise to pre-P.M.-Ex in the REP trial 
(Figure 5.8.A). When adjusted according to total leucocyte concentration a significant 
increase was observed in IL-10 from pre-exercise to post-P.M.-Ex in the SIN trial, and 
from pre-exercise to pre-P.M.-Ex in the REP trial (Figure 5.8.B). 
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Figure 5.6. IL-4 (Th2) concentration (A) and IL-4 production normalised to WBC concentration (B) before 
and after single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x 
trial interaction: Main effect of time: Main effect of trial. A: 0.062; <0.001; 0.999. B: 0.125; 0.001; 0.609. 
The first p value represents the trial (single versus repeat) x time interaction; the second p value represents 
the main effect of time; the third p value represents the main effect of trial. *, significantly different from pre-
exercise in single trial, p<0.01. #, significantly different from pre-exercise in repeat trial, p<0.01. 
 189 
0
2 0
4 0
6 0
8 0
1 0 0
T im e
IL
-6
 (
p
g
.m
L
-1
)
7 :0 0 9 :0 0 1 1 :0 0 1 3 :0 0 1 5 :0 0 1 7 :0 0 7 :0 0
0
3
6
9
1 2
T im e
IL
-6
 (fg
.c
e
ll -1
)
SINGLE
REPEAT
7 :0 0 9 :0 0 1 1 :0 0 1 3 :0 0 1 5 :0 0 1 7 :0 0 7 :0 0
a .m . p .m .
A B
 
Figure 5.7. IL-6 (Th2) concentration (A) and IL-6 production normalised to WBC concentration (B) before 
and after single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x 
trial interaction: Main effect of time: Main effect of trial. A: 0.359; 0.294; 0.499. B: 0.472; 0.178; 0.506. The 
first p value represents the trial (single versus repeat) x time interaction; the second p value represents the 
main effect of time; the third p value represents the main effect of trial.  
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Figure 5.8. IL-10 (Th2) concentration (A) and IL-10 production normalised to WBC concentration (B) before 
and after single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x 
trial interaction: Main effect of time: Main effect of trial. A: 0.122; 0.004; 0.163. B: 0.125; 0.004; 0.581. The 
first p value represents the trial (single versus repeat) x time interaction; the second p value represents the 
main effect of time; the third p value represents the main effect of trial. *, significantly different from pre-
exercise in single trial, p<0.01. #, significantly different from pre-exercise in repeat trial, p<0.01. 
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Figure 5.9. IL-17A (Th17) concentration (A) and IL-17A production normalised to WBC concentration (B) 
before and after single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. 
Time x trial interaction: Main effect of time: Main effect of trial. A: 0.016; 0.426; 0.811. B: 0.029; 0.439; 
0.502. The first p value represents the trial (single versus repeat) x time interaction; the second p value 
represents the main effect of time; the third p value represents the main effect of trial. 
 
Th 17 cytokine 
Difference between trials. There was a significant time x trial interaction present for both 
IL-17A concentration (p=0.016) and IL-17A concentration normalised to WBC count 
(p=0.029). 
 
Correlations between cytokines and trials 
As displayed in Table 5.3, individual cytokines were compared via Pearson’s correlation 
coefficients to examine any possible relationships between each cytokine. Significant 
correlations were observed between all individual cytokines. Additionally, the relationships 
between SIN and REP cytokine release from post-P.M.-Ex to 24 h post-exercise were 
examined (Table 5.4). Significant associations were observed for IFN-γ and IL-4.  
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Table 5.3. Associations between cytokine profiles of each individual cytokine. 
 Th1 Th2 Th17 
 IL-2 TNF IFN-γ IL-4 IL-6 IL-10 IL-17A 
IL-2  0.70* 0.51* 0.83* 0.77* 0.82* 0.46* 
TNF 0.70*  0.93* 0.67* 0.64* 0.58* 0.42* 
IFN 0.51* 0.93*  0.53* 0.47* 0.34* 0.35* 
IL-4 0.83* 0.67* 0.53*  0.64* 0.75* 0.41* 
IL-6 0.77* 0.64* 0.47* 0.64*  0.79* 0.40* 
IL-10 0.82* 0.58* 0.34* 0.75* 0.79*  0.38* 
IL-17A 0.46* 0.42* 0.35* 0.41* 0.40* 0.38*  
* p < 0.001. 
 
Table 5.4. Associations between SIN and REP bouts for each individual cytokine following PM-Ex. 
 Th1 Th2 Th17 
 IL-2 TNF IFN-γ IL-4 IL-6 IL-10 IL-17A 
SIN vs 
REP 
0.10 0.07 0.30* 0.33* 0.27 0.22 0.04 
* p < 0.05. 
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Discussion 
This is the first study to analyse changes in Th1, Th2 and Th17 cytokine production in 
response to repeated exercise. Data were presented as absolute cytokine production 
following whole blood stimulation by PMA and ionomycin, and adjusted according to total 
leucocyte concentration at each corresponding time point. A significant increase in 
leucocyte concentration was present at each exercise bout, and there was a significant 
difference between trials at post-A.M.-Ex and pre-P.M.-Ex. Regarding Th1 cytokines, 
there was no significant difference between SIN and REP trials for IL-2, TNF, or IFN-, 
however there was a trend towards a significant time x trial interaction in IL-2. There was a 
significant increase from pre-exercise to post-P.M.-Ex in the SIN trial for IL-2 (both 
absolute and adjusted values), from pre-exercise to post-P.M.-Ex in the SIN trial for TNF 
(adjusted value), and from pre-exercise to post-P.M.-Ex in the SIN trial for IFN- (adjusted 
value). For Th2 cytokines there was no significant difference between SIN and REP trials 
for IL-4, IL-6, or IL-10, however there was a trend towards a significant time x trial 
interaction in IL-4.  For IL-4, there was a significant increase from pre-exercise to pre-
P.M.-Ex, post-P.M.-Ex, and 1 h, 2 h, and 4 h post-P.M.-Ex in the SIN trial, and from pre-
exercise to pre-P.M.-Ex, post-P.M.-Ex, and 2 h post-P.M.-Ex in the REP trial. There was 
no significant change from pre-exercise in IL-6 production. For IL-10, there was a 
significant increase from pre-exercise to 1 h, and 4 h post-P.M.-Ex in the SIN trial, and 
from pre-exercise to pre-P.M.-Ex in the REP trial. Finally, there was no significant 
difference between trials, nor a significant change from pre-exercise in IL-17A (Th17), 
however there was a significant time x trial interaction. 
 
There was a significant increase in the absolute concentrations of IL-2 (Th1), IL-4, and IL-
10 (both Th2) to post-exercise in the single trial, whereas in the repeat trial IL-4 and IL-10 
significantly increased. While the increase following the single trial appears to be exercise-
induced, this is not as clear in the repeat trial. There was no significant difference between 
SIN and REP trials including during the A.M.-Ex bout. When examining the repeated 
bouts, it would appear that exercise had no detectable effect on mitogen-stimulated 
cytokine production, and rather that the significant increase in production of IL-2, IL-4, 
and IL-10 were driven by normal daily changes (diurnal?) in cellular function. For IL-2 
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and IL-4 there was a trend towards a significant time x trial interaction. This suggests a 
difference in the change in cytokine concentration between single and repeat bouts over the 
period of collection. Potentially, the repeated exercise bout may alter the changes in 
cytokine IL-2 and IL-4 compared to a single bout of exercise, although this is not as clear 
cut as an ‘carry-over’ or ‘additive effect’ as previously described [177-179, 186-188]. 
Rather, the pattern of change post-exercise (or pre-P.M.-Ex) may be causing the interaction 
effect. In particular, from pre- to post-P.M.-Ex there appears to be contrast in the change in 
cytokine concentration between the two trials; for both IL-2 and IL-4 the single trial is 
increasing in concentration while the repeat trial is decreasing. It may be possible that the 
A.M.-Ex drove cytokine production after exercise, only to decrease during the second bout, 
while the single bout of exercise drove that same increase in the single trial during P.M.-
Ex.  
 
As mentioned above, IL-17A did not significantly change at any time point, nor was there 
a significant difference between SIN and REP trials. However, there was a significant time 
x trial interaction present. This suggests a difference the change in cytokine concentration 
between single and repeat bouts over the period of collection. When examining the two 
trials, the pattern of change appears quite different. It appears that A.M.-Ex increased 
cytokine production after exercise, only to decrease during the second bout, while the 
single bout of exercise drove that same increase in the single trial during P.M.-Ex. 
Potentially, this may be demonstrating the effect of repeated exercise on IL-17A 
production. IL-17A is primarily released by Th17 cells. The Th17 subset is the first CD4+ 
subset to be generated allowing rapid response against infection [49]. If repeated exercise 
does effect the ability for IL-17A to be produced, this may be of concern when considering 
rapid response to infection. Previous research has demonstrated that IL-17 is induced by 
IL-6 and activated by IL-23 which may promote neutrophil activation following prolonged 
endurance exercise [337]. When Spearman’s correlation analysis was used to examine the 
relationship between IL-6 and IL-17A, a significant positive correlation (r = 0.43) was 
observed. When considered in the context of all cytokine associations of the present study, 
this association would be considered quite weak, as mitogen stimulation is likely to not 
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demonstrate the same effect as IL-6 would have on IL-17A production with no other 
stimulant present. 
 
As the assay used was a whole blood analysis, cytokine production was normalised 
according to leucocyte concentration at each time point. This was to allow comparison of 
function on a “per cell” scale. This analysis demonstrated a significant increase from pre-
exercise in Th1 cytokines; IL-2, TNF, and IFN-, and Th2 cytokines; IL-4 and IL-10. It is 
difficult to determine if this increase in production is due to the exercise intervention, as 
the time course of changes does not follow that classic cellular redistribution kinetics 
during the recovery period [1, 197]. Compared to changes in leucocyte concentrations 
following acute stress or exercise, less is known about cytokine production following 
exercise, as few studies have examined changes during the post-exercise period. 
Previously, intracellular cytokines IL-2 (Th1), IFN-γ (Th1), and IL-4 (Th2) produced by 
CD4+ T cells were used to define T helper cell types and their functional changes. Using 
this method, a Th1-to-Th2 “shift” was described following exercise and hormone infusion 
[155, 167, 168, 310]. This ‘shift’ occurs when IL-2- and/or IFN-γ-producing T helper cells 
(Th1) decrease in cell concentration, while IL-4-producing T helper cells (Th2) remain 
unchanged. It is clear the present study did no show such changes. Compared to 
intracellular analysis of cytokine production, whole blood mitogen-stimulation analysis is a 
much more complex display of the cytokine network. Cytokines are not solely secreted 
from T helper cells, but include cytotoxic T cells, natural killer cells, dendritic cells, 
macrophages and even skeletal muscle [311, 312]. This suggests there is a much more 
complex array of interactions that are occurring following exercise-induced stress. When 
examining IFN-γ and TNF there was a significant increase in adjusted concentration 
immediately post-exercise in the single trial (but not the repeat trial). As there was no 
significant increase in absolute IFN-γ and TNF concentrations at this time point, it would 
suggest that this was driven by a change in the relationship between leucocyte 
concentration and cytokine concentration. This occurred immediately after the single 
exercise bout when mean concentration was at its peak (although not significant), and 
cytokine production per cell was also at its peak. This may suggest exercise increased 
immune cells ability to produce cytokines, unfortunately this was not a reproducible 
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change, it did not occur following repeat bouts of exercise. Previously, following a 6-h 
endurance run, LPS-stimulated production of TNF decreased post-exercise [338]. This was 
not seen in the present study, which may be due to the mode of stimulation, or potentially 
the duration of the exercise bout.  
 
Whole blood mitogen-stimulation provides a challenge to the cellular immune system. This 
is because a stressor is applied (PMA and ionomycin) to drive cytokine production after an 
initial stressor is applied (exercise), which is also reported to alter cytokine production [96, 
339]. The resultant changes in cytokine concentrations between sampling points are then 
used to determine the influence of exercise on this production. In the present study, 
exercise would appear to have minimal effect on leucocyte ability to produce cytokines 
following mitogenic stimulation. Although, previous research has largely used PHA-
stimulation of PBMCs to analyse the above effect, conflicting results still remain. In one 
study, IFN-γ concentration significantly increased from pre-exercise to 24 h following 
moderate, but not exhaustive exercise, whereas no significant change was reported in IL-2 
concentration [254]. Whereas, no significant change was apparent in IFN-γ or IL-2 
production following PHA-stimulation of PBMCs after cycling for 60 min at 75 % of 
V̇O2peak [255]. Conversely, following cycling for both, 60 min at 60 % of V̇O2peak, and a 
19 min exhaustive effort, PHA-stimulation of PBMCs resulted in a significant decrease in 
IL-2 production [250, 256]. These results did use a different stimulant and highlights the 
variable nature of previous results examining this phenomenon.  When associations 
between individual cytokines at each time point were examined using Pearson’s correlation 
analysis, there was a significant correlation amongst all cytokines, ranging from p=0.93 to 
p=0.34. This may suggest that while results were quite variable over time, stimulation at 
each time point appeared to drive a similar response in all cytokines, suggesting PMA and 
ionomycin are quite suitable as stimuli for Th1/Th2/Th17 cytokines, although perhaps not 
when examining the effect of exercise on cytokine production.  
 
There is certainly a trade-off between the quantity and the specificity of data when 
examining cytokine production following mitogen stimulation. One argument is that the 
cytokines are not just produced by T helper cells, but include cytotoxic T cells, natural 
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killer cells, dendritic cells, macrophages and even skeletal muscle [311, 312]. Hence, to 
examine a single cell type and production of one or two selected cytokines may not present 
a normal physiological response. Conversely, whole blood stimulation over multiple time 
points appears to be a hugely complex array of changes, often making it difficult to 
highlight the significance of results. The present study suggests prior exercise didn’t have 
an effect on cytokine production except for perhaps IL-17A, which may be important 
regarding rapid response to infection. 
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6. STUDY IIIB – REPEATED PROLONGED HEAVY EXERCISE AND ITS EFFECT ON 
CELLULAR REDISTRIBUTION 
 
Abstract 
The purpose of this study was to investigate the effects of prior heavy-intensity exercise on 
circulating dendritic cell subpopulations, γδ T cell subpopulations and memory 
phenotypes, and subsequent changes in these cells following a second bout of exercise. Ten 
well-trained endurance cyclists (mean ± SD: age 23.2 ± 3.2 years; height 1.82 ± 0.06 m; 
body mass 74.8 ± 6.2 kg; peak oxygen uptake 59.0 ± 4.3 mL.kg-1.min-1) performed two 
exercise trials on different occasions. On the first occasion, they cycled in the morning and 
afternoon for 1.5 h at 90% of their second ventilatory threshold, with 4 h between the two 
bouts. On the second occasion, they cycled for 1.5 h at the same intensity, but only in the 
afternoon. Blood samples were collected throughout the recovery period post-exercise and 
flow cytometry was used to examine changes in cell numbers and cell-surface receptor 
expression. Significant exercise-induced increases were observed in total lymphocytes, 
neutrophils, total γδ T cells, δ1 and δ2 subsets, total dendritic cells, and the plasmacytoid 
dendritic cell subset concentrations. Furthermore, among the γδ T cells, those with high 
expression of CD11a, CD62L, and CD94 were preferentially mobilised. However, no 
significant differences were observed between the single and repeated exercise trials for 
any variable, except total lymphocytes, neutrophils, and plasmacytoid DCs. Indeed, many 
immune markers (particularly total lymphocytes and related subsets) featured near identical 
recovery patterns between the single and repeated exercise bouts. In contrast to previous 
findings, prior exercise may have less effect on lymphocyte redistribution following a 
subsequent bout of prolonged heavy-intensity exercise than previously suggested. Energy 
intake between exercise trials may be an important determinant of these responses.   
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Introduction 
Regular heavy-intensity endurance exercise is associated with transient changes in 
circulating leucocyte concentrations, immune cell function, and potentially, an increased 
risk of upper respiratory illnesses (URIs) [1-5]. Previous research has demonstrated that 
acute stress (such as regular exercise) induces positive effects on the immune system, 
whereas chronic stress is considered harmful [102, 108]. In their training, endurance 
athletes regularly challenge the balance between a healthy immune system and training-
induced immunosuppression [34, 36, 334]. Notably, the increased incidence of symptoms 
associated with URIs in elite athletes regularly occurs during periods of heavy training and 
competition [3-5, 24, 32, 335], which are associated with regular and more severe stressors, 
and decreased recovery time. Repeated exercise, without sufficient recovery, may cause 
suppression in immune function, which may in turn increase susceptibility to URIs [76, 
108, 336].  
 
Various studies have examined the influence of successive bouts of exercise on immune 
function [156, 177-188], with several of these studies highlighting a ‘carry-over’ or 
‘additive’ effect of on lymphocyte and neutrophil concentration changes [177-179, 186-
188]. Potentially, these carry-over effects may lead to chronic suppression of immune 
function [76]. Repeated exercise appears to induce a more pronounced increase in 
catecholamine and cortisol concentrations compared to a single bout, resulting in a more 
severe ingress of lymphocytes and neutrophils into peripheral circulation [177, 179]. It is 
largely unknown how prior intense exercise alters the cellular immune system during and 
following a subsequent exercise bout. To date, only neutrophils and lymphocytes 
(including CD4+, CD8+ and CD56+ cells) have been examined within this context [177-
179, 186-188]. No research has investigated the effects of repeated bouts of exercise on a 
number of lymphocyte subsets or dendritic cells. 
 
γδ T cells have been labelled ‘the bridge between innate and adaptive immunity’; they play 
an important role in early immune responses to a variety of pathogens [78]. Displaying a 
wide array of functions, γδ T cells are capable of MHC-independent activation, T cell 
receptor-dependent recognition of conserved antigens, and professional antigen 
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presentation, while possessing protective memory and reactive memory capabilities [78, 
79]. αβ T cells are involved in adaptive immunity, and are abundant in the peripheral 
circulation. Previous research has extensively examined these cells in response to stress 
and exercise [1, 157, 179, 340]. Conversely, γδ T cells constitute only 1-5% of T 
lymphocytes in the blood stream in humans and mice [80]. These cells are, however, found 
in abundance in the epithelia of skin, genital, intestinal and respiratory tract [81-83]. These 
areas are regularly expose to an array pathogens; consequently, γδ T cells play an 
important role in early innate recognition and antigen presentation in response to a variety 
of invading agents. Previous research has demonstrated that acute exercise and 
psychological stress stimulates ingress of γδ T cells with high cytotoxic capabilities, tissue 
homing potential, and the capacity for rapid, innate-like target recognition [104, 160].  
 
Dendritic cells (DCs) function as professional antigen-presenting cells (APC)s in the blood, 
and appear to have immature/precursor characteristics, because they undergo a maturation 
process after exiting the circulation [63]. These cells play a crucial role in initiating and 
regulating both cellular and humoral immune responses. Previous research has revealed 
conflicting changes in redistribution of these cell types, following a marathon run. In 
particular, mDCs in circulation increased significantly, whereas pDCs decreased 
significantly below pre-exercise values [164]. Following a 1-hour ice-hockey training 
session, circulating mDC and pDC concentrations both increased significantly compared 
with rest [165]. No studies to our knowledge have examined changes in DCs under 
conditions where exercise intensity and duration are controlled, nor in response to repeated 
exercise bouts. 
 
Exercise-induced stress alters the distribution and function of immune cells for hours after 
the end of exercise. Questions remain, however, regarding the effect of repeated exercise 
on immune cell redistribution and function. Few studies have examined the immune 
response to successive exercise bouts. Specifically, a number of cell types including γδ T 
cells and dendritic cells have not been examined at all under these conditions, but are 
known to respond to acute stress, whether exercise, psychological stress, surgery, or β-
agonist infusion [104, 105, 164]. Previous research has highlighted a greater cellular 
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ingress of  CD4+ and CD8+ T cells in response to a second bout of exercise [179]. This 
study aimed to examine the influence of prior heavy endurance exercise on the subsequent 
cellular immune system changes during a second exercise bout. Specifically, changes in the 
numbers of circulating leucocytes, γδ T cells and dendritic cells were measured during and 
after exercise that was performed 4 hours after an initial exercise bout. It was hypothesized 
that due to a repeated, prolonged exercise-induced stress, the cellular ingress would be 
greater in the subsequent bout of exercise.   
 
  
 204 
Methods 
Subjects  
Ten highly-trained male cyclists volunteered to participate in the present study.  Physical 
characteristics of the cyclists are presented in Table 6.1. Subjects were excluded if they 
exhibited any cardiovascular, metabolic, neurological, or autoimmune disorders. The 
cyclists provided written informed consent for participation in the study, which was 
approved by the Bond University Human Research Ethics Committee. 
 
Table 6.1. Physical characteristics, aerobic capacity, and threshold performance data 
Subject Characteristics (n=10) Mean ± SD 
Age (years) 23.2 ± 3.2 
Height (m) 1.82 ± 0.06 
Body mass (kg) 74.8 ± 6.2 
BMI (kg.m-2) 22.5 ± 1.6 
Absolute V̇O2peak (L.min-1) 4.4 ± 0.3 
Relative V̇O2peak (mL.kg-1.min-1) 59.0 ± 4.3 
Peak Power (W) 411 ± 28 
Peak Power-to-weight (W/kg) 5.5 ± 0.5 
VT1 Power (W) 287 ± 23 
VT1 Power-to-weight (W/kg) 3.8 ± 0.3 
VT2 Power (W) 342 ± 30 
VT2 Power-to-weight (W/kg) 4.6 ± 0.4 
Training (km/week 316 ± 75 
Data are mean ± standard deviation. BMI: body mass index. V̇O2peak: peak oxygen uptake. VT1: first 
ventilatory threshold. VT2: second ventilatory threshold. Training: volume in kilometres performed during 
training per week. 
 
Experimental Design 
Each cyclist visited the laboratory on four occasions; for a screening/familiarization 
session, a maximal exercise test, and two experimental exercise sessions. The experimental 
exercise sessions (Figure 6.1) involved each cyclist completing both a morning (A.M.-Ex) 
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and afternoon (P.M.-Ex) bout of exercise (Repeat Trial - REP), and on a separate occasion, 
only an afternoon bout of exercise (Single Trial - SIN).  The two experimental trials were 
separated by a minimum of seven days, during which time the cyclists were permitted to 
train as normal. Participants completed the SIN and REP trial in a counter-balanced order. 
Throughout the testing period, cyclists were required to report any upper respiratory or 
gastrointestinal symptoms. All cyclists refrained from exercise for 48 h prior to both the 
maximal exercise test and the experimental trials. Alcohol or caffeine consumption was not 
permitted during the exercise and post-exercise sample period. 
  
Peak oxygen consumption (V̇O2peak) was determined during a graded exercise test in 
which the participants cycled at their preferred cadence within the range of 70–100 
rev.min-1. The test was performed on an electromagnetically-braked cycle ergometer (Lode 
Excalibur Sport, Groningen, Netherlands). The cyclists commenced the graded exercise 
test at 90 W for 4 min, after which the work rate increased by 30 W/min until volitional 
fatigue and/or when the cyclists could not maintain their cadence above 70 rev.min-1, 
despite strong verbal encouragement. The criteria used to determine maximal effort at the 
end of the test were: (i) a plateau in V̇O2 (defined as an increase in V̇O2 values of less than 2 
mL.kg-1.min-1 between two consecutive 1-min periods in the final stages of the test), (ii) a 
maximal respiratory exchange ratio ≥ 1.1 and/or (iii) a maximal heart rate within 5% of 
their individual age-predicted maximum (220-age) [304]. Each cyclist’s first (VT1) and 
second (VT2) ventilatory threshold was determined from the gas-exchange data collected 
during incremental exercise (ParvoMedics' TrueOne® 2400, Utah, USA), using the 
ventilatory equivalents methods [267].  
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Figure 6.1. Exercise, blood collection, and meal schedule for the Single and Repeat bout data collection 
protocols. Boxes represent exercise bouts. Arrows represent times of blood collection and scheduled meals. 
 
On arrival for the SIN or REP trials, the cyclists consumed a standardised breakfast (2,000 
kJ) of cereal, milk, and juice. Pre-exercise blood samples were collected from the cyclists 
following breakfast. On the day of the REP trial, the cyclists exercised for 1.5 h at 90% 
VT2 on a stationary cycle ergometer (Monark Ergomedic 828 E, Sweden) beginning at 
7:00 a.m. (A.M.-Ex) and again at 12:30 p.m. (P.M.-Ex). For the SIN trial, the cyclists also 
exercised for 1.5 h at 90% VT2, but only once, beginning at 12:30 p.m. (P.M.-Ex). Heart 
rate was monitored continuously throughout exercise. Pulmonary gas exchange was 
sampled for 4 min at 20-min intervals during the exercise bouts to ensure that the cyclists 
were consistently exercising at the work rate associated with 90% VT2, and that no drift in 
V̇O2 occurred. The cyclists ingested water ad libitum during exercise. Immediately after 
exercise, a venous blood sample was collected. In total, eight blood samples were collected 
at 6.30 a.m. (rest), 8.30 a.m. (post A.M.-Ex), 12.00 p.m. (pre P.M.-Ex), 2.00 p.m. (post 
P.M.-Ex), 3.00 p.m. (1-h post P.M.-Ex), 4.00 p.m. (2-h post P.M.-Ex), 6.00 p.m. (4-h post 
P.M.-Ex) and 6.30 a.m. (24-h post rest) on the subsequent day. A post-exercise snack was 
provided at 8.45 a.m. and 2.15 p.m. consisting of breakfast cereal, milk and honey (1,500 
kJ), while larger meals were provided to the cyclists at 11.30 a.m. and 4.15 p.m. consisting 
of sandwiches and a milkshake (4,500 kJ). 
 
TIME 
Meals 
Single bout (SIN) 
Blood Sampling 
Repeat bout (REP) 
P.M. 
Ex 
A.M. 
Ex 
P.M. 
Ex 
6        7       8        9       10      11     12       1       2        3       4        5        6        7           
6        7 
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Flow cytometry 
Venous blood was sampled from an antecubital vein and collected into blood collection 
tubes containing K3EDTA (BD Vacutainer, New Jersey, USA). Samples were analysed to 
determine the full blood cell count (Coulter HmX Hematology Analyzer, Beckman 
Coulter). Percent change in blood, cell and plasma volumes were calculated for each 
sample [291], and subsequently  all cell concentrations were adjusted for shifts in blood 
volume. Cells were identified by immunofluorescent antibody staining of whole blood 
using four-colour flow cytometry (FACS-Calibur, BD Biosciences). 
 
Lymphocyte subsets 
Total γδ T cells, δ1 and δ2 subsets, memory phenotypes, and surface molecules were 
determined using the following antibodies; CD3 PerCP (BD Biosciences), Vδ-1 TCR FITC 
(Thermo Scientific), γδ TCR APC, Vδ-2 TCR APC, CD27 FITC, CD27 PE, CD45RA 
APC, CD11a FITC, CD62L PE, CD94 FITC (BD Pharmingen) (Anane et al., 2010). 
Briefly, 100 µL whole blood were incubated with appropriate concentrations of antibody 
(as determined by titration) for 30 min in the dark at room temperature. Erythrocytes were 
subsequently lysed using FACS lysing solution (BD Bioscience). Following lysis, samples 
were centrifuged (350  g, 5 min, at room temperature). Samples were then washed and 
fixed in 1% paraformaldehyde. Fixed preparations were analysed immediately, collecting a 
minimum of 100,000 events from each sample. Appropriate, matched isotype controls were 
used to set negative staining criteria. The FACS-Calibur flow cytometer (BD Biosciences) 
was calibrated weekly using Calibrite beads (BD Biosciences). Total lymphocytes were 
gated using the forward versus side scatter plot to identify the target population. γδ T cells 
were then gated as the CD3+ γδ TCR+ population, δ1 T cell were gated as CD3+Vδ1+ and 
δ2 T cells were gated as CD3+ Vδ2+. Lymphocyte subset concentrations were quantified 
using the percentage values obtained from each lymphocyte subset gate. The total 
lymphocyte concentration was obtained from the full blood count. 
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Dendritic cell phenotypes 
Total dendritic cells (tDCs), dendritic cell phenotypes (pDCs, mDCs, CD14-/lowCD16+ 
DCs), and total monocytes were identified by the combination of HLA-DR PerCP, lineage 
cocktail-2 FITC (CD3, CD14, CD19, CD20, CD56), CD123 PE (BD Bioscience), CD33 
APC, CD11c PE and CD16 APC (BD Pharmingen) antibodies. tDCs were identified based 
on the expression of CD33 and HLA-DR, and the absence of the lineage cocktail-2 
antigens with intermediate forward and side scatter characteristics located between 
lymphocytes and monocytes. Dendritic cells were further defined into three 
subpopulations: (1) mDCs , which included a subset of CD123dim/CD33high/CD16- cells, 
with strong expression of HLA-DR; (2) a subset of CD123inter/CD33inter/CD16+ cells–
CD14-/lowCD16+ DCs, and (3) pDCs, which included CD123high/CD33-/dim/CD16- cells, 
both with intermediate expression of HLA-DR [289]. Cell concentrations were quantified 
using percentage values obtained from each lymphocyte and monocyte subset gate. The 
total monocyte concentration was obtained from the full blood count. 
 
Statistics 
All data are presented as mean ± standard deviation. All statistical analyses were 
performed using SPSS software version 22.0 (SPSS Inc., Chicago, USA).  Performance 
measures (heart rate, cadence, power output) across the three exercise trials were compared 
using one-way ANOVA with repeated measures. All immunological data were analysed 
using a 2 (single and repeated exercise bouts) x 8 (times of measurement) repeated 
measures ANOVA. Data were assessed for the assumptions of normality, homogeneity of 
variance and sphericity. If the assumption of sphericity was violated, the degrees of 
freedom were adjusted using the Greenhouse-Geisser correction. The time  trial 
interaction effect is reported. Where significant effects between trials were found (p<0.05), 
separate paired t-tests with Bonferroni corrections for multiple comparisons were 
performed between each time point across the two trials (SIN versus REP trial). If 
significant time effects were found (p<0.05), separate paired t-tests with Bonferroni 
corrections for multiple comparisons were performed to compare the pre-exercise resting 
sample to each subsequent time point. 
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Results 
Physiological variables during exercise 
Power output, heart rate and cycling cadence did not differ between exercise trials (Table 
6.2).  
 
Table 6.2. Physiological variables during exercise  
 SIN P.M.-Ex REP A.M.-Ex REP P.M.-Ex P value 
Mean HR (beats.min-1) 151 ± 11 150 ± 11 150 ± 10 0.359 
Mean Cadence (revolutions.min-1) 87.9 ± 7.7 87.3 ± 7.8 87.7 ± 7.9 0.089 
Mean Power Output (W) 297.0 ± 28.5 297.4 ± 27.4 294.5 ± 27.0 0.143 
Data are mean ± standard deviation. HR: heart rate.  
 
Leucocyte concentrations 
Difference between trials. Before the start of P.M.-Ex (REP), changes in cell 
concentrations due to A.M.-Ex (REP) had returned to resting values in the lymphocyte and 
monocyte subpopulations. Immediately post-A.M.-Ex lymphocyte and neutrophil 
concentrations were significantly higher in the REP trial, compared to the SIN trial. The 
neutrophil concentration of the REP trial continued to be significantly above the SIN trial 
at pre-P.M.-Ex.  
Effect of exercise. When trials were examined individually, all exercise bouts resulted in an 
increase in lymphocyte, neutrophil and monocyte concentrations (all p<0.001, Figure 6.2). 
 
γδ T cells 
Difference between trials. When comparing between bouts, there was a significant time x 
trial interaction for total γδ T cells (p<0.05) and the δ1 subset (p<0.05). Further analysis 
demonstrated a trend towards a main effect between trials (δ1; p=0.059, γδ T cells; 
p=0.052). 
Effect of exercise. A significant time effect was present for total γδ T cells, δ1, and δ2 
subsets. A significant increase was evident in both the SIN and REP trials for total γδ T 
cell concentration, and δ1 and δ2 subset concentrations (all p<0.05, Figure 6.3).  
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Figure 6.2. Total lymphocyte, neutrophil, and monocyte concentrations before and after single and repeat 
bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x trial interaction: Main effect 
of time: Main effect of trial. Lymphocytes: 0.266; <0.001; 0.116. Neutrophils: 0.197; <0.001; 0.039. 
Monocytes: 0.125; <0.001; 0.115. The first p value represents the trial (single versus repeat) x time 
interaction; the second p value represents the main effect of time; the third p value represents the main effect 
of trial. *, signifies a significant difference between trials at time point. #, signifies a significant difference 
from pre- to immediately post-exercise for the REP trial. +, signifies a significant difference from pre- to 
immediately post-exercise for the SIN trial.   
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Figure 6.3. Total γδ T cells (A), δ1 (B) and δ2 (C) subset concentrations before and after single and repeat 
bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x trial interaction: Main effect 
of time: Main effect of trial. δ1: 0.012; 0.027; 0.059. δ2: 0.132; 0.016; 0.125. γδ T cells: 0.031; 0.002; 0.052. 
The first p value represents the trial (single versus repeat) x time interaction; the second p value represents 
the main effect of time; the third p value represents the main effect of trial. #, signifies a significant 
difference from pre- to immediately post-exercise in the REP trial. +, signifies a significant difference from 
pre- to immediately post-exercise for the SIN trial. 
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Memory phenotypes 
Difference between trials. No significant difference was observed between the two trials, 
both during exercise and recovery.  
Effect of exercise. All memory phenotypes did not exhibit any significant time effect as a 
result of the exercise bouts (Figure 6.4). There was a trend towards significance in EMRA 
(p=0.082) and CM (p=0.063) phenotypes. 
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Figure 6.4. δ2 CD45RA+ effector memory (A), effector memory (B), naïve (C), and central memory (D) 
phenotype concentrations before and after a bout of prolonged heavy-intensity exercise. Data represent mean 
± SD. Time x trial interaction: Main effect of time: Main effect of trial. EMRA: 0.297; 0.082; 0.142. EM: 
0.306; 0.127; 0.262. NA: 0.248; 0.109; 0.129. CM: 0.192; 0.063; 0.164. The first p value represents the trial 
(single versus repeat) x time interaction; the second p value represents the main effect of time; the third p 
value represents the main effect of trial. 
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Receptor expression 
Difference between trials. When comparing between bouts, the pattern of change did not 
differ between trials, both during exercise and subsequent recovery period. There was a 
trend towards a significant time x trial interaction in CD94- (p=0.063). 
Effect of exercise. A significant exercise-induced increase was evident immediately 
following P.M.-Ex in CD11ahi, CD62Lhi, and CD94+ γδ T cell concentrations (all p<0.05, 
Figure 6.5, 6.6, 6.7). 
0
1 0
2 0
3 0
T im e
C
e
ll
s
 (
1
0
6
/L
)
7 :0 0 9 :0 0 1 1 :0 0 1 3 :0 0 1 5 :0 0 1 7 :0 0 7 :0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
T im e
C
e
lls
 (1
0
6/L
)
SINGLE
REPEAT
7 :0 0 9 :0 0 1 1 :0 0 1 3 :0 0 1 5 :0 0 1 7 :0 0 7 :0 0
a .m . p .m .
A B
#
 
Figure 6.5. Total γδ T cell CD11alow (A) and CD11ahigh (B) expression before and after single and repeat 
bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x trial interaction: Main effect 
of time: Main effect of trial. CD11alow: 0.137; 0.765; 0.347. CD11ahigh: 0.149; 0.023; 0.107. The first p value 
represents the trial (single versus repeat) x time interaction; the second p value represents the main effect of 
time; the third p value represents the main effect of trial. #, signifies a significant difference from pre- to 
immediately post-exercise in the REP trial.   
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Figure 6.6. Total γδ T cell CD62Llow (A) and CD62Lhigh (B) expression before and after single and repeat 
bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. Time x trial interaction: Main effect 
of time: Main effect of trial. CD62Llow: 0.221; 0.181; 0.350. CD62Lhigh: 0.191; 0.003; 0.175. The first p value 
represents the trial (single versus repeat) x time interaction; the second p value represents the main effect of 
time; the third p value represents the main effect of trial. #, signifies a significant difference from pre- to 
immediately post-exercise in the REP trial.   
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Figure 6.7. Total γδ T cell CD94- (A) and CD94+ (B) expression before and after single and repeat bouts of 
prolonged heavy-intensity exercise. Data represent mean ± SD. Time x trial interaction: Main effect of time: 
Main effect of trial. CD94-: 0.063; 0.086; 0.060. CD94+: 0.138; 0.050; 0.136. The first p value represents the 
trial (single versus repeat) x time interaction; the second p value represents the main effect of time; the third p 
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value represents the main effect of trial. #, signifies a significant difference from pre- to immediately post-
exercise in the REP trial.   
 
Dendritic cell phenotypes 
Difference between trials. A significant trial x time interaction was evident in CD16+ DCs 
and total DCs. pDCs were significantly higher in the REP trial at post-A.M.-Ex compared 
to the SIN trial.  
Effect of exercise. A significant exercise-induced increase in concentration was evident in 
tDCs, and pDCs following P.M.-Ex (p<0.05, Figure 6.8). 
 216 
C
D
1
6
+
D
C
s
 (
1
0
6
/L
)
0
2 5
5 0
7 5
p
D
C
s
 (
1
0
6
/L
)
0
1 0
2 0
3 0
4 0
m
D
C
s
 (
1
0
6
/L
)
1 0
2 0
3 0
4 0
0
5 0
REPEAT
SINGLE
T im e
T
o
ta
l 
D
C
s
 (
1
0
6
/L
)
7 :0 0 7 :0 0
2 5
5 0
7 5
0
9 :0 0 1 1 :0 0 1 3 :0 0 1 5 :0 0 1 7 :0 0
1 0 0
a .m . p .m .
A
B
C
D
#
#
*
 
Figure 6.8. Dendritic phenotype subsets; mDC (A), CD16+ (B), and pDC (C) and total dendritic cell (D) 
concentrations single and repeat bouts of prolonged heavy-intensity exercise. Data represent mean ± SD. 
tDC: total dendritic cells. mDC: myeloid dendritic cells. pDC: lymphoplasmacytoid dendritic cells. CD14-
/lowCD16+ DC: monocyte-related dendritic cells. Time x trial interaction: Main effect of time: Main effect of 
trial. mDC: 0.523; 0.243; 0.220. CD16+ DC: 0.004; 0.275; 0.224. pDC: 0.116; 0.013; 0.001. Total DC: 0.040; 
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0.036; 0.117. The first p value represents the trial (single versus repeat) x time interaction; the second p value 
represents the main effect of time; the third p value represents the main effect of trial. *, signifies a 
significant difference between trials at time point. #, signifies a significant difference from pre- to 
immediately post-exercise in the REP trial.   
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Discussion  
The main finding of this study was that prior heavy exercise did not alter the time course of 
redistribution of circulating immune cells following a second bout of prolonged heavy-
intensity exercise performed on the same day. While neutrophil concentration remained 
elevated immediately prior to the start of the second exercise bout, lymphocyte 
concentration, total γδ T cells, δ1 and δ2 subsets, memory phenotypes, and surface 
receptors, and dendritic cells did not significantly differ between the SIN and REP trials 
following P.M.-Ex, however there was a significant time x trial interaction in total γδ T 
cells, δ1 subset, CD16+ DCs and total DCs. Additionally, despite the increased neutrophil 
concentration before the second cycling bout (P.M.-Ex), prior heavy exercise did not 
influence the neutrophil response during the exercise period, nor the time course of 
neutrophil recovery following exercise. Indeed, many of the subsets (particularly total 
lymphocyte concentration and its related subsets) featured near identical recovery patterns 
following P.M.-Ex between both trials. These results are important, in contrast to previous 
findings, prior exercise may have less effect on lymphocyte cell redistribution following a 
subsequent bout of prolonged heavy-intensity exercise than previously suggested.  
 
An increase in neutrophil concentration immediately before the second exercise bout in the 
REP trial in the present study is consistent with previous findings [178, 179, 186-188]. The 
elevated neutrophil response resulted in a more pronounced change in neutrophil 
concentration following the subsequent bout of exercise performed on the same day. A 
collection of publications from Ronsen et al monitored nine endurance trained athletes who 
completed one or two bouts of cycling for 75 min at ~75% V̇O2peak separated by a 3 h or 6 
h rest period [177-179, 188]. Following the second bout of endurance exercise, comparing 
single and repeated protocols, there was a significant increase in neutrophil, lymphocyte, 
CD4+, CD8+, and CD56+ cell concentrations, and hormones; adrenaline, noradrenaline, and 
cortisol [177, 179]. Similar results were reported following 1 h of cycling sub-divided into 
three segments each of 20 min duration (5 min at 50% V̇O2peak and 15 min at 70% 
V̇O2peak) on two occasions separated by 4 h. Both neutrophil and lymphocyte 
concentrations were significantly higher after two bouts of exercise than after the single 
bout [187]. Another study analysed the immune response to two 2 h bouts of cycling at 
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60% of V̇O2max, separated by 3 h. Similar results were found in leucocyte concentrations 
and stress hormones, with a decrease observed in neutrophil function [186]. This 
redistribution of neutrophils is likely the result of the combined effects of stress hormones, 
including growth hormone, epinephrine, norepinephrine and cortisol [115, 116, 125, 137, 
341, 342]. In contrast to previous findings [179], no difference was observed between trials 
in lymphocyte concentration following P.M.-Ex. Previous research has observed a greater 
lymphocytosis during exercise that was performed subsequent to an initial bout. These 
previous studies utilised exercise protocols of shorter duration and comparable intensity to 
the present study [178, 179, 187]. In contrast, the present findings are consistent with a 
study that reported no difference in lymphocyte concentration between repeated exercise 
bouts that employed 2 h efforts at 60% of V̇O2max [186]. A possible explanation for the 
inconsistency between these studies may be due to food intake between exercise bouts. 
Both, McFarlin et al. (2002), and Ronsen et al. (2001a and 2001b), used protocols where 
muscle glycogen stores were not fully replenished between bouts. Estimated energy 
expenditure exceeded energy in take by 1,500 kJ in these two studies [177, 179, 187]. 
Total energy expenditure for each exercise bout was estimated using reported V̇O2 values 
during exercise, multiplied by an approximate value of 21 kJ.L-1.min-1, multiplied by total 
minutes of exercise [131]. This value was then compared to the reported energy intake 
during the study period. Results of this were calculated as ~3,580 kJ expenditure versus 
2,125 kJ intake, and ~5,692 kJ expenditure versus 4,184 kJ intake, respectively [177, 179, 
187]. One explanation for a greater stress hormone response (particularly epinephrine), and 
resultant increase in circulating lymphocyte concentration, following the second exercise 
bout, has been explained by decreased blood glucose levels [177]. In the present study, we 
attempted to match energy expenditure and intake (~6141 kJ expenditure versus 6000 kJ 
intake), which we expected would help to replenish muscle glycogen as much as possible 
before P.M.-Ex. In the study by Li and Gleeson (2004), participants were not fed for the 
entirety of the sampling period between the two 2-h exercise bouts. This exercise duration 
coupled with the lack of meals, would be expected to drive a greater rise in lymphocyte 
concentration following the second bout. This is due to the combined effects of increased 
exercise duration [126], and low blood glucose concentration [196], on circulating stress 
hormone concentrations, and the resultant effect on cellular ingress. However, the subjects 
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were only able to complete ~75 min of the proposed 120 min afternoon exercise protocol 
[186]. Previous research has demonstrated that exercise duration influences the severity of 
lymphocytosis [156, 157]. Potentially, in the study by Li and Gleeson (2004), the effect of 
carbohydrate depletion on stress hormone release was offset by the significantly shorter 
exercise duration, to cause a similar post-exercise lymphocytosis between single and repeat 
trials. Together, these results may suggest that matching adequate energy intake before or 
during exercise to total work performed is imperative to minimise disturbances in 
leucocyte distribution after exercise. Furthermore, total lymphocyte concentration and its 
subsets featured very similar recovery patterns post-P.M.-Ex, between SIN and REP trials. 
This may suggest regardless of prior exercise-induced stress, the leucocyte redistribution 
follows a distinctly repeatable concentration change in the circulation. 
 
A significant increase was evident immediately following all exercise bouts in δ1 and δ2 
subset, and total γδ T cells in the peripheral circulation. However, there were no significant 
differences in δ1 and δ2 subset, and total γδ T cell concentrations at any time point 
between SIN and REP trials in the present study. There was however, a significant time x 
trial interaction for total γδ T cells and the δ1 subset, suggesting a difference in cell 
concentrations between single and repeat bouts over the period of collection, although this 
is likely due to the difference in response following A.M.-Ex. Similar to the present study, 
previous research has demonstrated a significant increase in total γδ T cell concentration 
[104, 161], and both δ1 and δ2 subsets [163], following short duration exercise (30 min), 
and in response to psychological stress and β-agonist infusion [104]. These cells are 
regarded as being highly stress responsive. Ingress into peripheral circulation is driven 
primarily through β-adrenergic mechanisms causing a release of cells from leucocyte 
“marginal pools” located within the respiratory circulation, spleen and liver [111, 162, 
343]. When the δ2 subset was differentiated into memory phenotypes, no significant 
difference was present between the two trials at any time point. There was a trend towards 
a significant time effect for CM (p=0.063) and EMRA (p=0.082). Compared to the results 
of Study II, this may be a repeatable effect, particularly for CM δ2 γδ T cells. Although 
there was no immediate post-exercise increase in Study II, both studies featured a decrease 
(egress) post-exercise in the central memory subset. When analysing expression of CD11a, 
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CD62L, and CD94 on total γδ T cells, no significant difference at any time point was 
present between the two trials, however exercise did result in a significant increase in 
CD11ahi and CD62Lhi immediately post-exercise. The response of CD11a reflects similar 
results following acute psychological stress [163], and has been observed previously in NK 
and CD8+ T cells [162, 344, 345]. The surface receptor CD11a is involved in cellular 
adhesion, is typically up-regulated on endothelial cells in proximity of inflamed tissues 
[92], and is highly sensitive to catecholamine secretion [162]. Immediately post-exercise, a 
significant increase in γδ T cells expressing high levels of CD62L occurred. CD62L 
expression reflects lymph node-migratory potential [86]. These exercise-induced results are 
similar to the response following acute psychological stress [163]. This psychological 
stress-induced increase in γδ T cells expressing high levels of CD62L was in contrast with 
findings of CD62L expression on NK and CD8+ T cells following acute stress [318, 344, 
345]. However, with the support of the present study, the increase in CD62Lhi γδ T cell 
concentration appears to be a consistent phenomenon. There was a significant increase 
post-exercise in γδ T cells expressing CD94+, while no significant change was evident for 
those cells with no expression of CD94 (CD94-). CD94 is involved in innate recognition of 
aberrant MHC expression on infected and cancerous cells. These results partially resemble 
previous observations, where psychological stress did drive ingress in both subsets, with a 
more aggressive mobilisation evident for the CD94+ population [163]. There was a trend 
towards an exercise-induced time effect of CD94- γδ T cells, however this was not 
considered significant. There was also a trend towards a time x trial interaction of CD94- 
(p=0.063) however, when examining Figure 6.7.A, the biggest difference between trials 
appears to be during the morning priming bout of exercise. There was no significant 
difference in CD11a, CD62L, or CD94 expression of γδ T cells between the SIN and REP 
trials at any time point. 
 
Exercise significantly increased in circulating concentrations of pDCs and total DCs in the 
immediately post-exercise period. Additionally, pDC concentration was significantly 
higher in the REP trial compared to the SIN trial at post-A.M.-Ex. However, no significant 
differences were observed in mDC, CD16+ DCs, and total DCs between REP and SIN 
trials. There was however, a significant time x trial interaction present in tDCs and CD16+ 
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DCs. Previous research has reported that total DC concentration increases acutely 
following surgery, or a treadmill exercise test to exhaustion, with an equal rise in mDCs 
and pDCs [105]. Furthermore, immediately following a marathon run, mDC concentration 
increased while pDC concentration decreased [164]. On the other hand, following a 1-hour 
ice-hockey training session, both mDCs and pDCs increased significantly immediately 
after exercise [165]. The differences among these results may reflect varying sampling 
times after exercise. Additionally, differences in exercise intensity and duration may 
influence the cellular redistribution kinetics. As previous research has highlighted, 
significant changes in leucocyte redistribution can occur during the early stages of an 
exercise bout (30 min), but may return to near resting concentration after 2.5 h of exercise 
[155], due to the biphasic nature of the lymphocyte response to exercise [111]. Regardless, 
in the present study, pDCs appear to be responsible for the greatest change in total DC 
concentration due to exercise. Additionally, the significant time x trial interactions may be 
due to either the recovery period or the A.M.-Ex period. There appear to be differing 
recovery patterns occurring between SIN and REP trials, although they were not 
considered significantly different at any specific time point. The DC concentration kinetics 
appear to be different to be different between SIN and REP groups, although this may be 
due to the greater range of values seen post-exercise in the REP compared to the SIN group 
for both tDCs and CD16+ DCs.   
 
Concerning limitations of the present study, no stress hormone data was collected in the 
present study. While measuring the concentrations of cortisol, epinephrine and 
norepinephrine would be a luxury, it was not a primary aim of the research. Although 
hormonal analysis would provide further evidence to support the hypothesis that acute 
stress hormone increases are driving changes in cellular components, the cost of analysis 
would outweighed the value of the data collected. It would be expected that any stress 
hormone data would merely support countless previous research articles, rather than 
provide any new information. Indeed, studies of very similar duration and intensity, 
repeated 1.5 h bouts at ~75% V̇O2peak [177, 178], have previously examined these stress 
hormones, to expected and repeatable results. As such, it was decided not to analyse stress 
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hormone concentrations and rather complete more detailed analysis of cellular components 
of the immune system.  
 
As noted above, many subsets (particularly total lymphocytes and its related subsets) 
featured near identical recovery patterns following P.M.-Ex between both trials. This may 
suggest that regardless of prior exercise, cellular redistribution follows a repeatable pattern 
following prolonged heavy exercise. These results are both novel and meaningful: our 
study suggests that prior exercise has less effect on cellular redistribution following a 
subsequent bout of prolonged heavy-intensity exercise than previously thought. We 
propose that this finding is possibly linked to the provision of adequate energy intake 
employed in the present study both prior to and in-between exercise sessions. This is 
important when considering the increased incidence of symptoms associated with URIs 
during periods of heavy training and competition [1-5]. It is during these times, that stress 
is at its greatest, and recovery is most important. This highlights the importance of 
maintaining carbohydrate stores, and ensuring adequate energy intake before exercise, not 
only for bioenergetics, but also for immune function.   
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7. DISCUSSION 
 
This thesis examined the complex relationship between acute stress, exercise and immune 
function. The increased occurrence of upper respiratory illnesses during periods of heavy 
training, taper and competition is a cause for concern [8, 13, 14, 24-28]. Previous research 
in overtraining have observed URS were associated with significant persisting fatigue and 
poor performance [13-17]. Indeed, any interruption to optimal training is likely to impact 
an athlete’s ability to train at the highest level. Closely linked to this repetitive training is 
the concept of stress. While exercise is one often studied stressor, many others exist which 
exhibit similar effects [104, 105].  
 
Endurance athletes regularly undergo significant physiological stress caused by large 
training volumes. Training may occur multiple times per day, every day of the week, 
resulting in repetitive, stress-induced activation of the immune system. What appears to be 
the prominent question driving exercise immunology research in elite endurance athletes 
is: “What are the origins of the increased incidence of symptoms associated with URIs in 
these individuals?” Advances in research over the last 30 years has allowed a greater 
understanding of how the immune system functions and coordinates immune responses 
among the cells, proteins, and structures. When an individual is more or less susceptible to 
infection, what is causing this? Is it a single immune variable, cell type, protein, structure 
or otherwise that is compromising the entire integrity of a person’s defence mechanisms? 
A compromise that can be exploited by an opportunistic pathogen. Or is it an overall 
decrease in holistic immune function which results in a greater chance of a pathogen 
entering the system and mounting a successful infection? In many diseases, it is very much 
the former. The human immunodeficiency virus (HIV) infects CD4+ T cells, macrophages 
and dendritic cells, impairing the hosts’ ability to function optimally in immune 
surveillance resulting in acquired immune deficiency syndrome (AIDS) [346]. 
Furthermore, those individuals presenting with Selective IgA Deficiency [49], and poor 
saliva flow rates (hyposalivation) [347], have been shown to have a high incidence of 
symptoms associated with URIs. In contrast to these two examples with a definite cause for 
a state of immunocompromise, stress-induced immune-dysfunction appears to be much 
more multifactorial. This is because the stress response is part of normal, healthy human 
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function [313]. Why then does this response sometimes cause a state of 
immunocompromise? And is the entire immune system affected, or is it a single or few 
small variables that are altered to the way of slight immune-dysfunction allowing the 
contraction of a URI? These are the questions that the area of exercise immunology as a 
whole are striving to answer, and are important to consider when looking to understand the 
complexity of this response.  
 
One of the most important concepts throughout this thesis is the relationship between the 
stress response and subsequent immunological changes. Specifically, cellular redistribution 
following stress is paramount in understanding both the potentially positive and potentially 
negative effects of exercise on immune function. The influence of changes in circulating 
stress hormones and blood flow on cellular redistribution and function cannot be 
understated. It is important to remember, throughout this thesis, an increase in cell 
concentration of any leucocyte population in the blood following a stress response was 
defined as cellular ingress. Whereas, a decrease in cell concentration of any leucocyte 
population in the blood following a stress response was defined as cellular egress. Stress 
itself was defined as “a constellation of events, consisting of a stimulus (stressor), that 
precipitates a reaction in the brain (stress perception), that activates physiological fight or 
flight systems in the body (stress response)” (reproduced with permission) [102, 103]. 
Specifically, this cellular ingress into peripheral circulation occurs by transportation of 
cells from areas of storage (i.e. spleen, lungs, marginated pool of respiratory tract, bone 
marrow, lymph nodes), into the circulation (i.e. blood vessels and lymphatics) and out to 
the tissues (i.e. skin, lung, gastro-intestinal and urinary-genital tracts, mucosal surfaces, 
and lymph nodes) [106, 107]. This stress response may (incidently) prepare immune cells 
to respond to opportunistic infectious pathogens [106, 108]. It has been suggested that the 
effect of stress on the immune system depends on the duration of the exposure to stress. 
Acute and intense stress may enhance immune function, and mild stress of moderate 
duration may promote immunosurveillance, while chronic stress may cause immune 
dysregulation [102, 109]. 
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Referring to specific results of this thesis regarding cellular redistribution, one of the 
results that may be considered in contrast to previous findings was that no significant 
increase was present in circulating lymphocyte concentration following the 2 h cycle at 
90% VT2 in Study II. Immediately, this is in contrast to a large portion of previous research 
examining the cellular response to stress or exercise [1, 107, 315]. Indeed, when compared 
to Study IIIB, there is a distinct difference in the results immediately post-exercise in 
relation to the same cell types (total lymphocytes, total γδ T cells and subsets, total DCs 
and subsets). There would seem to be a disconnect between the two, as we observed a 
significant increase in lymphocyte concentration in Study IIIB compared to no change in 
Study II. This is particularly odd as all samples for both studies were analysed by the same 
haematology analyser undergoing regular and routine calibration (Coulter HmX 
Hematology Analyzer, Beckman Coulter). An alternative hypothesis for the difference 
between studies may be related to the duration of the bouts. Previously, during a 2.5-h 
treadmill run at 75 % of V̇O2peak, there was no significant change in lymphocyte 
concentration immediately post-exercise, while midway through the exercise bout, a 
significant increase occurred [155]. Although comparison between running and cycling can 
be risky due to the effects of eccentric loading on circulating leucocyte concentrations 
[348], one study examining lymphocyte concentrations in response to 2.5 h of running or 
cycling at ~75% VO2peak (with and without carbohydrate supplementation) demonstrated 
no difference in lymphocyte concentrations during the post-exercise period, regardless of 
exercise mode, in experienced triathletes [196]. Potentially, a peak in ingress may occur 
during the exercise bout, but after 2 h of exercise, egress may be up-regulated enough to 
decrease circulating lymphocyte concentration (or cause it to appear unchanged) at the 
immediately post-exercise sampling point. This phenomenon has been previously observed 
in rats. After an initial increase in circulating concentration (ingress), a decrease occurs 
below resting concentrations (egress) while the stress stimulus (psychological stress in this 
case) is ongoing [106].  
 
In addition to the differences between Studies II and IIIB in relation to circulating 
lymphocyte concentration immediately post exercise, dendritic cells and  T cells also 
demonstrated differences between the two studies. For  T cells, Study II demonstrated a 
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significant decrease in the concentration of γδ T cells and the δ2 subset up to 4 h post-
exercise. Furthermore, phenotypical differentiation revealed a significant decrease in naïve 
and central memory δ2 cells. Additional analysis revealed preferential egress of γδ T cells 
expressing CD11ahigh and CD62Lhigh. Conversely, Study IIIB revealed significant exercise-
induced increases in total lymphocytes, total γδ T cells, δ1 and δ2 subsets, and γδ T cells 
with high expression of CD11a, CD62L, and CD94. This was then followed by a decrease 
in the concentration of these subsets from 1 h post-exercise. Additionally, when comparing 
DCs, Study II showed a significant decrease in total DCs at 1 h post-exercise, together with 
decreases in mDCs and CD16+ DCs up to 2 h post-exercise. Conversely, Study IIIB 
showed a significant immediate post-exercise increase in total DCs and pDCs followed by 
a decrease at 1 h post-exercise. As suggested above, these contrasting results between 
Study II and Study IIIB would appear to be related to the timing of sampling. This is 
highlighted by a similar pattern of circulating cell concentration changes during the post-
exercise recovery period. Although, recovery points examined in the two studies aren’t 
identical making direct comparison more difficult, changes in circulating DC concentration 
feature a decrease following exercise (egress) which returns to approximate resting 
concentration at 4 h or 6 h post-exercise. This appears to be consistent following both a 
single bout of exercise (Study II and Study IIIB), or repeated exercise (Study IIIB). These 
observations may suggest that cellular egress follows a repeatable pattern following 
exercise. Although it is clear that certain cell types are preferentially mobilised in response 
to stressors such as exercise [104], less is known about the process that occur during 
cellular egress. 
 
It must be noted that the mitogen-stimulation assay was changed from Study I to Study 
IIIA. The original study used stimulated isolated PBMCs with PHA at a concentration of 1 
× 106 cells/mL. This stimulation lasted for 72 h at 37C. In contrast, Study IIIA involved a 
whole blood stimulation assay with PMA and ionomycin for 4 h at 37C. Both these assays 
are used regularly in analysing immune function [155, 241, 242, 258, 349]. The reasons for 
the change of assay were two-fold: 1) in Study I, a high degree of variability between 
samples in a small cohort made analysis difficult, and; 2) stimulation with PMA and 
ionomycin was used previously when examining intracellular cytokine production of T 
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cells [155, 159], however, this stimulation cocktail has not been used to quantify cytokine 
production from whole blood. It was hoped the use of a different stimulation assay, that has 
proven effective in intracellular cytokine analysis, would provide further information that 
may have been missed in Study I. Unfortunately, due to the change in assay, comparing T 
helper cytokine concentrations between studies is impractical. This is because stimulation 
is via different mechanisms, on a different population of cells for a different duration. 
Examining the data of the Studies I & IIIA shows a large difference in concentrations of 
these different cytokines, with a different pattern of change among the seven cytokines that 
were analysed. Finally, magnitude-based inference analysis was employed in Study I but 
not Study IIIA. For Study I, this form of analysis was used as no significant changes at any 
time point for all cytokines analysed, however in Study IIIA significant changes and 
interactions were discovered using traditional statistics. Due to this, it was decided to not 
use magnitude-based inference for analysis Study IIIA, but rather a combination of 
ANOVA with repeated measures and correlation analysis.  
 
Throughout this thesis, the immune recovery period is mentioned. By definition, this is 
referring to the period following the cessation of an acute stressor when cellular 
redistribution is occurring, until the point of where circulating cell concentration returns to 
resting levels. This is quite non-specific, primarily due to gaps in knowledge regarding the 
immune recovery period. This thesis aimed to uncover some of the changes that occur 
during this period. And indeed, previous research has highlighted the kinetics of certain 
changes, and the locations and directions certain cell types relocate to during this period 
[350-352]. But the question still remains concerning immune system recovery. In the 
muscle physiology, recovery is required to replete endogenous fuels sources, repair 
damaged muscle tissue, and produce proteins (such as enzymes and mitochondria), which 
will facilitate adaptation to a specific stressor and return to homoeostasis [353, 354]. 
Immune system recovery does not fit within the above terms. Other than the time period in 
which this occurs, there does not appear to be any similarities. So should we examine 
immune recovery the same way as muscle recovery? Some previous research has 
demonstrated short-term functional decreases in certain cell types. And indeed, there is a 
period of greater than eight hours for some cell types to return to resting concentrations [1]. 
But the issue lies in identifying a repeatable phenomenon driven by the exercise-induced 
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stress response which decreases host defence. Questions remain whether the increased 
occurrence of symptoms associated with URIs during periods of heavy training and 
competition related to a decreased ability to mount an immune response during this 
recovery period, rather than the “killing ability” of a single cell type.  
 
A potentially important finding from this thesis is that of adequate energy intake prior to 
prolonged exercise. By no measure a new concept in exercise physiology and nutrition 
[355], less focus has been placed on energy intake in exercise immunology research. 
Although carbohydrate ingestion during exercise has been demonstrated to attenuate the 
rise in stress hormones (particularly cortisol) [196, 332], and more recent reviews have 
recommended carbohydrate as an imperative part of maintaining immune health with 
exercise [108, 356], many studies preferentially select fasted protocols during research, 
even during sampling periods of more than ten hours duration [186, 197, 357]. This choice 
is likely driven by the desire to remove the effect of food ingestion on circulating hormone 
concentrations. The issue is that this method provides an inaccurate representation of how 
the immune system is affected by exercise, both during, and following the exercise bout. It 
is recommended in exercise physiology that maintaining optimum blood glucose, and 
adequate glycogen stores are imperative to optimal performance, in training and 
competition [355]. In the present thesis, no ‘carry-on’ effect of prior exercise was evident 
in cell types other than neutrophils. Importantly, there was no significant difference 
between trials during afternoon exercise and recovery. It must be noted that there was no 
control group in which energy intake was controlled or limited to contrast with the energy 
matched protocol of the present studies. This makes reaching a conclusion difficult when 
considering the influence of energy intake on the potential ‘carry-on’ effect, however it 
does raise questions that could be answered in further research. Additionally, this may 
support the argument for normal recommended dietary intake to continue during exercise 
immunology research. Ensuring adequate energy intake in exercise immunology research 
may present an effect more demonstrative of the immunological changes that occur in 
athletes undergoing regular training, rather than an altered effect due to fasting or 
inadequate energy intake during/before exercise. The feeding protocol used in this thesis 
was decided on to reflect the eating habits of the highly trained cyclists who undertook the 
study. Specifically, it was deemed imperative that energy intake should match energy 
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expenditure to mirror training recommended protocols used by such highly trained athletes 
[358].  
 
Another concept previously unexamined in exercise immunology literature is that of 
concentration groups. As mentioned above, the concept of sorting subjects into “high” and 
“low” and/or “non” responder groups has been used in research previously [323-327]. 
However, to our knowledge, no study in exercise and stress immunology has expressed 
changes in the immune system following an acute stressor by the resting concentration 
circulating cell subsets. As highlighted in Study II, in many cell subsets, those subjects 
with a higher resting cell concentration of a specific subset demonstrated a greater decrease 
in concentration during the egress phase, however this wasn’t consistent throughout, in 
particular total DCs. When examining cellular ingress into circulation of granulocytes and 
monocytes, resting concentration didn’t appear to influence peak concentrations. This may 
provide a basis for further research, as resting cell concentrations appear to be linked to 
magnitude of cellular egress post-exercise. It is recognised that elite athletes experience 
leucopenia driven primarily by neutropenia at rest [328, 329]. Potentially, these two 
findings may be related. Certainly, there is an interesting relationship between resting 
concentration of circulating leucocytes and the ability for these cell types to respond to 
stress. It has been hypothesised that an athlete’s stress response is more efficient than 
untrained due to regularly experiencing such efforts [329]; however, limited research has 
tested such a phenomenon.  
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Limitations 
A number of limitations existed in the studies of this thesis. The lack of a non-exercising 
trial made parts of the analysis difficult in Studies I & II. In particular, Study II saw a 
number of changes during the post-exercise period which have not been seen before, and 
were in contrast to previous research. The reasons for the disparity between the present 
study and previous research may be due to the novelty of the variables analysed: both γδ T 
cells and DCs have rarely been measured in exercise immunology research. Furthermore, 
acute short-term stress (such as a psychological stress test) can drive different changes in 
the stress response and cellular redistribution compared to prolonged, heavy-intensity 
exercise. This makes drawing comparisons between studies more difficult. Regardless, a 
non-exercising trial may have provided a more solid foundation of which to contrast the 
findings against. In particular, the effects of diurnal variation could be separated from 
exercise-induced effects. As diurnal variation drives changes in plasma cortisol 
concentration, resulting in small changes in circulating leucocyte populations [309], it may 
have been advantageous to include a control trial. Although, the effects of diurnal changes 
are much smaller in magnitude compared to exercise-induced changes [177-179, 189, 197]. 
No non-exercising trial was included because one of the primary aims of the thesis was to 
acutely analyse the recovery period post-exercise. This required a large number of 
sampling points, which double when including a control trial. In previous research, the 
recovery period has been largely neglected, quite possibly due to the cost of analysing so 
many samples. This has become abundantly clear in the present studies. In the repeated 
bouts design, each subjects was sampled on sixteen occasions, multiplied by ten subjects 
and the cost of analysis using flow cytometry compounds very quickly. But the focus on 
the recovery period was one of the main aims of this research, and therefore, worthwhile.  
 
Results from the mitogen stimulation assays (Studies I & IIIA) featured few significant 
changes between time points. Although mitogen stimulation is used widely in immunology 
research, contrasting results are often present between studies [96, 339]. Generally, these 
type of assays are used to analyse resting samples of individuals, in groups with quite 
pronounced immune deficiencies [243, 359, 360], although exercise immunology research 
has also used these analysis techniques [155, 159, 242, 250, 254-256]. In contrast, the 
current study was examining healthy subjects in an attempt to identify small changes in 
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immune function due to exercise. It would appear that exercise may not be drive large 
changes in cellular function, compared to a state of immune deficiency. As mentioned 
previously, two different stimulation assays were used. Study I employed at PHA-
stimulation assay of isolated PBMCs, and Study IIIA used whole blood stimulation with 
PMA and ionomycin. Both these protocols are used in research regularly, however, may 
not have been adequate for the present research. Potentially, intracellular cytokine analysis 
may have been more useful. This involves a similar process to the present studies of 
mitogen stimulation, however additional steps are included where the cells undergoing 
analysis are bound to fluorescent monoclonal antibodies and permeated. Next, additional 
fluorescent monoclonal antibodies are added specific to the intracellular cytokines of 
choice. Flow cytometry is then used to examine production of cytokines by a specific cell 
type. Certainly, fewer time points and cytokines could be analysed compared to the present 
studies. However, previous research could have been used as a basis from which to design 
potential studies [155, 247]. These methods are more likely to be used for profiling cell 
types according to cytokine production, rather than cytokine production itself, however 
these results may be more useful in demonstrating the effects of exercise-induced stress on 
cellular immunity. Specifically, previous research has suggested the post-exercise decrease 
in T lymphocyte concentration is due primarily to a more pronounced decrease in Type 1 T 
cells (compared to Type 2 T cells). Potentially, intracellular cytokine production could be 
used to profile more cell types, such as dendritic cells which provide a large array of 
functions depending on their location current interactions, to better understand the specific 
response to stress during the post-exercise period. Ultimately, the goal is to determine if 
immune changes that occur with exercise can be linked directly with an increased risk of 
URIs. 
 
In addition to changing certain assays, additional analysis would certainly have painted a 
more detailed picture, particularly when considering the more novel immune markers 
examined. Both  T cells and dendritic cells have been scarcely examined in previous 
research. In addition to the assays used in the present study, a functional analysis would be 
quite complimentary. Of course, one cannot analyse everything, but a functional assay 
would assist in discovering the acuities of these largely unexamined cell types. In this 
context, a functional tests analysing antigen-presenting capabilities, cytokines production 
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capabilities, or cytotoxic function could be meaningful. The primary difficulty, other than 
cost, would likely be related to very low circulating concentrations of DCs and  T cells. 
Potentially, an intracellular cytokine assay (such as that mentioned previously) would be 
the most effective and accurate measure of function. Regardless, both these cell types are 
of great interest; dendritic cells because of their role in coordinating immune responses; 
from recognition through to presentation and coordination of effector functions, or  T 
cells in their role as both an innate and adaptive cell located in high concentrations in the 
tissues, areas more at risk of potential infection.  
 
For a thesis examining the stress responses effect on immune function, only Study I 
examined any form of stress hormone release. It was abundantly clear from the first study 
onwards that, while measuring the concentrations of cortisol, epinephrine and 
norepinephrine would be a luxury, it was not a primary aim of the research. Although 
hormonal analysis would provide further evidence to support the hypothesis that acute 
stress hormone increases are driving changes in cellular components, however the cost of 
analysis would outweighed the value of the data collected. It would be expected that any 
stress hormone data would merely support countless previous research articles, rather than 
provide any new information. Indeed, studies of very similar duration and intensity, 2 h at 
~75% V̇O2peak (Study I & II) [197, 308], and repeated 1.5 h bouts at ~ 75% V̇O2peak 
(Study III) [177, 178], have previously examined these stress hormones, to expected and 
repeatable results. As such, it was decided not to analyse stress hormone concentrations 
and rather complete further analysis of cellular components of the immune system.  
 
Finally, the participants recruited for this thesis were highly trained endurance cyclists. It is 
necessary to mention that results of the present study would not be identical to another 
athlete cohort (such as power or speed athletes) or a sedentary population. As highly 
trained endurance athletes undergo regular prolonged, heavy-intensity exercise-induced 
stress, their immune system would likely be more accustomed to dealing with such a 
stressor. Although few studies have directly compared cellular components of trained 
versus untrained individuals, one study demonstrated increased NK cell function in a group 
of highly trained cyclists [361]. Additionally, regular exercise has been showed to decrease 
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symptoms associated with URI compared to sedentary individuals [362]. Furthermore, elite 
swimmers undertaking intensive training have significantly lower neutrophil oxidative 
activity at rest than age- and sex-matched sedentary individuals, but URTI rates do not 
differ between the swimmers and sedentary controls [363]. As concluded on in a recent 
position statement “the nature of the reported changes measured depends on a number of 
variables that include the training status of the individual, the intensity of the exercise bout, 
and the nutritional status of the individual” [111]. This is important to consider when 
examining the results of the present study.  
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Recommendations & Future Directions 
At the end of the day, the most important information to discover in the field of exercise 
immunology with elite athletes would be; 1) a single or combination of biomarkers that can 
accurately predict when an athlete is immunocompromised and at a greater risk of illness, 
and 2) a number of recommendations, interventions, and supplements that can be easily 
used by athletes to decrease the risk of contracting an illness. In the bubble of elite sport, 
these are the two major goals of research in this area. Previous research and practice of 
common sense allows the partial fulfilment of these goals. The most accurate biomarker 
currently in practice is sIgA. Functioning as part of the mucosal immune system, sIgA 
provides the ‘first line of defence’ against pathogens. To date, the majority of exercise 
studies have assessed saliva sIgA as a marker of mucosal immunity, but more recently the 
importance of other antimicrobial proteins in saliva (e.g. α-amylase, lactoferrin and 
lysozyme, cathelicidin antimicrobial peptide, human neutrophil alpha-defensins, human 
beta-defensin 2, chromogranin A) has gained greater recognition [364-373]. Depressed 
secretion of sIgA into saliva during periods of intensified training and chronic stress are 
likely linked to altered activity of the hypothalamic-pituitary-adrenal axis, with inhibitory 
effects on IgA synthesis and/or transcytosis [5, 26, 374, 375]. Consensus exists that 
reduced levels of saliva sIgA are associated with increased risk of URI during heavy 
training [111]. Additionally, sIgA is used in many professional sporting teams through the 
sporting season as a monitoring tool. Regarding potential recommendation, interventions 
and supplements to maintain immune health, the position statement by published by a 
consortium in Exercise Immunology Review has provided the “gold standard” for dealing 
with illness in athletes [108], in addition to nutritional considerations which are of high 
importance [356]. Ensuring adequate energy, carbohydrate and protein intake and avoiding 
deficiencies of micronutrients are key to maintaining immune health. Evidence is 
accumulating that some nutritional supplements such as quercetin and probiotics can 
augment some aspects of immune function and reduce illness rates in exercise stressed 
athletes [244, 376, 377]. Of course, prevention of infection is always superior to treatment. 
Although there is no single method that completely eliminates the risk of contracting an 
infection, there are several effective methods of reducing the risk of infection. These means 
include appropriate management of training loads, use of appropriate recovery strategies, 
good personal hygiene, avoiding contact with large crowds, young children and sick 
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people, good nutrition, getting adequate good quality sleep and limiting other life stresses 
to a minimum [108].  
 
Regarding findings of the present thesis, the following recommendations have been 
suggested regarding specifics markers examined and the protocols used. Repeated exercise 
appeared to have less of an effect on cellular mobilization that previously observed. 
Although a firm conclusion isn’t possible, this may be due to energy intake during the 
testing period. Adequate nutrition is clearly important in maintaining immune health, 
perhaps when designing protocols in the future energy expenditure and consumption 
should be matched to more accurately reflect conditions predominantly seen in real life, 
rather than fasting. Furthermore, repeated exercise may be less detrimental to immune 
health than previously thought, provided that adequate energy intake in completed 
specifically in trained individuals. The present study decided to employ an exercise 
protocol determined by a percentage of the second ventilatory threshold, rather than a 
percentage of VO2max. This was to allow a more accurate representation of exercise 
intensity that would limit the effects of oxygen consumption and cardiac drift, which would 
in turn affect circulating stress hormone concentrations. A large proportion of previous 
research in exercise immunology has determined exercise intensity as a percentage of 
maximum. This is dangerous, as each individuals thresholds differ, as does their perception 
of the exercise effort. By calculating exercise intensity according to the anaerobic or 
second ventilatory threshold (or potentially critical power), a much more standardised mark 
would be set, applicable across all participants regardless of training status. Regarding 
training status, the present study elected to examine highly trained cyclists. This made 
recruitment very difficult as strict recruitment criteria were used to ensure an elite level 
group. This was important when examining the effects of repeated exercise-induced stress 
on a population that regularly undertakes such efforts in Study III. However, in Study I and 
Study II it may have been much easier (and likely to demonstrate similar results), if a 
recreationally active healthy population was used. Recruitment can be one of the most 
difficult parts of research, made much more difficult by recruiting a rare population group 
that is required to give up time, energy and blood in the name of research. Finally, 
regarding cellular immune markers and mitogen-stimulated cytokine release, while some 
meaningful results were found, the way forward in exercise immunology research may be a 
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more holistic approach. Of course, there is no better simulator of the effects of elite level 
training, than completing a training study on elite level athletes. In order to identify a 
biomarker which could be used to identify when an athlete is immunocompromised, a 
study on an elite population throughout a season is likely the way to discover this. A 
holistic approach would be necessary to understand the complexities of the immune system 
under different forms of stress. Surveys such as daily analysis of life demands for athletes 
(DALDA) [378], profile of mood states (POMS) [379], and quantification of training load 
can be used to understand life stressors. Simple, less invasive techniques like saliva 
collection can be used to analyse an array of measures such as SIgA, cortisol, α-amylase, 
lactoferrin and lysozyme, cathelicidin antimicrobial peptide, human neutrophil alpha-
defensins, human beta-defensin 2, and chromogranin A. Blood collection to analyse 
hormones, cytokines, proteins, and cells of the immune system; both at rest and during 
exercise may be used. Additionally, immunological stress tests such as delayed-type 
hypersensitivity response could be used to assess immune function. Furthermore, URI 
episodes should be properly defined and medically verified. Such a research undertaking 
may be required to identify a single, or combination of variables that are truly indicative of 
compromised host defence.  
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Conclusion 
This thesis aimed to examine the immune system response and subsequent recovery period 
following prolonged heavy-intensity exercise in highly trained individuals. Specifically, to 
analyse the effect of single and repeated bouts of prolonged heavy-intensity exercise on a 
number of novel markers of immune system function including, dendritic cells, γδ T cells, 
and T helper cytokines with focus on both the immediate exercise effect and the 
subsequent immune recovery period after exercise. The results of the present thesis were 
planned to be two-fold; 1) expand the knowledge base for a number of novel immune 
markers previous unexamined under severe, prolonged stress stimuli, and 2) provide 
further evidence of how repeated immune stimulation may be detrimental to healthy 
immune function when recovery between sessions is not sufficient. Qualitative analysis 
revealed post-exercise changes in concentrations of plasma cortisol, IL-2, TNF, IL-4, IL-6, 
IL-10, and IL-17A compared to pre-exercise values. A Th1/Th2 shift was evident 
immediately post-exercise. Furthermore, for multiple cytokines including; IL-2 and TNF 
(Th1), IL-6 and IL-10 (Th2), and IL-17 (Th17) no meaningful (magnitude-based inference) 
change in concentration occurred until more than 4 hours post-exercise, highlighting the 
duration of exercise-induced changes in immune function. Study II demonstrated a 
significant decrease in the circulating concentration of γδ T cells and the δ2 subset up to 4 
h post-exercise. Phenotypical differentiation revealed a significant decrease in circulating 
naïve and central memory δ2 cell concentrations. Additional analysis revealed preferential 
egress out of circulation of γδ T cells expressing CD11ahigh and CD62Lhigh. Finally, a 
significant decrease was evident in circulating total dendritic cell concentration at 1 h post-
exercise, together with decreases in circulating myeloid dendritic cells and CD14-/lowCD16+ 
dendritic cells up to 2 h post-exercise. Additionally, Study IIIA showed significant 
increases in stimulated cytokine concentrations (compared to pre-exercise) of Th1 
cytokine; IL-2, and Th2 cytokines; IL-4 and IL-10. When adjusted for total leucocyte 
concentration at each time point, a significant increase from pre-exercise was observed in 
Th1 cytokines; IL-2, TNF, and IFN-, and Th2 cytokines; IL-4 and IL-10. However, there 
were no significant differences between the single and repeat exercise bout trials at any 
time point. Finally, Study IIIB revealed a significant exercise-induced increase in 
circulating concentrations of total lymphocytes, neutrophils, total γδ T cells, δ1 and δ2 
subsets, total dendritic cells, and the plasmacytoid dendritic cells. Furthermore, among the 
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γδ T cells, those with high expression of CD11a and CD62L were preferentially mobilised. 
However, no significant differences were observed between the single and repeated 
exercise trials for any variable, except total circulating lymphocyte and neutrophil 
concentrations. It appears the second aim resulted in some unexpected effects. Primarily, 
that repeated exercise did not result in a “carry-on” effect from the first exercise bout to the 
second may suggest repeated exercise with minimal recovery may not be as detrimental to 
cellular components of immune function as previously thought, provided there is adequate 
energy intake between sessions. Together, these results highlight the multifactorial nature 
of both; the stress response, and the immune system with its complex interactions of 
proteins, cells and structures functioning together to defend the host against invading 
pathogenic agents. 
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A. Supplementary Flow Cytometry Information – γδ T cells 
δ1/δ2 T cells and memory phenotypes 
Total lymphocytes were gated using forward versus side scatter (Figure A.1.A). δ1 T cell were defined as CD3+Vδ1+ lymphocytes and 
δ2 T cells as CD3+ Vδ2+ lymphocytes (Figure A.1.B). δ1 and δ2 T cells were further defined as NA, CM, EM, or EMRA according to 
expression of CD27 and CD45RA (Figure A.1.D).  As a comparison, CD3+ lymphocytes differentiated according to expression of CD27 
and CD45RA is displayed in (Figure A.1.C). Lymphocyte subset numbers were quantified using the percentage values obtained from 
each lymphocyte subset gate. The absolute lymphocyte concentration was obtained from the full blood count. 
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Figure A.1. Identification of δ1 and δ2 T cell memory phenotypes. A: Forward vs. side scatter of lysed whole blood. B: CD3 vs. Vδ2 TCR of gated lymphocyte 
population. C: CD27 vs. CD45RA of CD3+ gated lymphocyte population. D: CD27 vs. CD45RA of CD3+/ Vδ2+ lymphocytes. 
C 
Total γδ T cells and CD11a, CD94, and CD62L expression  
Total γδ T cells were gated as CD3+ γδTCR+ (Figure A.2). These cells were then examined 
for expression of CD62L (Figure A.3.A) and (Figure A.3.D), CD11a (Figure A.3.B) and 
(Figure A.3.E), and CD94 (Figure A.3.C) and (Figure A.3.F). The gated lymphocyte 
population expressing CD3 was used to determine expression of CD11a (low/high), 
CD62L (low/high), and CD94 (-/+). These gates were then applied to CD3+ γδ TCR+ cells.   
 
  
 
 
 
 
 
 
 
 
Figure A.2. Identification of total γδ T cells. CD3 vs. γδ TCR of gated lymphocyte population  
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Figure A.3. Surface expression of CD11a, CD94, and CD62L. A: CD62L expression of CD3+ lymphocytes. B: CD11a expression of CD3+ lymphocytes. C: CD94 
expression of CD3+ lymphocytes. D: CD62L expression of CD3+/ γδ+ lymphocytes. E: CD11a expression of CD3+/ γδ+ lymphocytes. F: CD94 expression of CD3+/ 
γδ+ lymphocytes. J 
H 
F 
B. Supplementary Flow Cytometry Information – Dendritic Cells 
Expression of CD33 and HLA-DR and absence of the lineage cocktail 2 with intermediate 
forward (FSC) and side scatter (SSC) between those of lymphocytes and monocytes was 
used to determine tDCs (Figure B.1.A) and (Figure B.1.B). Dendritic cells were further 
defined into three subpopulations:  
 mDC (CD123dim/CD33high/CD16-) (Figure B.1.C) 
 CD14-/lowCD16+ DC (CD123inter/CD33inter/CD16+) (Figure B.1.D) 
 pDC (CD123high/CD33-/dim/CD16-) (Figure B.1.E) 
Absolute counts were quantified using percentage values obtained from each lymphocyte 
and monocyte subset gate. 
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Figure B.1. Identification of total dendritic cells and subpopulations. A: Forward vs. side scatter of lysed whole blood. B: Lineage cocktail vs. HLA.DR of gated 
lymphocyte/monocyte population. C: CD33 expression of Lin-/HLA.DR+ gated population. . D: CD16 expression of Lin-/HLA.DR+ gated population. E: CD123 
expression of Lin-/HLA.DR+ gated population.  
C. Explanatory Statement – RO955 (2009) – Study I 
 
Bond University 
Faculty of Health Sciences & Medicine 
Exercise Immunology Study 
Explanatory Statement 
The effects of sub-maximal exercise on acute immunological function 
BUHREC Protocol Number: RO-955 
Purpose: 
Determination of Maximum Oxygen Consumption (VO2max) and immune markers 
during 2hrs at 70% VO2max 
Investigator’s contact details: 
Supervisors:  Assistant Professor Sonya Marshall-Gradisnik 
   Email:  smarshal@staff.bond.edu.au 
   Phone: 5595 4447 
   Assistant Professor Bon Gray 
   Email:  bgray@staff.bond.edu.au 
   Phone: 5595 4454 
Co-Supervisor: Dr Jonathan Peake 
   Email: jpeake@hms.uq.edu.au 
Honours Student: Michael Kakanis 
   Email:  mkakanis@student.bond.edu.au 
   Phone: 0421 212 534 
Faculty of Health Sciences and Medicine, Bond University 
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Ethics officer details: 
Caroline Carstens 
Bond University Research Ethics Committee (BUHREC) 
Email: buhrec@bond.edu.au 
Phone: 5595 4194 
 
Where will the testing be conducted? 
Our testing will be conducted in the Faculty of Health Sciences and Medicine Building 
at Bond University. This building is located on the southern side of the campus. The 
Exercise-Testing Laboratory is on the ground floor. 
 
Directions as follows:  
1. Turn into University Drive. 
2. Turn right at the second round-a-bout. 
3. Take the first left turn into the service road (Western side of University). 
4. Park one of the bays directly outside the Faculty of Health Sciences and 
Medicine building. 
5. Reception is on level 1 (Ground Floor) in the middle of the building.  
Change rooms with showers are available close to the area where the exercise testing 
program will be conducted. 
 
Overview of the testing and pre-testing 
The VO2max Test 
Prior to the test 
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Once you arrive you will be taken through the Explanatory Statement, PAR-Q, Health 
and Training Questionnaires in which you will sign a consent form once all your 
questions have been answered.  You will have a 12 lead ECG attached to your chest 
and will be seated.  
Note: At any time you may asked for the test to be stopped and have no obligation to 
continue with any testing. 
 
Your VO2max Test 
The VO2max test will be conducted on a stationary cycle ergometer (exercise bike) 
according to the American College of Sports Medicine (ACSM) Guidelines where you 
will be monitored by a qualified exercise physiologist. No blood sampling will occur 
during this test. You will have a 12 lead ECG attached to your chest and will be seated 
with your ECG monitored. You will then be invited to sit on the stationary bike at 
which time you will be able to warm up (relaxed pedalling on a light resistance). 
Following the warm up a spirometer (oxygen mask) will be fastened to your face (with 
addition of a nose clip) to allow you to only breathe through your mouth into the 
breathing apparatus. The test will begin once you have indicated you are ready in 
which you will commence the protocol below. 
 Warm Up - 6 min at 80W. 
 Test - Increase 10W every 20 sec. 
 Warm Down - 50W 
You will remain cycling on the stationary bike to the point at which you reach 
maximum oxygen output. Following reaching maximum you will be instructed to warm 
down while your ECG is continuously monitored. You may withdraw from the test at 
any time. 
 
Following Exercise 
Once you have completed the VO2max test you will be seated or directed to a bed to 
recover and be continually monitored. After 30min you are able to return home 
following a health check questionnaire to ensure you are safe to leave the premises. 
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Health risks associated with a max test 
With the right preparation, the VO2max test is a safe procedure. However, even with the 
right preparation there is a risk that a misadventure could occur. The misadventure 
may include falling over, dizziness, heart attack and death. The American College of 
Medicine states, “exercise only provokes cardio-vascular (heart) events in individuals 
with pre-existing heart disease. Exercise does not provoke cardiac (heart) events in 
individuals with normal cardiovascular systems”. 
When you arrive at the Exercise Testing Laboratory at Bond University you will be 
asked to complete a general health questionnaire and a training questionnaire. 
Additionally a resting 12 Lead Electrocardiogram and resting blood pressure will be 
taken. 
These pre-exercise-screening procedures are intended to prepare you for the VO2max 
test and to ensure your safety and well-being during the exercise test. 
 
Exercise related cardiac events in adults 
The overall risk of exercise testing in a mixed subject population is approximately 4-6 
cardiac events per 10,000 exercise tests. Cardiac events include heart attack, very 
rapid and irregular heartbeats and death. 
With the correct pre-screening (preparation) before the VO2max, and with your 
heartbeat and heart rhythm closely monitored during the VO2max test by an 
experienced exercise physiologist, the risk of cardiac misadventure is small. 
 
Our strategies to minimize risk of a cardiac event 
We will minimize the risk of a cardiac (heart) event during your VO2max test and 2hrs 
at 70% VO2max Test by asking you to complete the following; 
1. A modified physical activity readiness questionnaire (PAR-Q). The PAR-Q is a 
medical questionnaire which provides preliminary information about your 
health. 
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2. A medical questionnaire detailing your medical history, your family history, 
your smoking, drinking, and physical activity habits. You will also be asked 
about any drugs you may take. 
3. A training questionnaire detailing your training habits of the past year. 
 
The 2hrs at 70% VO2max Test 
On the day of the test 
Once you arrive, you will have a 12 lead ECG attached to your chest and will be 
seated. After 15 minutes you will have a blood sample taken from an antecubital vein, 
where a total of 45mL of blood will be taken. Blood will be taken on 7 occasions, 45mL 
each time. A 10min passive drool will also be taken pre-exercise and at each of the 
blood sampling points. 
 
Your 2hrs at 70% VO2max Test 
The 2hrs at 70% VO2max Test will be conducted on a stationary cycle ergometer 
(exercise bike) according to the American College of Sports Medicine (ACSM) 
Guidelines where you will be monitored by a qualified exercise physiologist. Blood 
sampling will occur pre-exercise, post-exercise, 2hr, 4hrs, 6 hrs, 8 hrs, and 24hrs 
post-exercise (see figure 1).  
Total number of blood/saliva samples = 7 samples. 
 
 
Figure 1 – Blood Sampling during 2hrs at 70% VO2max Test 
 
Following Exercise 
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Once you have completed the 2hrs at 70% VO2max you will be seated or directed to a 
bed to recover and be continually monitored. Between the sampling times of 2hr, 
4hrs, 6hrs, and 8hrs you will be allowed to move around within the confines of the 
confines of the testing area.   
Following the sample at 8hrs you are able to return home following a health check 
questionnaire to ensure you are safe to leave the premises. If you do not live close to 
Bond University you may chose to stay overnight on Gold Coast (nearby the 
university) free of charge.   
A call by the Honours Student/PI at approximately 8hrs post-exercise will be made to 
check on you. You are required to return for a final sample to be taken 24hrs post-
exercise, also you will be required to answer a health check questionnaire to ensure it 
is safe for you to leave the premises. 
 
Passive Drool 
A passive drool will be taken at every sampling point (n=7). This 10 min passive drool 
will be used to test for salivary immunoglobulin A. This can be quite an awkward 
process and thus it is recommended you follow these instructions to obtain the best 
and most efficient sample.  
 
Prior to Collection:  
- Do not eat a major meal within 60 min prior to sample collection. 
- Avoid alcohol consumption 24 hours prior to sample collection. 
- Avoid eating dairy productions during the 30 min prior to sample collection. 
- Avoid acidic (eg. Cola drinks) or high sugar foods and drinks (eg. Confectionary, 
sports drinks, or soft drinks) during 60 min prior to sample collection. 
- Do not brush your teeth within 2 hours of sample collection. 
- Wash your mouth out with water 10 min prior to giving sample. 
 
Saliva Sample Collection: 
- The collection procedure will involve a 10 min sample collection period. Passive 
drool spit will be collected though a short plastic straw into a 5 ml vial.  
- To effectively provide a sample of your salivary drool you should allow saliva to 
“pool” in your mouth and then without spitting, open your mouth to drool down 
through the straw into the collection vial with your head tilted forward. 
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- This method can be repeated as often as necessary until a sufficient sample of 
saliva is collected. 
- Collection tubes will be weighed before and after sample collection to determine 
flow rate and volume. 
  
Benefits from you participation 
You will receive a substantial amount of information about your physiological and 
immunological response to exercise. We will explain the implications of all results 
which include; VO2max, T- and Natural killer lymphocyte numbers, natural killer cell 
lysis activity, TH1/TH2, erythrocyte aggregation and deformability, neutrophil 
phagocytic function and respiratory burst capacity. 
 
Information about the results of your test 
Who will use the information from your results? 
The results of your test will be confidential and contained within the people conducting 
the exercise test.  
 
Do I get a copy of my results and feedback on participation? 
You will receive collective results of the study of which the implication will be explained 
to you. This also provides an opportunity for you to ask questions.   
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D. Explanatory Statement – RO955 (Amended 2011) – Study II 
Bond University 
Faculty of Health Sciences & Medicine 
Exercise Immunology Study 
Explanatory Statement 
The effects of sub-maximal exercise on acute immunological function 
BUHREC Protocol Number: RO-955 
 
Purpose: 
Determination of Maximum Oxygen Consumption (V̇O2max) and immune markers 
during 2 h at 70% V̇O2max 
 
Investigator’s contact details: 
Supervisors:  Associate Professor Sonya Marshall-Gradisnik 
   Email:  smarshal@staff.bond.edu.au 
   Phone: 5595 4447 
Co-Supervisor: Assistant Professor Bon Gray 
   Email:  bgray@staff.bond.edu.au 
   Phone: 5595 4454 
Dr Michael Simmonds 
Email:  misimmon@bond.edu.au  
Dr Jonathan Peake 
   Email: jpeake@hms.uq.edu.au 
PhD Researcher: Michael Kakanis 
   Email: mkakanis@student.bond.edu.au 
   Phone: 0421 212 534 
Faculty of Health Sciences and Medicine, Bond University 
Ethics officer details: 
Caroline Carstens 
Bond University Research Ethics Committee (BUHREC) 
Email: buhrec@bond.edu.au 
Phone: 5595 4194 
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Where will the testing be conducted? 
Our testing will be conducted in the Faculty of Health Sciences and Medicine Building 
at Bond University. This building is located on the southern side of the campus. The 
Exercise-Testing Laboratory is on the ground floor. 
 
Directions as follows:  
1. Turn into University Drive. 
2. Turn right at the second round-a-bout. 
3. Take the first left turn into the service road (Western side of University). 
4. Park one of the bays directly outside the Faculty of Health Sciences and 
Medicine building. 
5. Reception is on level 1 (Ground Floor) in the middle of the building.  
Change rooms with showers are available close to the area where the exercise testing 
program will be conducted. 
 
Overview of the testing and pre-testing 
The Familiarisation Session 
Once you arrive the Explanatory Statement, PAR-Q, Health and Training 
Questionnaires will be explained to you. If you still wish to participate, we will ask that 
you sign a consent form once all your questions have been answered.  
Lung function will be examined using a spirometer where forced vital capacity (FVC) 
will be tested to rule out pulmonary disorders.  A finger prick blood sample will be 
taken to test for cholesterol and glucose. Additionally, if cholesterol is found to be 
outside the normal range, further blood sample will be taken for blood lipids to be 
tested.  
 
You will have a 12 lead ECG attached to your chest that will be monitored while you 
are seated for 15 minutes. Additionally, supine/standing blood pressure will be taken.  
Note: At any time you may asked for the test to be stopped and have no obligation to 
continue with any testing. 
 309 
 
The Familiarisation session will be conducted on a stationary cycle ergometer (exercise 
bike) according to the American College of Sports Medicine (ACSM) Guidelines where 
you will be monitored by an exercise physiologist with extensive experience testing 
individuals with chronic disease and high-level athletes. You will then be invited to sit 
on the stationary bike at which time you will be able to warm up (relaxed pedalling on 
a light resistance). Following the warm up a spirometer (oxygen mask) will be 
fastened to your face (with addition of a nose clip) to allow you to only breathe 
through your mouth into the breathing apparatus. The test will begin once you have 
indicated you are ready. During the test, you will cycle against a series of increasing 
resistance levels (at 30W per minute). You will continue cycling on the stationary bike 
until the point your heart rate reaches 120 beats/minute. Following reaching the 
resistance level associated with 120 beats/minute, you will be instructed to warm 
down while your ECG and blood pressure are monitored. You may withdraw from the 
test at any time. 
 
This session is used to get you accustomed to wearing the oxygen mask and nose clip 
while exercising, to ensure you reach your maximal possible output during the 
V̇O2max test. 
Following Exercise 
Once you have completed the familiarisation you will be seated or directed to a bed to 
recover and be continually monitored. After 15 min you are able to return home 
following a health check questionnaire to ensure you are safe to leave the premises. 
The V̇O2max test will be at least 12 hours after the familiarisation. 
 
The V̇O2max Test 
Prior to the test 
Once you arrive you will be taken through the PAR-Q again to ensure you are safe to 
exercise. You will have a 12 lead ECG attached to your chest and will be seated for 15 
minutes. Blood pressure will also be taken. 
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Note: At any time you may asked for the test to be stopped and have no obligation to 
continue with any testing. 
 
Your V̇O2max Test 
The V̇O2max test will be conducted on a stationary cycle ergometer (exercise bike) 
according to the American College of Sports Medicine (ACSM) Guidelines where you 
will be monitored by an exercise physiologist. You will then be invited to sit on the 
stationary bike at which time you will be able to warm up (relaxed pedalling on a light 
resistance at 80W). Following the warm up a spirometer (oxygen mask) will be 
fastened to your face (with addition of a nose clip) to allow you to only breathe 
through your mouth into the breathing apparatus. The test will begin once you have 
indicated you are ready in which you will cycle against a series of increasing resistance 
levels (30W per minute) while cycling on the stationary bike to the point at which you 
reach maximum oxygen output. Your blood pressure will be taken at the approximate 
midpoint of the test. This test lasts approximately 15 min. Following reaching 
maximum you will be instructed to warm down while your ECG and blood pressure are 
monitored. You may withdraw from the test at any time. At all times during the test 
you must remain seated.  
You may terminate the test at any time. Alternatively, we may terminate your test if: 
o Adverse changes in your ECG and/or blood pressure are seen 
o Your cadence drops 15 rpm below your preferred cadence 
 
Following Exercise 
Once you have completed the V̇O2max test you will be seated or directed to a bed to 
recover and be continually monitored. After 30 min you are able to return home 
following a health check questionnaire to ensure you are safe to leave the premises. 
 
Health risks associated with a max test 
With the right preparation, the V̇O2max test is a safe procedure. However, even with 
the right preparation there is a risk that a misadventure could occur. The 
misadventure may include falling over, dizziness, heart attack and death. The 
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American College of Medicine states, “exercise only provokes cardio-vascular (heart) 
events in individuals with pre-existing heart disease. Exercise does not provoke 
cardiac (heart) events in individuals with normal cardiovascular systems”. 
When you arrive at the Exercise Testing Laboratory at Bond University you will be 
asked to complete a general health questionnaire and a training questionnaire. 
Additionally a resting 12 Lead Electrocardiogram and resting blood pressure will be 
taken. 
These pre-exercise-screening procedures are intended to prepare you for the VO2max 
test and to ensure your safety and well-being during the exercise test. 
 
Exercise related cardiac events in adults 
The overall risk of exercise testing in a mixed subject population is approximately 4-6 
cardiac events per 10,000 exercise tests. Cardiac events include heart attack, very 
rapid and irregular heartbeats and death. 
With the correct pre-screening (preparation) before the VO2max, and with your 
heartbeat, heart rhythm, and blood pressure closely monitored during the VO2max test 
by an experienced exercise physiologist, the risk of cardiac misadventure is small. 
 
Our strategies to minimize risk of a cardiac event 
We will minimize the risk of a cardiac (heart) event during your VO2max Test and 
Repeated 1 h Steady State Exercise Tests by continuously monitoring you ECG and 
blood pressure, and by asking you to complete the following; 
4. A modified physical activity readiness questionnaire (PAR-Q). The PAR-Q is a 
medical questionnaire which provides preliminary information about your 
health. 
5. A medical questionnaire detailing your medical history, your family history, 
your smoking, drinking, and physical activity habits. You will also be asked 
about any drugs you may take. 
6. A training questionnaire detailing your training habits of the past year. 
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The 2 h at ~70% VO2max Test  
(This session will occur on TWO occasions – both Placebo and Carbohydrate 
supplementation during exercise) 
Before the test 
We ask you not to exercise at a high intensity within 2 days before the 2 hour test. 
Furthermore, we would like you not to exercise at all the day before the 2 h cycle test 
as this will have implications on your immune system.  
We will provide you with a list of food options to eat the night before to ensure you 
ingest enough carbohydrates, protein and fat for the experimental trial. 
We will also ask you to keep a simple training and illness log for a month, which will 
be explained by the researcher. 
Please abstain from caffeine and alcohol for the 24 h before the test. 
 
On the day of the test 
On the day of the test, please do not eat breakfast. We will take your resting blood 
and saliva sample and then you will be fed before you begin exercising on the bike. 
You will then have a 12 lead ECG attached to your chest and will be seated for 15 
minutes. 
 
Your 2 h at ~70% VO2max Test 
The 2 h at ~70% VO2max Test will be conducted on a stationary cycle ergometer 
(exercise bike) according to the American College of Sports Medicine (ACSM) 
Guidelines where you will be monitored by a qualified exercise physiologist. A 
carbohydrate drink or placebo will be fed to you during the exercise. Blood sampling 
will occur pre-exercise, post-exercise, 1 h, 2 h, 4 h, and 6 h post-exercise (see figure 
1). Total number of blood/saliva samples = 7 samples. 
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Figure 1 – Blood Sampling during 2 h at 70% VO2max Test 
 
Following Exercise 
Once you have completed the 2 h at ~70% VO2max you will be seated or directed to a 
bed to recover and be continually monitored. Between the sampling times of 1 h, 2 h, 
4 h, and 6 h you will be allowed to move around within the confines of the testing 
area. Meals will be provided throughout this period.  
Following the sample at 6 hrs you are able to return home following a health check 
questionnaire to ensure you are safe to leave the premises.  
 
Passive Drool 
A passive drool will be taken at every sampling point (n=7). This 10 min passive drool 
will be used to test for salivary immunoglobulin A. This can be quite an awkward 
process and thus it is recommended you follow these instructions to obtain the best 
and most efficient sample.  
 
Prior to Collection:  
- Do not eat a major meal within 60 min prior to sample collection. 
- Avoid alcohol consumption 24 hours prior to sample collection. 
- Avoid eating dairy productions during the 30 min prior to sample collection. 
- Avoid acidic (e.g. Cola drinks) or high sugar foods and drinks (eg. Confectionary, 
sports drinks, or soft drinks) during 60 min prior to sample collection. 
- Do not brush your teeth within 2 hours of sample collection. 
- Wash your mouth out with water 10 min prior to giving sample. 
Time (24-h) 
Exercise 
Blood Sampling 
Ex. 
    7             8            9           10           11          12          13          14          15          16  
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Saliva Sample Collection: 
- The collection procedure will involve a 10 min sample collection period. Passive 
drool spit will be collected though a short plastic straw into a 5 ml vial.  
- To effectively provide a sample of your salivary drool you should allow saliva to 
“pool” in your mouth and then without spitting, open your mouth to drool down 
through the straw into the collection vial with your head tilted forward. 
- This method can be repeated as often as necessary until a sufficient sample of 
saliva is collected. 
- Collection tubes will be weighed before and after sample collection to determine 
flow rate and volume. 
  
Benefits from you participation 
You will receive a substantial amount of information about your physiological and 
immunological response to exercise. We will explain the implications of all results 
which include; VO2max and threshold data, Natural killer lymphocyte numbers, natural 
killer cell lysis activity, TH1/TH2/Th17 cytokines, neutrophil phagocytic function and 
respiratory burst capacity and a full blood count. Furthermore, preliminarily blood 
glucose and blood lipid measurements will be taken to measure your risk of 
cardiovascular and metabolic diseases. 
 
Information about the results of your test 
Who will use the information from your results? 
The results of your test will be confidential and contained within the people conducting 
the exercise test.  
 
Do I get a copy of my results and feedback on participation? 
You will receive your personal results and the collective results of the study of which 
the implication will be explained to you. This also provides an opportunity for you to 
ask questions.  
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E. Explanatory Statement – RO1145 
Bond University 
Faculty of Health Sciences & Medicine 
Exercise Immunology Study 
Explanatory Statement 
Immune responses to repeated bouts of exercise 
BUHREC Protocol Number:  RO-1145 
Purpose: 
Determination of Maximum Oxygen Consumption (VO2max) and measurement of 
immune markers during repeat bouts of exercise (Repeated 1.5 h Submaximal 
Exercise Tests) 
Investigator’s contact details: 
Supervisor:  Associate Professor Sonya Marshall-Gradisnik 
   Email:  s.marshall-gradisnik@griffith.edu.au 
   Phone: 0413425025 
Co-Supervisor: Assistant Professor Bon Gray 
   Email: bgray@bond.edu.au     
 Phone: 0424113284  
Co-Supervisor: Dr Michael Simmonds 
   Email: misimmon@bond.edu.au 
   Phone: 0424113284 
PhD Student: Michael Kakanis 
   Email:  mkakanis@student.bond.edu.au 
   Phone: 0421 212 534 
 
Ethics officer details: 
Caroline Carstens 
Bond University Research Ethics Committee (BUHREC) 
Email: buhrec@bond.edu.au 
Phone: 5595 4194 
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Where will the testing be conducted? 
Our testing will be conducted in the Faculty of Health Sciences and Medicine Building 
at Bond University. This building is located on the southern side of the campus. The 
Exercise Testing Laboratory is on the ground floor. 
Directions as follows:  
1. Turn into University Drive. 
2. Turn right at the second round-a-bout. 
3. Take the first left turn into the service road (Western side of University). 
4. The Faculty of Health Sciences and Medicine is located 300m down the service 
road on the left. 
5. Reception is on level 1 (Ground Floor) in the middle of the building.  
Change rooms with showers are available close to the area where the exercise testing 
program will be conducted. 
 
Overview of the testing and pre-testing 
Prior to Testing 
On each testing occasion you will be required to bring a number of items: 
 Towel 
 Water bottle 
 Cycling attire 
 Pedals 
 Cycling shoes/cleats 
Note: We have a set of Shimano pedals and a set of Look pedals, so if you have 
Shimano cleats you do not need to bring in your own pedals, however if you have 
another brand of pedals (e.g. Time, Speedplay, etc.) you will be required to bring 
them with you.  
 
In the lead up to any of the exercise tests you should avoid the following: 
 Alcohol the day before the test 
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 Caffeine the day of the test 
 A large meal in the 3 hours before the test 
 Heavy exercise the day before the test 
 
The Familiarisation Session 
Once you have arrived the Explanatory Statement, Physical Activity Readiness 
Questionnaire, Medical History and Training Questionnaires will be explained to you. If 
you still wish to participate, we will ask that you sign a consent form once all your 
questions have been answered. 
 
Lung function will be examined using a spirometer where forced vital capacity (FVC) 
will be tested to rule out pulmonary disorders.  A finger prick blood sample will be 
taken to test for cholesterol and glucose. Additionally, if cholesterol is found to be 
outside the normal range, further blood sample will be taken for blood lipids to be 
tested. Next, your height and body mass will be taken. 
 
You will have a 12 lead ECG attached to your chest that will be monitored while you 
are resting for 15 minutes. Additionally, supine/standing resting blood pressure 
measurements will be taken.  
 
Note: At any time you may asked for the test to be stopped and have no obligation to 
continue with any testing. 
 
The Familiarisation session will be conducted on a cycle ergometer (exercise bike) 
according to the American College of Sports Medicine (ACSM) Guidelines where you 
will be monitored by an exercise physiologist with extensive experience testing 
individuals with chronic disease and high-level athletes. You will be invited to sit on 
the cycle ergometer at which point another blood pressure measurement will be taken 
in your preferred exercise position. Adjustments can be made to the cycle ergometer 
seat height, handlebar height, and stem length to ensure you are comfortable. Next, a 
spirometer (oxygen mask) will be fastened to your face (with addition of a nose clip) 
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to allow you to only breathe through your mouth into the breathing apparatus. The 
test will begin once you have indicated you are ready. During the test, you will cycle 
against a series of increasing resistance levels (at 30W per minute). You will continue 
cycling on the cycle ergometer until the point your heart rate reaches 120 
beats/minute. During this test, blood pressure will be taken every 3 min and your ECG 
trace will be monitored continuously. Following reaching the resistance level 
associated with a heart rate of 120 beats/minute, you will be instructed to warm down 
while your ECG and blood pressure are monitored. You may withdraw from the test at 
any time. 
 
This session is used as a health screening session to ensure minimal risk of an adverse 
event during the exercise test, and to get you accustomed to wearing the oxygen 
mask and nose clip while exercising. This is hoped to ensure that you reach your 
maximal possible output during the VO2max test. 
 
Following Exercise 
Once you have completed the familiarisation on the cycle ergometer you will be seated 
or directed to a bed to recover and be continually monitored. After 15 min you are 
able to return home following a health check to ensure you are safe to leave the 
premises. 
 
The VO2max test will be at least 12 hours after the familiarisation. 
 
The VO2max Test 
Prior to the test 
Once you arrive you will be taken through the Physical Activity Readiness 
Questionnaire again to ensure you are safe to exercise. Your body mass will be taken 
again, and your supine blood pressure will be verified. You will also be asked if any of 
your answers have changed in your heath questionnaire. Next, you will have a 12 lead 
ECG attached to your chest and will be seated for monitoring.  
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Note: At any time you may asked for the test to be stopped and have no obligation to 
continue with any testing. 
 
Your VO2max Test 
The VO2max test will be conducted on a cycle ergometer (exercise bike) according to 
the American College of Sports Medicine (ACSM) Guidelines where you will be 
monitored by an exercise physiologist. You will then be invited to sit on the cycle 
ergometer and another blood pressure measurement will be recorded. When you are 
ready a spirometer (oxygen mask) will be fastened to your face (with addition of a 
nose clip) to allow you to only breathe through your mouth into the breathing 
apparatus. The test will begin once you have indicated you are ready. The test will 
involve you cycling against a series of increasing resistance levels (30W per minute) to 
the point at which you reach maximum oxygen output. Your blood pressure will be 
taken every 3 min during the test. This test will last approximately 15 min. Following 
reaching maximum you will be instructed to warm down while your ECG and blood 
pressure are monitored. You may withdraw from the test at any time. At all times 
during the test you must remain seated.  
You may terminate the test at any time. Alternatively, we may terminate your test if: 
o Adverse changes in your ECG and/or blood pressure are seen 
o Any signs of poor perfusion or confusion 
o Your cadence drops 15 rpm below your preferred cadence 
 
Normal and Abnormal Responses to Maximal Exercise 
During the test, it is very normal to experience increased sweatiness, heat, some 
shortness of breath (particularly towards the end of the test), and a local soreness in 
your muscles (like a burning sensation). However, it is not normal to feel tightness 
across your chest, light headedness, tingling in your fingertips, unusual joint pain, or 
unusual shortness of breath (relative to the difficulty of the exercise you are 
performing). If at any stage during the test you experience something that is 
‘unusual’, please let a researcher know immediately. It is very important that you let 
the researcher know whether something is not right with your present health. 
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Following Exercise 
Once you have completed the VO2max test you will warm down on the cycle ergometer 
while your blood pressure and ECG are continuously monitored. Once your heart rate 
has dropped to below your warm up heart rate you will allowed to sit or lay on a bed 
to recover and be continually monitored. After 30 min you are able to return home 
following a health check to ensure you are safe to leave the premises. 
 
The Repeated 1.5 hr Steady State Exercise Tests must be at least 1 day after the 
VO2max test. 
 
Health risks associated with a max test 
With the right preparation, the VO2max test is a safe procedure. However, even with 
the right preparation there is a risk that a misadventure could occur. The 
misadventure may include falling over, dizziness, heart attack and death. The 
American College of Medicine states, “exercise only provokes cardio-vascular (heart) 
events in individuals with pre-existing heart disease. Exercise does not provoke 
cardiac (heart) events in individuals with normal cardiovascular systems”. 
When you arrive at the Exercise Testing Laboratory at Bond University you will be 
asked to complete a general health questionnaire and a training questionnaire. 
Additionally a resting 12 Lead Electrocardiogram, resting blood pressure, blood glucose 
and blood lipids will be taken. 
These pre-exercise-screening procedures are intended to prepare you for the VO2max 
test and to ensure your safety and well-being during the exercise test. 
 
Exercise related cardiac events in adults 
The overall risk of exercise testing in a mixed subject population is approximately 4-6 
cardiac events per 10,000 exercise tests. Cardiac events include heart attack, very 
rapid and irregular heartbeats and death. 
With the correct pre-screening (preparation) before the VO2max, and with your 
heartbeat, heart rhythm, and blood pressure closely monitored during the VO2max test 
by an experienced exercise physiologist, the risk of cardiac misadventure is small. 
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Our strategies to minimize risk of a cardiac event 
We will minimize the risk of a cardiac (heart) event during your VO2max Test and 
Submaximal Exercise Tests by continuously monitoring you ECG and blood pressure, 
and by asking you to complete the following; 
7. A modified physical activity readiness questionnaire (PAR-Q). The PAR-Q is a 
medical questionnaire which provides preliminary information about your 
health. 
8. A medical questionnaire detailing your medical history, your family history, 
your smoking, drinking, and physical activity habits. You will also be asked 
about any drugs you may take. 
9. A training questionnaire detailing your training habits of the past year. 
 
The Exercise Trials 
Following the VO2max test you will be required to return for the two Exercise Trials 
(Single Exercise Bout Trial and Repeated Exercise Bout Trial). See Figure 1.  
The Single Exercise Bout Trial involves a single 1.5 h submaximal exercise bout 
involving blood and saliva sampling before and after exercise.   
The Repeated Exercise Bout Trial involves two 1.5 h submaximal exercise bouts 
separated by five hours involving blood and saliva sampling before and after exercise.  
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Figure 1 – Blood sampling, saliva sampling, and meal schedules during Repeated and 
Single Exercise Bout Trials 
 
The Single Exercise Bout Trial and the Repeated Exercise Bout Trial will be separated 
by at least 3 days. 
Before the day of the test 
Please follow the below guidelines in the lead up to the Exercise Trials: 
 Do not exercise at a high intensity within 2 days before the Exercise Trial 
 Do not exercise at all the day before the before the Exercise Trial 
 Do not drink alcohol the day before the Exercise Trial 
 Do not drink caffeine the day of the Exercise Trial 
 
On the day of the test 
On the day of the test, please do not eat breakfast. We will take your resting blood 
and saliva sample and then you will be fed before you begin exercising on the bike.  
Time 
Meals 
Saliva Sampling 
Single Exercise Bout Trial 
Blood Sampling 
Repeated Exercise Bout Trial 
7       8       9      10      11      12      1        2       3       4        5       6       7       8        9       10      6       7        8 
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Your 1.5 h Submaximal Exercise Tests 
The 1.5 h Submaximal Exercise Test will be conducted on a cycle ergometer according 
to the American College of Sports Medicine (ACSM) Guidelines where you will be 
monitored by a qualified exercise physiologist. You will be taken through the PAR-Q 
again to ensure you are safe to exercise. Your body mass will be taken again, and your 
supine blood pressure will be verified. You will also be asked if any of your answers 
have changed in your heath questionnaire. Next, you will have a 12 lead ECG attached 
to your chest and will be seated for monitoring.  
You will then be invited to sit on the cycle ergometer and another blood pressure 
measurement will be recorded. When you are ready a spirometer (oxygen mask) will 
be fastened to your face (with addition of a nose clip) to allow you to only breathe 
through your mouth into the breathing apparatus. The test will begin once you have 
indicated you are ready.  
 
The test will involve you cycling against a resistance level that corresponds to 90% of 
your Second Ventilatory Threshold (which corresponds to approximately 75% of your 
VO2max). The spirometer will not remain in your mouth the entire test, it will be used 
to ensure you are cycling at the correct intensity throughout; this sampling will occur 
every 20 min for approximately 4 min. Your blood pressure will be taken every 10 min 
during the test.  
  
Following Exercise 
Once you have completed each 1.5 h Submaximal Exercise Test you will be seated or 
directed to a bed to recover and be continually monitored. Blood and saliva samples 
will be collected at the time points indicated by Figure 1. 
 
Between the sampling times of immediately post-exercise to 6 h post-exercise you will 
be allowed to move around within the confines of the testing area. Entertainment, 
including television and magazines will be provided. Meals will also be provided 
throughout this period.  
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Following the sample at 6 h post-exercise you are able to return home following a 
health check to ensure you are safe to leave the premises. You will not be permitted to 
ingest alcohol or caffeine until after the 24 h blood sample.  
 
A call by the PhD Student/PI at approximately 1 h after leaving the premises will be 
made to check on you. 
 
You are required to return for a final sample to be taken 24 h post-exercise, also you 
will be required to answer a health check questionnaire to ensure it is safe for you to 
leave the premises. 
 
You will not be permitted to exercise between any of the blood samples (i.e. Pre-
exercise to 24 hours post-exercise). 
 
 
Blood Sampling 
During both Exercise Trials blood samples will be taken at 9 time points (see Figure 1). 
The pre-exercise, immediately post-exercise and 24 h post-exercise samples will be 
taken by venepuncture. Samples from 1 h to 6 h post-exercise will be taken via 
cannulation. All blood samples will be collected by a qualified phlebotomist.  
 
Passive Drool 
A passive drool will be taken at 9 time points (see Figure 1). This 10 min passive drool 
will be used to test for a number of different immune variables in saliva. This can be 
quite an awkward process and thus it is recommended you follow these instructions to 
obtain the best and most efficient sample.  
 
Prior to Collection:  
 Do not eat a major meal within 60 min prior to sample collection 
 Avoid alcohol consumption 24 hours prior to sample collection. 
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 Avoid eating dairy productions during the 30 min prior to sample collection 
 Avoid acidic (e.g. Cola drinks) or high sugar foods and drinks (eg. 
Confectionary, sports drinks, or soft drinks) during 60 min prior to sample 
collection 
 Do not brush your teeth within 2 hours of sample collection. 
 Wash your mouth out with water 10 min prior to giving sample. 
 
Saliva Sample Collection: 
 Before you begin collection, first swallow any saliva to empty the mouth 
 The collection procedure will involve a 10 min sample collection period. Passive 
drool spit will be collected into a 5 ml vial 
 To effectively provide a sample of your salivary drool you should allow saliva to 
“pool” in your mouth and then without spitting, open your mouth to drool into 
the collection vial with your head tilted forward 
 It is requested that you make minimal olfactory movements (i.e. chewing, etc.) 
 This method can be repeated as often as necessary until a sufficient sample of 
saliva is collected within the 10 min period 
 Collection tubes will be weighed before and after sample collection to determine 
flow rate and volume. 
  
Benefits from you participation 
You will receive a substantial amount of information about your physiological and 
immunological responses to exercise. We will explain the implications of all results 
which include; VO2max and threshold data, markers of immune function in the 
respiratory tract, saliva, and blood. Furthermore, preliminarily blood glucose and blood 
lipid measurements will be taken to measure your risk of cardiovascular and metabolic 
diseases. 
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Information about the results of your test 
Who will use the information from your results? 
The results of your test will be confidential and contained within the people conducting 
the exercise test.  
 
Do I get a copy of my results and feedback on participation? 
You will receive your personal results and the collective results of the study of which 
the implication will be explained to you. This also provides an opportunity for you to 
ask questions.  
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F. Consent Form – RO955 (2009) – Study I 
Bond University 
Faculty of Health Sciences & Medicine 
Exercise Immunology Study 
 
Consent Form 
 
Title:  VO2max Test and 2hrs at 70% VO2max Test:  
 
Important 
 
The signing of this Consent Form is a very important part of your participation.  The signed Consent 
Form is a legal document. 
By signing the Consent Form, you are indicating that you clearly understand what we are asking 
you to do in the VO2max test and 2hrs at 70% VO2max test.   
By signing the Consent Form, you are giving us your permission to proceed with the VO2max test 
and 2hrs at 70% VO2max test and with the procedures that we have listed in the Explanatory 
Statement. 
By signing the Consent Form, you are indicating that you have read the Explanatory Statement, 
that you clearly understand what is being asked of you and that you have had all your questions 
about the project answered to your satisfaction. 
Having signed the Consent Form, you can still withdraw from the VO2max test and 2hrs at 70% 
VO2max test at any time.  You can still ask questions about any aspect of the both tests at any time. 
By signing the Consent Form, you are not waiving your rights to legal action or legal representation.  
We can still be sued for negligence. 
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The Formal Giving of Your Consent to participate in the: VO2max test and 2hrs at 70% 
VO2max test:  
Please carefully read each statement below. If you agree with each statement [(i)to(x)], would 
you place your  initials in the box next to each statement to indicate that you understand and 
agree with the statement. 
 
i. I have read the Explanatory Statement for the VO2max test and 2hrs at 70% 
VO2max test. 
Please initial in the box if you agree with the Statement (i)  
 
ii. I understand what is being asked of me and I have had all my questions about 
the VO2max test and 2hrs at 70% VO2max test answered to my satisfaction. 
Please initial in the box if you agree with the Statement (ii)  
 
iii. I have read the section in the Explanatory Statement about the risks involved 
with my participation in the VO2max test and 2hrs at 70% VO2max test. I clearly 
understand the risks to my health and life by participating in the VO2max test and 
2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (iii)  
  
iv. I have been told and accept the potential benefits that are expected from my 
participation in the VO2max test and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (iv)  
 
v. I understand that my results and personal information will remain confidential. 
Please initial in the box if you agree with the Statement (v)  
 
vi. I understand that I will receive feedback on my performance in the VO2max test 
and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (vi)   
 
vii. I understand that the VO2max test and 2hrs at 70% VO2max test will be carried out 
as described in the Explanatory Statement, and on that basis, I agree to 
participate in the VO2max test and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (vii)   
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viii. I understand that you will give me a copy of the Explanatory Statement and a 
copy of my signed Consent Form.  
Please initial in the box if you agree with the Statement (viii)   
 
ix. I understand that my participation is voluntary; that I can choose not to 
participate in the VO2max test and 2hrs at 70% VO2max test, and that I can 
withdraw freely at any stage from the VO2max test and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (ix)   
 
x. I have read the information about the taking of my blood and saliva and 
understand what is required of me to give a sample pre- the 2hrs at 70% VO2max 
test immediately post, 2hrs, 4hrs, 6hrs, 8hrs, and 24hrs post 2hrs at 70% VO2max 
test.  
Please initial in the box if you agree with the Statement (x)   
 
If you have initialled all boxes (i-x), would you sign in the space below indicating that you give 
us your consent for you to participate in the VO2max test and 2hrs at 70% VO2max test. 
 
Name of Participant  
 
Signature of Participant 
 
Date  
 
Witness to Signature 
 
Name  
 
Signature of Witness 
 
Date  
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G. Consent Form – RO955 (Amended 2011) - Study II 
 
Bond University 
Faculty of Health Sciences & Medicine 
Exercise Immunology Study 
 
Consent Form 
 
Title:  VO2max Test and 2hrs at 70% VO2max Test:  
 
Important 
 
The signing of this Consent Form is a very important part of your participation.  The 
signed  Consent Form is a legal document. 
By signing the Consent Form, you are indicating that you clearly understand what we 
are asking you to do in the VO2max test and 2hrs at 70% VO2max test.   
By signing the Consent Form, you are giving us your permission to proceed with the 
VO2max test and 2hrs at 70% VO2max test and with the procedures that we have listed in 
the Explanatory Statement. 
By signing the Consent Form, you are indicating that you have read the Explanatory 
Statement, that you clearly understand what is being asked of you and that you have 
had all your questions about the project answered to your satisfaction. 
Having signed the Consent Form, you can still withdraw from the VO2max test and 2hrs 
at 70% VO2max test at any time.  You can still ask questions about any aspect of the both 
tests at any time. 
By signing the Consent Form, you are not waiving your rights to legal action or legal 
representation.  We can still be sued for negligence. 
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The Formal Giving of Your Consent to Participate in the: VO2max test and 2hrs 
at 70% VO2max test:  
Would you carefully read each statement below? If you agree with each 
statement [(i)to(x)], would you place your  initials in the box next to each 
statement to indicate that you understand and agree with the statement. 
xi. I have read the Explanatory Statement for the VO2max test and 2hrs at 
70% VO2max test. 
Please initial in the box if you agree with the Statement (i)  
 
xii. I understand what is being asked of me and I have had all my questions 
about the VO2max test and 2hrs at 70% VO2max test answered to my 
satisfaction. 
Please initial in the box if you agree with the Statement (ii)  
 
 
xiii. I have read the section in the Explanatory Statement about the risks 
involved with my participation in the VO2max test and 2hrs at 70% VO2max 
test. I clearly understand the risks to my health and life by participating 
in the VO2max test and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (iii)   
 
xiv. I have been told and accept the potential benefits that are expected from 
my participation in the VO2max test and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (iv)  
 
xv. I understand that my results and personal information will remain 
confidential. 
Please initial in the box if you agree with the Statement (v)   
 
xvi. I understand that I will receive feedback on my performance in the 
VO2max test and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (vi)   
 
xvii. I understand that the VO2max test and 2hrs at 70% VO2max test will be 
carried out as described in the Explanatory Statement, and on that basis, 
I agree to participate in the VO2max test and 2hrs at 70% VO2max test. 
Please initial in the box if you agree with the Statement (vii)   
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xviii. I understand that you will give me a copy of the Explanatory Statement 
and a copy of my signed Consent Form.  
Please initial in the box if you agree with the Statement (viii)   
 
xix. I understand that my participation is voluntary; that I can choose not to 
participate in the VO2max test and 2hrs at 70% VO2max test, and that I can 
withdraw freely at any stage from the VO2max test and 2hrs at 70% 
VO2max test. 
Please initial in the box if you agree with the Statement (ix)   
 
xx. I have read the information about the taking of my blood and understand 
what is required of me to give a blood sample pre- the 2hrs at 70% 
VO2max test immediately post, 1hr, 2hrs, 4hrs, and 6hrs post 2hrs at 70% 
VO2max test.  
Please initial in the box if you agree with the Statement (x)   
 
If you have initialled all boxes (i-x), would you sign in the space below indicating that 
you give us your consent for you to participate in the VO2max test and 2hrs at 70% 
VO2max test. 
 
Name of Participant  
Signature of Participant 
Date  
 
Witness to Signature 
Name   
Signature of Witness 
Date 
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H. Consent Form – RO1145 
Bond University 
Faculty of Health Sciences & Medicine 
Exercise Immunology Study 
 
Consent Form 
Immune responses to repeated bouts of exercise 
BUHREC Protocol Number:  RO-1145 
 
Important 
The signing of this Consent Form is a very important part of your participation.  The 
signed Consent Form is a legal document. 
By signing the Consent Form, you are indicating that you clearly understand what we 
are asking you to do in the VO2max Test and the Repeated 1.5 h Submaximal Exercise 
Tests. 
By signing the Consent Form, you are giving us your permission to proceed with testing 
your VO2max and immune markers during Repeated 1.5 h Submaximal Exercise Tests 
with the procedures that we have listed in the Explanatory Statement. 
By signing the Consent Form, you are indicating that you have read the Explanatory 
Statement, that you clearly understand what is being asked of you and that you have 
had all your questions about the project answered to your satisfaction. 
Having signed the Consent Form, you can still withdraw from the VO2max test and 
Repeated 1.5 h Submaximal Exercise Tests at any time.  You can still ask questions 
about any aspect of the both tests at any time. 
By signing the Consent Form, you are not waiving your rights to legal action or legal 
representation.  We can still be sued for negligence. 
 
 
 
 
 
 336 
 
The Formal Giving of Your Consent to Participate in the: Determination of 
Maximum Oxygen Consumption (VO2max) and measurement of immune markers during 
repeat bouts of exercise (Repeated 1.5 h Submaximal Exercise Tests).  
 
Please carefully read each statement below. 
If you agree with each statement [(i) to (x)], would you place your initials in the 
box next to each statement, to indicate that you understand and agree with the 
statement. 
xxi. I have read the Explanatory Statement for the VO2max test and immune 
markers during repeat bouts of exercise (Repeated 1.5 h Submaximal Exercise 
Tests) 
Please initial in the box if you agree with the Statement (i)  
 
xxii. I understand what is being asked of me and I have had all my questions 
answered about the VO2max test and immune markers during repeat bouts of 
exercise (Repeated 1.5 h Submaximal Exercise Tests) 
Please initial in the box if you agree with the Statement (ii)  
 
 
xxiii. I have read the section in the Explanatory Statement about the risks involved 
with my participation in the VO2max test and immune markers during repeat 
bouts of exercise (Repeated 1.5 h Submaximal Exercise Tests). I clearly 
understand the risks to my health and life by participating in these tests. 
Please initial in the box if you agree with the Statement (iii)   
 
xxiv. I have been told and accept the potential benefits that are expected from my 
participation in the VO2max test and immune markers during repeat bouts of 
exercise (Repeated 1.5 h Submaximal Exercise Tests). 
Please initial in the box if you agree with the Statement (iv)  
 
xxv. I understand that my results and personal information will remain confidential. 
Please initial in the box if you agree with the Statement (v)   
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xxvi. I understand that I will receive feedback on my performance in the VO2max test 
and immune markers during repeat bouts of exercise (Repeated 1.5 h 
Submaximal Exercise Tests). 
Please initial in the box if you agree with the Statement (vi)   
 
xxvii. I understand that the VO2max test and immune markers during repeat bouts of 
exercise (Repeated 1.5 h Submaximal Exercise Tests) will be carried out as 
described in the Explanatory Statement, and on that basis, I agree to participate 
in the VO2max test and immune markers during repeat bouts of exercise (Repeated 
1.5 h Submaximal Exercise Tests). 
Please initial in the box if you agree with the Statement (vii)   
 
xxviii. I understand that you will give me a copy of the Explanatory Statement and a 
copy of my signed Consent Form.  
Please initial in the box if you agree with the Statement (viii)   
 
xxix. I understand that my participation is voluntary; that I can choose not to 
participate in the VO2max test and immune markers during repeat bouts of 
exercise (Repeated 1.5 h Submaximal Exercise Tests), and that I can withdraw 
freely at any stage from these tests. 
Please initial in the box if you agree with the Statement (ix)   
 
xxx. I have read the information about the taking of my blood and saliva and 
understand what is required of me to give a blood and saliva sample before the 
familiarisation session, before each 1.5 h Submaximal Exercise Tests, 
immediately post-, 1 h, 2 h, 4 h, 6 and 24 h post-exercise.  
Please initial in the box if you agree with the Statement (x)   
 
If you have initialled all boxes (i-x), would you sign in the space below indicating that 
you give us your consent for you to participate in the VO2max Test and measurement 
of immune markers during repeat bouts of exercise (Repeated 1.5 h Submaximal 
Exercise Tests). 
Name of Participant  
Signature of Participant 
Date  
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I. Medical History Questionnaire 
 
RISK STRATIFICATION MATRIX 
 
POSITIVE RISK FACTORS  DEFINING CRITERIA 
Age    Men ≥45 yr; Women ≥55 yr 
Family History Myocardial infarction, coronary revascularisation, or sudden death 
before 55 yr of age in father or other male first-degree relative, or 
before 65 yr of age in mother or other female first degree relative 
Cigarette smoking Current cigarette smoker or those who quit within the previous 6 
months or exposure to environmental tobacco smoke 
Sedentary lifestyle Not participating in at least 30 min of moderate intensity (40%−60% 
VO2max) physical activity on at least three days of the week for at least 
three months  
Obesitya Body mass index ≥30 kg.m2 or waist girth >102 cm for men and >88 cm 
for women 
Hypertension Systolic blood pressure ≥140 mmHg and/or diastolic ≥90 mm Hg, 
confirmed by measurements on at least two separate occasions, or on 
antihypertensive medication  
Dyslipidemia Low-density lipoprotein (LDL-C) cholesterol ≥130 mg.dL-1 (3.37 mmol.L-
1) or high-density lipoprotein (HDL-C) cholesterol <40 mg.dL-1 (1.04 
mmol.L-1) or on lipid-lowering medication. If total serum cholesterol is 
all that is available use ≥200 mg.dL-1 (5.18 mmol.L-1) 
Prediabetes Impaired fasting glucose (IFG) = fasting plasma glucose ≥100 mg.dL-1 
(5.5 mmol.L-1) but <126 mg.dL-1 (6.93 mmol.L-1) or impaired glucose 
tolerance (IGT) = 2-hour values in oral glucose tolerance test (OGTT) 
≥140 mg.dL-1 (7.70 mmol.L-1) but <200 mg.dL-1 (11.00 mmol.L-1) 
 
 
NEGATIVE RISK FACTORS DEFINING CRITERIA 
High-serum HDL cholesterol ≥60 mg.dL-1 (1.55 mmol.L-1) 
 
Note: It is common to sum risk factors in making clinical judgements. If HDL is high, subtract one risk factor from the 
sum of positive risk factors, because high HDL decreases CVD risk. 
a Professional opinions vary regarding the most appropriate markers and thresholds for obesity; therefore, allied health 
professionals should use clinical judgement when evaluating this risk factor.  
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KNOWN CARDIOVASCULAR, PULMONARY, OR METABOLIC DISEASE 
Cardiovascular  Cardiac, peripheral vascular, or cerebrovascular disease 
Pulmonary  COPD, asthma, interstitial lung disease, or cystic fibrosis 
Metabolic  Diabetes mellitus, (types 1 and 2), thyroid disorders, renal or liver disease 
 
MAJOR SIGNS OR SYMPTOMS SUGGESTIVE OF CARDIOVASCULAR, PULMONARY, OR METABOLIC DISEASE 
o Pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from ischemia 
o Shortness of breath at rest or with mild exertion 
o Dizziness or syncope 
o Orthopnea or paroxysmal nocturnal dyspnea 
o Ankle oedema 
o Palpitations or tachycardia 
o Intermittent claudications 
o Known heart murmur 
o Unusual fatigue or shortness of breath with usual activities 
 
RISK STRATIFICATION CATEGORIES 
1. Low risk  Individuals who are asymptomatic and meet no more than one risk factor 
threshold 
 
2. Moderate risk Those who are asymptomatic who meet the threshold for two or more risk 
factors 
 
3. High risk  Individuals with one or more signs or symptoms suggestive of, or individuals with
  known cardiovascular, pulmonary, or metabolic disease 
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J. Exercise History Questionnaire 
 
Bond University 
Faculty of Health Sciences & Medicine 
Exercise Immunology Study 
Training Questionnaire 
Criteria to be used 
 
Subject Inclusion criteria: 
 
1. Males aged 18-35 years 
2. A minimum of 1 year cycling racing experience. 
Currently racing in Elite A and/or A Grade club racing. 
3. Health Insurance (i.e. Australian residence and/or citizens).  
 
Subject Exclusion Criteria:  
 
1. Contraindications or risk to exercise (recent injuries and/or overt 
contraindicators for performing maximal exercise as defined by 
risk stratification matrix).  
2. Thyroid and/or other autoimmune disease 
3. Primary or secondary immune deficiency 
 
If you are unsure about any of the following questions please seek 
clarification before responding. 
 
Subjects name:  
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1. On average over the past 3 months, approximately how many kilometres per 
week have you trained? 
    
 
2. On average how many sessions per week do you train? 
 
3. Do you compete in any other sport competitively?  YES  NO 
 
Sport: 
If so, what is you training/competition regime? 
 
 
 
4. Approximately how often do you compete in cycling races (For example, once 
a week/once a month/etc.)? Please include the type of racing (e.g. 
criteriums/road races/time trials/triathlon/mountain biking) 
 
 
 
5. How many years have you been competing in cycle racing? 
 
 
6. Please specify your current racing Grades? 
 
Club level: 
 
Open Grading: 
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7. Are you currently suffering from any chronic (long-term) injury that you feel 
may affect your ability to reach maximum outputs on a bike? Give details if 
relevant: 
 
 
8. Do you use any nutritional supplements?     YES  NO 
 
Please specify (such as vitamin C, multivitamin, protein powder, etc.) 
 
 
9. Do you have a thyroid disorder, or any other autoimmune disorder (such as 
Type I Diabetes/Addison’s Disease)?     
YES  NO 
10. Do you a primary (such as selective IgA deficiency) or secondary (such as 
Hepatitis, HIV) immune deficiencies?   
          YES  NO 
11. Family History – Indicate if any of your immediate family (grandparents, 
parents, brothers, sisters) have experienced any of the following (list their 
age and relationship to you): 
 
Relationship and Age    
   
Heart Disease 
 
Stroke 
 
Diabetes 
 
Cancer 
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12. Do you have Health Insurance?     YES  NO 
 
Emergency Contact Form 
In case of emergency I authorise the research team, or a representative 
thereof, to contact the following persons. 
Person One 
Name: 
Relationship: 
Phone Number (s): 
Person Two 
Name: 
Relationship: 
Phone Number (s): 
 
I have provided a truthful response to all of these questions. 
 
 
Signed:       Date: 
 
  
 345 
K. Physical Activity Readiness Questionnaire  
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L. Individual Subject Characteristics – Study I 
 
Study I 
  
Age 
  
Height 
  
Body 
Mass 
  
BMI 
  
FVC 
  
FEV1 
  
FEV1/FVC 
  
Supine 
HR 
Supine 
Systolic 
BP 
Supine 
Diastolic 
BP 
  
Training 
Absolute  
VO2peak 
Relative 
VO2peak Subject 
1 23 1.86 73.50 21.15 6.46 5.18 80.12 42 130 74 250 4.61 62.7 
2 18 1.87 74.20 21.26 6.26 4.95 79.02 48 120 80 450 4.41 59.4 
3 22 1.82 71.10 21.54 5.92 4.85 82.00 50 124 80 275 5.35 75.3 
4 26 1.93 88.70 23.86 6.43 5.21 81.02 45 110 66 350 4.97 56 
5 19 1.78 67.10 21.08 5.54 4.67 84.23 53 110 70 300 4.76 70.9 
6 34 1.75 64.50 21.18 5.46 4.27 78.12 41 110 68 400 4.87 75.5 
7 24 1.80 72.80 22.57 5.69 4.91 86.21 45 120 80 300 5.26 72.3 
8 20 1.80 74.50 22.89 5.74 4.61 80.30 57 118 74 150 4.37 58.7 
9 24 1.72 73.90 24.86 5.45 4.36 79.93 43 128 68 250 4.79 64.8 
10 32 1.92 77.60 21.16 6.84 5.56 81.29 36 122 76 200 4.92 63.5 
                            
Mean 24.20 1.82 73.79 22.16 5.98 4.85 81.22 46.00 119.20 73.60 292.50 4.83 65.91 
SD 5.27 0.07 6.47 1.34 0.49 0.40 2.42 6.16 7.32 5.40 89.79 0.32 7.12 
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M. Individual Subject Characteristics – Study II 
Subject Age Height 
Body 
mass BMI 
Fasting 
Glucose HDL LDL 
Total 
Chol. 
HDL/ 
Chol. FVC FEV1 
FEV1/ 
FVC 
Supine 
HR 
Supine 
Systolic 
Supine 
Diastolic 
1 31 1.79 70.9 22.13 4.4 1.72 2.28 4.03 0.43 6.06 4.87 80.36 42 130 74 
2 22 1.79 67.5 21.07 4.8 0.94 2.55 3.42 0.27 5.43 4.39 80.85 48 120 80 
3 30 1.79 80.8 25.22 4.5 1.04 4.19 4.68 0.22 6.5 5.27 81.08 50 124 80 
4 20 1.77 76 24.26 5.4 1.16 4.03 3.13 0.37 5.72 4.97 86.89 45 110 66 
5 24 1.81 70.7 21.58 4.6 1.7 3.1 5 0.34 5.76 4.99 86.63 53 110 70 
6 26 1.93 81.6 21.91 4.7 1.24 2.27 2.87 0.43 6.6 5.28 80.00 41 110 68 
7 18 1.81 72.2 22.04 3.3 0.84 2.9 2.65 0.32 5.3 4.42 83.40 45 120 80 
8 23 1.79 65.3 20.38 3.8 1.19 1.69 3.37 0.35 6.24 5.12 82.05 57 118 74 
9 24 1.87 79.3 22.68 4.2 1.29 4.16 5.74 0.22 7.36 5.03 68.34 43 128 68 
10 22 1.76 68.4 22.08 4.3 1.5 1.87 2.77 0.54 5.8 4.7 81.03 36 122 76 
Mean 24.00 1.81 73.27 22.33 4.40 1.26 2.90 3.77 0.35 6.08 4.90 81.06 46.00 119.20 73.60 
SD 4.08 0.05 5.81 1.43 0.57 0.30 0.94 1.06 0.10 0.62 0.31 5.11 6.16 7.32 5.40 
 
Subject Training 
Absolute 
VO2peak 
Relative 
VO2peak 
Peak 
Power 
Peak 
W/kg 
VT1 
Power 
VT1 
W/kg 
VT2 
Power 
VT2 
W/kg 
Mean 
HR 
Mean 
VO2 
Mean 
Cadence 
Mean 
Power 
1 480 4.71 66.43 505 7.12 300 4.23 345 4.87 141.07 3.375 100.2 315 
2 400 4.46 66.07 405 6.00 278 4.11 330 4.89 163.56 3.537 98.7 280 
3 350 4.74 58.66 465 5.75 330 4.08 353 4.36 156.84 3.582 95.9 300 
4 300 4.74 62.37 435 5.72 270 3.55 338 4.44 140.43 3.5415 92.8 285 
5 300 4.66 65.91 450 6.36 300 4.24 383 5.41 174.95 3.6225 90.9 315 
6 300 5.03 61.64 522 6.40 330 4.04 405 4.96 142.15 3.9645 91.6 330 
7 350 4.17 57.76 420 5.82 263 3.64 323 4.47 157.97 3.1635 96.2 285 
8 350 3.90 59.72 405 6.20 270 4.13 330 5.05 150.18 3.123 95.6 285 
9 350 4.18 52.71 435 5.49 285 3.59 338 4.26 158.22 3.1545 94 290 
10 300 3.82 55.85 410 5.99 245 3.58 320 4.68 152.18 2.907 87.5 275 
Mean 348.00 4.44 60.71 445.20 6.09 287.00 3.92 346.25 4.74 153.76 3.40 94.34 296.00 
SD 57.12 0.40 4.64 41.10 0.47 28.03 0.29 27.37 0.36 10.96 0.31 3.79 18.23 
 350 
 
 
